# EDGAR Filing Document

**Accession Number:** 0001868419
**File Stem:** 0001868419-25-000020
**Filing Date:** 2025-11
**Character Count:** 247181
**Document Hash:** a64f586484470e9f98fbcb6d9cccc3f3
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001868419-25-000020.hdr.sgml**: 20251114

**ACCESSION NUMBER**: 0001868419-25-000020

**CONFORMED SUBMISSION TYPE**: 10-Q

**PUBLIC DOCUMENT COUNT**: 96

**CONFORMED PERIOD OF REPORT**: 20250930

**FILED AS OF DATE**: 20251114

**DATE AS OF CHANGE**: 20251114

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Cycurion, Inc.
- **CENTRAL INDEX KEY:** 0001868419
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-COMPUTER PROGRAMMING SERVICES [7371]
- **ORGANIZATION NAME:** 06 Technology
- **EIN:** 863720717
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 10-Q
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-41214
- **FILM NUMBER:** 251486887

**BUSINESS ADDRESS:**
- **STREET 1:** 1640 BORO PLACE, FOURTH FLOOR
- **CITY:** MCLEAN
- **STATE:** VA
- **ZIP:** 22102
- **BUSINESS PHONE:** 888-341-6680

**MAIL ADDRESS:**
- **STREET 1:** 1640 BORO PLACE, FOURTH FLOOR
- **CITY:** MCLEAN
- **STATE:** VA
- **ZIP:** 22102

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Western Acquisition Ventures Corp.
- **DATE OF NAME CHANGE:** 20210617

?xml version='1.0' encoding='ASCII'? cycu-20250930

**<u>[Table of Content](#i20cde463f9bc41bd8d781febc1d65735_7)[s](#i20cde463f9bc41bd8d781febc1d65735_7)</u>**

**UNITED STATES**

**SECURITIES AND COMMISSION**

**Washington, D.C. 20549**

**FORM 10-Q**

☒ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

**For the quarterly period ended: September 30, 2025**

☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

**For the transition period from __________ to __________**

**Commission File Number: 001-41214**

![Image_1.jpg](cycu-20250930_g1.jpg)

---

| | |
|:---|:---|
| **Cycurion, Inc.** | **Cycurion, Inc.** |
| *(Exact name of registrant as specified in its charter)* | *(Exact name of registrant as specified in its charter)* |
| Delaware | 86-3720717 |
| (State or other jurisdiction<br>of incorporation or organization) | (I.R.S. Employer<br>Identification No.) |
| 1640 Boro Place, Suite 420C, McLean, VA | 22102 |
| (Address of principal executive office) | (Zip Code) |
| (888) 341-6680 | (888) 341-6680 |
| Registrant's telephone number, including the area code) | Registrant's telephone number, including the area code) |

---

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered |
| Common stock, par value $0.0001 per share | CYCU | The NASDAQ Stock Market LLC |
| Redeemable warrants, each exercisable for one share of common stock at an exercise price of $345.00 per share | CYCUW | The NASDAQ Stock Market LLC |

---

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.

Large accelerated filer ☐ Accelerated filer ☐ Non-accelerated filer ☒ <br> Smaller reporting company ☒ Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes ☐ No ☒

As of November 7, 2025, there were 2,712,489 shares of common stock outstanding.

------

**<u>[Table of Content](#i20cde463f9bc41bd8d781febc1d65735_7)[s](#i20cde463f9bc41bd8d781febc1d65735_7)</u>**

---

| | | |
|:---|:---|:---|
| **Table of Contents to Third Quarter 2025 Form 10-Q** | **Table of Contents to Third Quarter 2025 Form 10-Q** | |
| **<u>[Part I - FINANCIAL INFORMATION](#i20cde463f9bc41bd8d781febc1d65735_10)</u>** | **<u>[Part I - FINANCIAL INFORMATION](#i20cde463f9bc41bd8d781febc1d65735_10)</u>** | [3](#i20cde463f9bc41bd8d781febc1d65735_10) |
| [Item 1.](#i20cde463f9bc41bd8d781febc1d65735_13) | <u>[Financial Statements - (Unaudited)](#i20cde463f9bc41bd8d781febc1d65735_13)</u> | [3](#i20cde463f9bc41bd8d781febc1d65735_13) |
|  | <u>[Consolidated Balance Sheets](#i20cde463f9bc41bd8d781febc1d65735_16)</u> | [3](#i20cde463f9bc41bd8d781febc1d65735_16) |
|  | <u>[Consolidated Statements of Operations and Comprehensive (Loss)/Income](#i20cde463f9bc41bd8d781febc1d65735_19)</u> | [4](#i20cde463f9bc41bd8d781febc1d65735_19) |
|  | <u>[Consolidated Statements of Cash Flows](#i20cde463f9bc41bd8d781febc1d65735_22)</u> | [5](#i20cde463f9bc41bd8d781febc1d65735_22) |
|  | <u>[Consolidated Statements of Changes in Stockholders' Equity](#i20cde463f9bc41bd8d781febc1d65735_25)</u> | [6](#i20cde463f9bc41bd8d781febc1d65735_25) |
|  | <u>[Notes to the Unaudited Consolidated Financial Statements](#i20cde463f9bc41bd8d781febc1d65735_28)</u> | [7](#i20cde463f9bc41bd8d781febc1d65735_28) |
|  | &nbsp;&nbsp;&nbsp;&nbsp;<u>[1. Organization and Description of Business](#i20cde463f9bc41bd8d781febc1d65735_31)</u> | [7](#i20cde463f9bc41bd8d781febc1d65735_31) |
|  | &nbsp;&nbsp;&nbsp;&nbsp;<u>[2. Significant Accounting Policies](#i20cde463f9bc41bd8d781febc1d65735_34)</u> | [9](#i20cde463f9bc41bd8d781febc1d65735_34) |
|  | &nbsp;&nbsp;&nbsp;&nbsp;<u>[3. Accounts Receivable, Net](#i20cde463f9bc41bd8d781febc1d65735_37)</u> | [13](#i20cde463f9bc41bd8d781febc1d65735_37) |
|  | &nbsp;&nbsp;&nbsp;&nbsp;<u>[4. Property and Equipment, Net](#i20cde463f9bc41bd8d781febc1d65735_40)</u> | [13](#i20cde463f9bc41bd8d781febc1d65735_40) |
|  | &nbsp;&nbsp;&nbsp;&nbsp;<u>[5. Software Development Costs](#i20cde463f9bc41bd8d781febc1d65735_43)</u> | [13](#i20cde463f9bc41bd8d781febc1d65735_43) |
|  | &nbsp;&nbsp;&nbsp;&nbsp;<u>[6. Intangible Assets](#i20cde463f9bc41bd8d781febc1d65735_46)</u> | [14](#i20cde463f9bc41bd8d781febc1d65735_46) |
|  | &nbsp;&nbsp;&nbsp;&nbsp;<u>[7. Business Combination](#i20cde463f9bc41bd8d781febc1d65735_49)</u> | [14](#i20cde463f9bc41bd8d781febc1d65735_49) |
|  | &nbsp;&nbsp;&nbsp;&nbsp;<u>[8. Goodwill](#i20cde463f9bc41bd8d781febc1d65735_52)</u> | [16](#i20cde463f9bc41bd8d781febc1d65735_52) |
|  | &nbsp;&nbsp;&nbsp;&nbsp;<u>[9. Bank Loans](#i20cde463f9bc41bd8d781febc1d65735_55)</u> | [18](#i20cde463f9bc41bd8d781febc1d65735_55) |
|  | &nbsp;&nbsp;&nbsp;&nbsp;<u>[10. Loans Payable](#i20cde463f9bc41bd8d781febc1d65735_58)</u> | [20](#i20cde463f9bc41bd8d781febc1d65735_58) |
|  | &nbsp;&nbsp;&nbsp;&nbsp;<u>[11. Convertible Notes](#i20cde463f9bc41bd8d781febc1d65735_61)</u> | [21](#i20cde463f9bc41bd8d781febc1d65735_61) |
|  | &nbsp;&nbsp;&nbsp;&nbsp;<u>[12. Promissory Notes](#i20cde463f9bc41bd8d781febc1d65735_64)</u> | [21](#i20cde463f9bc41bd8d781febc1d65735_64) |
|  | &nbsp;&nbsp;&nbsp;&nbsp;<u>[13. Factoring Liability](#i20cde463f9bc41bd8d781febc1d65735_67)</u> | [22](#i20cde463f9bc41bd8d781febc1d65735_67) |
|  | &nbsp;&nbsp;&nbsp;&nbsp;<u>[14. Series A Convertible Preferred Stock](#i20cde463f9bc41bd8d781febc1d65735_70)</u> | [22](#i20cde463f9bc41bd8d781febc1d65735_70) |
|  | &nbsp;&nbsp;&nbsp;&nbsp;<u>[15. Equity](#i20cde463f9bc41bd8d781febc1d65735_73)</u> | [22](#i20cde463f9bc41bd8d781febc1d65735_73) |
|  | &nbsp;&nbsp;&nbsp;&nbsp;<u>[16. Concentrations, Risks and Uncertainties](#i20cde463f9bc41bd8d781febc1d65735_76)</u> | [31](#i20cde463f9bc41bd8d781febc1d65735_76) |
|  | &nbsp;&nbsp;&nbsp;&nbsp;<u>[17. Fair Value Disclosures](#i20cde463f9bc41bd8d781febc1d65735_79)</u> | [32](#i20cde463f9bc41bd8d781febc1d65735_79) |
|  | &nbsp;&nbsp;&nbsp;&nbsp;<u>[18. Related Party Transactions](#i20cde463f9bc41bd8d781febc1d65735_82)</u> | [33](#i20cde463f9bc41bd8d781febc1d65735_82) |
|  | &nbsp;&nbsp;&nbsp;&nbsp;<u>[19. Earnings Per Share](#i20cde463f9bc41bd8d781febc1d65735_85)</u> | [34](#i20cde463f9bc41bd8d781febc1d65735_85) |
|  | &nbsp;&nbsp;&nbsp;&nbsp;<u>[20. Commitments and Contingencies](#i20cde463f9bc41bd8d781febc1d65735_88)</u> | [34](#i20cde463f9bc41bd8d781febc1d65735_88) |
|  | &nbsp;&nbsp;&nbsp;&nbsp;<u>[21. Subsequent Events](#i20cde463f9bc41bd8d781febc1d65735_91)</u> | [39](#i20cde463f9bc41bd8d781febc1d65735_91) |
| [Item 2.](#i20cde463f9bc41bd8d781febc1d65735_94) | <u>[Management's Discussion and Analysis of Financial Condition and Results of Operations](#i20cde463f9bc41bd8d781febc1d65735_94)</u> | [41](#i20cde463f9bc41bd8d781febc1d65735_94) |
|  | <u>[Forward-Looking Statements](#i20cde463f9bc41bd8d781febc1d65735_97)</u> | [41](#i20cde463f9bc41bd8d781febc1d65735_97) |
|  | <u>[General and Business Overview](#i20cde463f9bc41bd8d781febc1d65735_100)</u> | [42](#i20cde463f9bc41bd8d781febc1d65735_100) |
|  | <u>[Financial Overview](#i20cde463f9bc41bd8d781febc1d65735_103)</u> | [45](#i20cde463f9bc41bd8d781febc1d65735_103) |
|  | <u>[Results of Operations](#i20cde463f9bc41bd8d781febc1d65735_106)</u> | [45](#i20cde463f9bc41bd8d781febc1d65735_106) |
|  | <u>[Liquidity and Capital Resources](#i20cde463f9bc41bd8d781febc1d65735_109)</u> | [46](#i20cde463f9bc41bd8d781febc1d65735_109) |
|  | <u>[Critical Accounting Policies and Estimates](#i20cde463f9bc41bd8d781febc1d65735_112)</u> | [47](#i20cde463f9bc41bd8d781febc1d65735_112) |
| [Item 3.](#i20cde463f9bc41bd8d781febc1d65735_115) | <u>[Quantitative and Qualitative Disclosures about Market Risk](#i20cde463f9bc41bd8d781febc1d65735_115)</u> | [48](#i20cde463f9bc41bd8d781febc1d65735_115) |
| [Item 4.](#i20cde463f9bc41bd8d781febc1d65735_118) | <u>[Controls and Procedures](#i20cde463f9bc41bd8d781febc1d65735_118)</u> | [48](#i20cde463f9bc41bd8d781febc1d65735_118) |
| **<u>[PART II - OTHER INFORMATION](#i20cde463f9bc41bd8d781febc1d65735_121)</u>** | **<u>[PART II - OTHER INFORMATION](#i20cde463f9bc41bd8d781febc1d65735_121)</u>** | [49](#i20cde463f9bc41bd8d781febc1d65735_121) |
| [Item 1.](#i20cde463f9bc41bd8d781febc1d65735_124) | <u>[Legal Proceedings](#i20cde463f9bc41bd8d781febc1d65735_124)</u> | [49](#i20cde463f9bc41bd8d781febc1d65735_124) |
| [Item 1A.](#i20cde463f9bc41bd8d781febc1d65735_127) | <u>[Risk Factors](#i20cde463f9bc41bd8d781febc1d65735_127)</u> | [49](#i20cde463f9bc41bd8d781febc1d65735_127) |
| [Item 2.](#i20cde463f9bc41bd8d781febc1d65735_130) | <u>[Unregistered Sales of Equity Securities and Use of Proceeds](#i20cde463f9bc41bd8d781febc1d65735_130)</u> | [51](#i20cde463f9bc41bd8d781febc1d65735_130) |
| [Item 3.](#i20cde463f9bc41bd8d781febc1d65735_133) | <u>[Defaults upon Senior Securities](#i20cde463f9bc41bd8d781febc1d65735_133)</u> | [51](#i20cde463f9bc41bd8d781febc1d65735_133) |
| [Item 4.](#i20cde463f9bc41bd8d781febc1d65735_136) | <u>[Mine Safety Disclosures](#i20cde463f9bc41bd8d781febc1d65735_136)</u> | [51](#i20cde463f9bc41bd8d781febc1d65735_136) |
| [Item 5.](#i20cde463f9bc41bd8d781febc1d65735_139) | <u>[Other Information](#i20cde463f9bc41bd8d781febc1d65735_139)</u> | [51](#i20cde463f9bc41bd8d781febc1d65735_139) |
| [Item 6.](#i20cde463f9bc41bd8d781febc1d65735_142) | <u>[Exhibits](#i20cde463f9bc41bd8d781febc1d65735_142)</u> | [52](#i20cde463f9bc41bd8d781febc1d65735_142) |
|  | <u>[SIGNATURES](#i20cde463f9bc41bd8d781febc1d65735_145)</u> | [53](#i20cde463f9bc41bd8d781febc1d65735_145) |

---

------

**<u>[Table of Content](#i20cde463f9bc41bd8d781febc1d65735_7)[s](#i20cde463f9bc41bd8d781febc1d65735_7)</u>**

**PART I – FINANCIAL STATEMENTS**

**Item 1. Financial Statements**

**CYCURION, INC. AND SUBSIDIARIES**

**CONSOLIDATED BALANCE SHEETS**

*(Unaudited)*

---

| | | |
|:---|:---|:---|
| | September 30, 2025 | December 31, 2024 |
| Assets: |  |  |
| &nbsp;&nbsp;Cash and cash equivalents | $3652074 | $38742 |
| &nbsp;&nbsp;Restricted cash | - | 2048 |
| &nbsp;&nbsp;Accounts receivable, net | 3097054 | 10353708 |
| &nbsp;&nbsp;Other receivables | 230175 | 434391 |
| &nbsp;&nbsp;Prepaid expenses and other current assets | 57137 | 99463 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total current assets | 7036440 | 10928352 |
| &nbsp;&nbsp;Deposit for acquisition target | - | 2000000 |
| &nbsp;&nbsp;Property and equipment, net | - | 20321 |
| &nbsp;&nbsp;Software development costs | 4419981 | 4151981 |
| &nbsp;&nbsp;Intangible assets, net | - | 25000 |
| &nbsp;&nbsp;Security deposits | 10351 | 10351 |
| &nbsp;&nbsp;Goodwill | 20842508 | 6592304 |
| &nbsp;&nbsp;Investments held in trust account | - | 1834540 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total non-current assets | 25272840 | 14634497 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total Assets | $32309280 | $25562849 |
| Liabilities, Mezzanine and Stockholders' Equity: |  |  |
| &nbsp;&nbsp;Bank loan-revolving credit line | $3231067 | $3249067 |
| &nbsp;&nbsp;Bank loan - current portion | 276012 | 774095 |
| &nbsp;&nbsp;Loans payable - current portion | 885240 | 408516 |
| &nbsp;&nbsp;Factoring liability | 1681981 | - |
| &nbsp;&nbsp;Subordinated convertible promissory notes | - | 3333335 |
| &nbsp;&nbsp;Promissory notes | 2658663 | 2486989 |
| &nbsp;&nbsp;Loans payable - related parties | 123650 | 148088 |
| &nbsp;&nbsp;Accounts payable | 2508771 | 3578374 |
| &nbsp;&nbsp;Due to related party | 18000 | - |
| &nbsp;&nbsp;Accrued liabilities | 4053326 | 3601242 |
| &nbsp;&nbsp;Excise tax payable | 1167173 | 1157161 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total current liabilities | 16603883 | 18736867 |
| &nbsp;&nbsp;Loans payable - non-current portion | 295296 | 146798 |
| &nbsp;&nbsp;Series A Convertible preferred stock ($0.001 par value, 500,000 shares designated, 0 and 345,528 issued and outstanding, respectively) | - | 1294117 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total non-current liabilities | 295296 | 1440915 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total liabilities | 16899179 | 20177782 |
| Commitments and contingencies (Note 21) |  |  |
| Mezzanine Equity: |  |  |
| &nbsp;&nbsp;Common stock subject to possible redemption, $0.0001 par value, 0 and 5,796 shares at redemption value of approximately $11.03 per share, respectively | - | 1917309 |
| Stockholders' Equity: |  |  |
| &nbsp;&nbsp;Preferred stock ($0.0001 par value, 20,000,000 shares authorized) |  |  |
| &nbsp;&nbsp;Series A convertible preferred stock ($0.0001 par value, 110,000 shares designated, 0 and 0 issued and outstanding, respectively) | - | - |
| &nbsp;&nbsp;Series B convertible preferred stock ($0.0001 par value, 3,000 shares designated, 1 and 3,000 issued and outstanding, respectively) | - | - |
| &nbsp;&nbsp;Series C convertible preferred stock ($0.0001 par value, 5,000 shares designated, 4,851 issued and outstanding) | - | - |
| &nbsp;&nbsp;Series D convertible preferred stock ($0.0001 par value, 6,666,700 shares designated, 150,000 and 0 issued and outstanding, respectively) | 15 | - |
| &nbsp;&nbsp;Series E convertible preferred stock ($0.0001 par value, 100 shares designated, 51 and 0 issued and outstanding, respectively) | - | - |
| &nbsp;&nbsp;Series F convertible preferred stock ($0.0001 par value, 10,000 shares designated, 0 and 0 issued and outstanding, respectively) | - | - |
| &nbsp;&nbsp;Series G convertible preferred stock ($0.0001 par value, 10,000 shares designated, 3,318 and 0 issued and outstanding, respectively) |  |  |
| &nbsp;&nbsp;Common stock ($0.0001 par value, 300,000,000 shares authorized, 2,662,489 and 353,087 shares issued and outstanding, respectively) | 266 | 35 |
| &nbsp;&nbsp;Additional paid in capital | 40866328 | 6671084 |
| &nbsp;&nbsp;Accumulated deficit | (21773931) | (3203361) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total stockholders' equity attributable to Cycurion | 19092678 | 3467758 |
| &nbsp;&nbsp;&nbsp;&nbsp;Deficit attributable to noncontrolling interests | (3682577) | - |
| &nbsp;&nbsp;&nbsp;&nbsp;Total stockholders' equity | 15410101 | 3467758 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total liabilities and stockholders' equity | $32309280 | $25562849 |
| See accompanying notes to unaudited consolidated financial statements. | See accompanying notes to unaudited consolidated financial statements. | See accompanying notes to unaudited consolidated financial statements. |

---

------

**<u>[Table of Content](#i20cde463f9bc41bd8d781febc1d65735_7)[s](#i20cde463f9bc41bd8d781febc1d65735_7)</u>**

**CYCURION, INC. AND SUBSIDIARIES**

**CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE (LOSS)/INCOME**

*(Unaudited)*

---

| | | | | |
|:---|:---|:---|:---|:---|
| | For the Three Months Ended | For the Three Months Ended | For the Nine Months Ended | For the Nine Months Ended |
| | September 30, 2025 | September 30, 2024 | September 30, 2025 | September 30, 2024 |
| Net revenues | $3833038 | $4450447 | $11591003 | $13694614 |
| Cost of revenues | 3562559 | 3732431 | 10406824 | 11605722 |
| &nbsp;&nbsp;Gross profit | 270479 | 718016 | 1184179 | 2088892 |
| &nbsp;&nbsp;Operating expenses: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Selling, general and administrative expenses | 2719600 | 299233 | 5244323 | 963000 |
| &nbsp;&nbsp;&nbsp;&nbsp;Stock compensation expenses | 2082000 | - | 3094443 | 10000 |
| &nbsp;&nbsp;&nbsp;&nbsp;Business combination expenses | - | - | 11240114 | - |
| &nbsp;&nbsp;Total operating expenses | 4801600 | 299233 | 19578880 | 973000 |
| &nbsp;&nbsp;Operating (loss)/income | (4531121) | 418783 | (18394701) | 1115892 |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest income | 1770 | - | 1770 | 20211 |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest expense | (712374) | (319666) | (1506657) | (1033496) |
| &nbsp;&nbsp;&nbsp;&nbsp;Gain on debt settlement, net | 2016469 | - | 1250139 | - |
| &nbsp;&nbsp;&nbsp;&nbsp;Other (expense)/income | (14761) | 16976 | (129468) | 7105 |
| &nbsp;&nbsp;Other income/(expense), net | 1291104 | (302690) | (384216) | (1006180) |
| (Loss)/income before income taxes | (3240017) | 116093 | (18778917) | 109712 |
| &nbsp;&nbsp;Provision for income tax | - | - | - | - |
| Net (loss)/income | (3240017) | 116093 | (18778917) | 109712 |
| &nbsp;&nbsp;Less: Net loss attributable to non-controlling interest | 116700 | - | 218359 | - |
| &nbsp;&nbsp;&nbsp;&nbsp;Net (loss)/income attributable to Cycurion | $(3123317) | $116093 | $(18560558) | $109712 |
| &nbsp;&nbsp;&nbsp;&nbsp;Comprehensive (loss)/income | $(3123317) | $116093 | $(18560558) | $109712 |
| (Loss)/Earnings per share: |  |  |  |  |
| &nbsp;&nbsp;Basic | $(1.59) | $0.23 | $(14.82) | $0.22 |
| &nbsp;&nbsp;Diluted | $(1.59) | $0.11 | $(14.75) | $0.11 |
| Weighted average shares outstanding: |  |  |  |  |
| &nbsp;&nbsp;Basic | 1965285 | 498941 | 1252543 | 498941 |
| &nbsp;&nbsp;Diluted | 1968618 | 1119834 | 1255876 | 1095037 |
| See accompanying notes to unaudited consolidated financial statements. | See accompanying notes to unaudited consolidated financial statements. | See accompanying notes to unaudited consolidated financial statements. | See accompanying notes to unaudited consolidated financial statements. | See accompanying notes to unaudited consolidated financial statements. |

---

------

**<u>[Table of Content](#i20cde463f9bc41bd8d781febc1d65735_7)[s](#i20cde463f9bc41bd8d781febc1d65735_7)</u>**

**CYCURION, INC. AND SUBSIDIARIES**

**CONSOLIDATED STATEMENTS OF CASH FLOWS**

*(Unaudited)*

---

| | | |
|:---|:---|:---|
| | For the Nine Months Ended | For the Nine Months Ended |
| | September 30, 2025 | September 30, 2024 |
| Cash flows from operating activities: |  |  |
| &nbsp;&nbsp;Net (loss)/income | $(18778917) | $109712 |
| &nbsp;&nbsp;Adjustments to reconcile net loss to net cash used in operating activities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Stock-based compensation | 3094443 | 10000 |
| &nbsp;&nbsp;&nbsp;&nbsp;Stock-based compensation - business combination related | 9521734 | - |
| &nbsp;&nbsp;&nbsp;&nbsp;Amortization of debt discount | 234430 | - |
| &nbsp;&nbsp;&nbsp;&nbsp;Depreciation of property and equipment | 20321 | 6590 |
| &nbsp;&nbsp;&nbsp;&nbsp;Amortization of software development costs | 25000 | - |
| &nbsp;&nbsp;&nbsp;&nbsp;Gain on debt settlement, net | (1250139) | - |
| &nbsp;&nbsp;&nbsp;&nbsp;Finance expense | 100000 | - |
| &nbsp;&nbsp;&nbsp;&nbsp;Changes in assets and liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts receivable, net and other receivables | (286701) | (1921546) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Prepaid expenses and other current assets | 42326 | 2403 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts payable and accrued liabilities | (1494416) | 627256 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash used in operating activities | (8771919) | (1165585) |
| Cash flows from investing activities: |  |  |
| &nbsp;&nbsp;Cash acquired on business combination | 34983 | - |
| &nbsp;&nbsp;Issuance of promissory notes | - | (354000) |
| &nbsp;&nbsp;Purchase of property and equipment | (268000) | (343001) |
| &nbsp;&nbsp;Cash withdrawn from Trust Account in connection with redemption | 1001216 | - |
| &nbsp;&nbsp;Release of Trust Account to Company's bank account | 833324 | - |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash provided by/(used in) investing activities | 1601523 | (697001) |
| Cash flows from financing activities: |  |  |
| &nbsp;&nbsp;Proceeds from exercise of warrants | 3664871 | - |
| &nbsp;&nbsp;Redemption of common stock subject to redemption | (1001216) | - |
| &nbsp;&nbsp;Proceeds from private placement | - | 1000000 |
| &nbsp;&nbsp;Proceeds from capital raise | 5874584 | - |
| &nbsp;&nbsp;Net proceeds from line of credit | (18000) | 106924 |
| &nbsp;&nbsp;Repayment of bank borrowings | (499180) | (6503) |
| &nbsp;&nbsp;Proceeds from convertible notes payable | 2376500 | - |
| &nbsp;&nbsp;Proceeds from notes payable | 513200 | 215000 |
| &nbsp;&nbsp;Proceeds from notes payable - related parties | - | 15000 |
| &nbsp;&nbsp;Repayments of notes payable - related parties | (27500) | - |
| &nbsp;&nbsp;Repayments of notes payable | (101579) | - |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash provided by financing activities | 10781680 | 1330421 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net increase/(decrease) in cash and cash equivalents | 3611284 | (532165) |
| Cash and cash equivalents, beginning of period | 40790 | 607869 |
| Cash and cash equivalents, end of period | $3652074 | $75704 |
| See accompanying notes to unaudited financial statements | See accompanying notes to unaudited financial statements | See accompanying notes to unaudited financial statements |

---

------

**<u>[Table of Content](#i20cde463f9bc41bd8d781febc1d65735_7)[s](#i20cde463f9bc41bd8d781febc1d65735_7)</u>**

**CYCURION, INC. AND SUBSIDIARIES**

**CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY**

*(Unaudited)*

---

| | | | | | | | | | | | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | Common stock subject to possible<br>redemption | Common stock subject to possible<br>redemption | Series A Convertible<br>Preferred Stock | Series A Convertible<br>Preferred Stock | Series B Convertible<br>Preferred Stock | Series B Convertible<br>Preferred Stock | Series C Convertible<br>Preferred Stock | Series C Convertible<br>Preferred Stock | Series D Convertible Preferred<br>Stock | Series D Convertible Preferred<br>Stock | Series E Convertible<br>Preferred Stock | Series E Convertible<br>Preferred Stock | Series G<br>Convertible<br>Preferred Stock | Series G<br>Convertible<br>Preferred Stock | Common Stock | Common Stock | Additional<br> Paid-In Capital | Accumulated<br>Deficit | Total | Non- <br>Controlling<br>Interest | Total <br>Stockholders<br>' Equity |
| | Shares | Amount ($) | Shares | Amount<br>($) | Shares | Amount<br>($) | Shares | Amount<br>($) | Shares | Amount<br>($) | Shares | Amount<br>($) | Shares | Amount<br>($) | Shares | Amount<br>($) | Additional<br> Paid-In Capital | Accumulated<br>Deficit | Total | Non- <br>Controlling<br>Interest | Total <br>Stockholders<br>' Equity |
| Balance as of December 31, 2024 | 5796 | $1917309 | - | $- | 3000 | $- | 4851 | $- | - | $- | - | $- | - | $- | 353087 | $35 | $6671084 | $(3203361) | $3467758 | $- | $3467758 |
| &nbsp;&nbsp;Common stock redeemed (Mezzanine Equity) | (3163) | (1001216) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| &nbsp;&nbsp;Release of common stock subject to redemption | (2633) | (916093) | - | - | - | - | - | - | - | - | - | - | - | - | 2633 | - | 916093 | - | 916093 | - | 916093 |
| &nbsp;&nbsp;Series A convertible preferred stock in exchange of Series A Convertible Preferred Stock categorized as liability | - | - | 106816 | 11 | - | - | - | - | - | - | - | - | - | - | - | - | 1391165 | - | 1391176 | - | 1391176 |
| &nbsp;&nbsp;Series D convertible preferred stock in exchange of convertible notes | - | - | - | - | - | - | - | - | 6666666 | 667 | - | - | - | - | - | - | 3332668 | - | 3333335 | - | 3333335 |
| &nbsp;&nbsp;Common stock issued for conversion of Series B and D Convertible Preferred Stock | - | - | - | - | (2999) | - | - | - | (6516666) | (652) | - | - | - | - | 417176 | 42 | 610 | - | - | - | - |
| &nbsp;&nbsp;Common stock issued for exercise of warrants | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 234830 | 23 | 3309898 | - | 3309921 | - | 3309921 |
| &nbsp;&nbsp;Common stock issued for business combination costs | - | - | - | **-** | - | **-** | - | **-** | - | **-** | - | **-** | - | **-** | 25000 | 3 | 8999997 | - | 9000000 | **-** | 9000000 |
| &nbsp;&nbsp;Common stock issued for settlement of liability | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 2627 | - | 945636 | - | 945636 | - | 945636 |
| &nbsp;&nbsp;Common stock issued for employment agreement | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 16667 | 2 | 249998 | - | 250000 | - | 250000 |
| &nbsp;&nbsp;SLG transaction | - | - | - | - | - | - | - | - | - | - | 51 | - | - | - | 16938 | 2 | 509069 | - | 509071 | - | 509071 |
| &nbsp;&nbsp;Excise tax liability arising from redemption of Class A shares | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | (10012) | (10012) | (3464218) | (3474230) |
| &nbsp;&nbsp;Net loss | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | (10248486) | (10248486) | - | (10248486) |
| Balance as of March 31, 2025 | **-** | - | 106816 | 11 | 1 | - | 4851 | - | 150000 | 15 | 51 | - | - | - | 1068958 | 107 | 26326218 | (13461859) | 12864492 | (3464218) | 9400274 |
| &nbsp;&nbsp;Series G convertible preferred stock in exchange of convertible notes and promissory notes | - | - | - | - | - | - | - | - | - | - | - | - | 3318 | - | - | - | 4183891 | - | 4183891 | - | 4183891 |
| &nbsp;&nbsp;Common stock issued for exercise of warrants | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 106968 | 11 | 354739 | - | 354750 | - | 354750 |
| &nbsp;&nbsp;Common stock issued for settlement of liability | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 91420 | 9 | 1028469 | - | 1028478 | - | 1028478 |
| &nbsp;&nbsp;Common stock issued for employment agreement | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 22782 | 2 | 256297 | - | 256299 | - | 256299 |
| &nbsp;&nbsp;Common Stock Issued - Equity Line | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 38334 | 4 | 265500 | - | 265504 | - | 265504 |
| &nbsp;&nbsp;SLG transaction | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 16671 | 2 | 250069 | - | 250071 | - | 250071 |
| &nbsp;&nbsp;Net loss | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | (5188755) | (5188759) | (101659) | (5290414) |
| Balance as of June 30, 2025 | - | $- | 106816 | $11 | 1 | $- | 4851 | $- | 150000 | $15 | 51 | $- | 3318 | $- | 1345133 | $135 | $32665183 | $(18650614) | $14014730 | $(3565877) | $10448853 |
| &nbsp;&nbsp;Conversion of Series A Convertible Preferred stock for common stock | - | - | (106816) | (11) | - | - | - | - | - | - | - | - | - | - | 161687 | 16 | 390050 | - | 390055 | - | 390055 |
| &nbsp;&nbsp;Common stock issued for exercise of warrants | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 66668 | 7 | 193 | - | 200 | - | 200 |
| &nbsp;&nbsp;Common stock issued for settlement of liability | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 8267 | - | 120530 | - | 120530 | - | 120530 |
| &nbsp;&nbsp;Common stock issued for employment agreement | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 200000 | 20 | 2081380 | - | 2081400 | - | 2081400 |
| &nbsp;&nbsp;Common Stock Issued - Equity Line | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 880734 | 88 | 5608992 |  | 5609080 |  | 5609080 |
| &nbsp;&nbsp;Net loss | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | (3123317) | (3123317) | (116700) | (3240017) |
| Balance as of September 30, 2025 | - | $- | - | $- | 1 | $- | 4851 | $- | 150000 | $15 | 51 | $- | 3318 | $- | 2662489 | $266 | $40866328 | $(21773931) | $19092678 | $(3682577) | $15410101 |
| See accompanying notes to unaudited financial statements. | See accompanying notes to unaudited financial statements. | See accompanying notes to unaudited financial statements. | See accompanying notes to unaudited financial statements. | See accompanying notes to unaudited financial statements. | See accompanying notes to unaudited financial statements. | See accompanying notes to unaudited financial statements. | See accompanying notes to unaudited financial statements. | See accompanying notes to unaudited financial statements. | See accompanying notes to unaudited financial statements. | See accompanying notes to unaudited financial statements. | See accompanying notes to unaudited financial statements. | See accompanying notes to unaudited financial statements. | See accompanying notes to unaudited financial statements. | See accompanying notes to unaudited financial statements. | See accompanying notes to unaudited financial statements. | See accompanying notes to unaudited financial statements. | See accompanying notes to unaudited financial statements. | See accompanying notes to unaudited financial statements. | See accompanying notes to unaudited financial statements. | See accompanying notes to unaudited financial statements. | See accompanying notes to unaudited financial statements. |

---

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| | Series B Convertible Preferred Stock | Series B Convertible Preferred Stock | Common Stock | Common Stock | Additional<br>Paid-In<br>Capital | Accumulated <br>Deficit | Total<br>Stockholders'<br>Equity |
| | Shares | Amount ($) | Shares | Amount ($) | Additional<br>Paid-In<br>Capital | Accumulated <br>Deficit | Total<br>Stockholders'<br>Equity |
| Balance as of December 31, 2023 | 2000 | $2000000 | 498941 | $499 | $7678574 | $(4432962) | $3246111 |
| &nbsp;&nbsp;Board compensation | - | - | - | - | 10000 | - | 10000 |
| &nbsp;&nbsp;Net loss | - | - | - | - | - | (312475) | (312475) |
| Balance as of March 31, 2024 | 2000 | 2000000 | 498941 | 499 | 7688574 | (4745437) | 2943636 |
| &nbsp;&nbsp;Series B convertible preferred stock and warrants issued | 1000 | 1000000 | - | - | - | - | - |
| &nbsp;&nbsp;Net income | - | - | - | - | - | 306094 | 306094 |
| Balance as of June 30, 2024 | 3000 | $3000000 | 498941 | $499 | $7688574 | $(4439343) | $3249730 |
| &nbsp;&nbsp;Net income |  |  |  |  |  | 116093 | 116093 |
| Balance as of September 30, 2024 | $3000 | $3000000 | $498941 | $499 | $7688574 | $(4323250) | $3365823 |
| See accompanying notes to unaudited consolidated financial statements. | See accompanying notes to unaudited consolidated financial statements. | See accompanying notes to unaudited consolidated financial statements. | See accompanying notes to unaudited consolidated financial statements. | See accompanying notes to unaudited consolidated financial statements. | See accompanying notes to unaudited consolidated financial statements. | See accompanying notes to unaudited consolidated financial statements. | See accompanying notes to unaudited consolidated financial statements. |

---

------

**<u>[Table of Content](#i20cde463f9bc41bd8d781febc1d65735_7)[s](#i20cde463f9bc41bd8d781febc1d65735_7)</u>**

**CYCURION, INC. AND SUBSIDIARIES**

**NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS**

1. ORGANIZATION AND DESCRIPTION OF BUSINESS

Cycurion, Inc. (f/k/a KAE Holdings, Inc.; f/k/a Cyber Secure Solutions, Inc.)(the "Company", "Cycurion", "we", "us" or "our") was incorporated on October 12, 2017, in the state of Delaware. Through its subsidiaries, the Company provides premier information technology security solutions. The Company continually strives to deliver top-notch services in the areas of risk management, cybersecurity, information assurance, systems engineering and help desk solutions. The Company is headquartered in McLean, Virginia. On July 14, 2020, the Company changed its corporate name from KAE Holdings, Inc. to Cyber Secure Solutions, Inc., and, on February 24, 2021, to Cycurion, Inc.

The Company has two first-tier wholly-owned subsidiaries, Cycurion Sub, Inc. (formerly Cycurion, Inc., until February 14, 2025) and Cycurion Crypto Inc., a Delaware corporation formed in July 2025, and three indirectly wholly-owned second-tier subsidiaries: (i) Axxum Technologies LLC ("Axxum"), a Virginia limited liability company formed in December 2006, (ii) Cloudburst Security LLC ("Cloudburst"), a Virginia limited liability company formed in January 2007, and (iii) Cycurion Innovation, Inc., a Delaware corporation formed in September 2021 ("Cycurion Innovation"), in connection with our acquisition of assets from Sabres Security Ltd. ("Sabres"), a leading Israeli-based cyber security provider.

*Business Combination*

On February 14, 2025, the Company completed the business combination and transactions (the "Business Combination") as set forth in an Agreement and Plan of Merger, dated November 21, 2022, as amended on April 26, 2024, December 31, 2024 and February 13, 2025 (the "Merger Agreement"), by and among Western Acquisition Ventures Corp. ("Western"), Western Acquisition Merger Inc., a Delaware corporation and a wholly-owned subsidiary of Western ("Merger Sub"), and Cycurion Sub, Inc., a Delaware corporation formerly known as Cycurion, Inc. ("Cycurion Sub"). As contemplated by the Merger Agreement, Merger Sub merged with and into Cycurion Sub with Cycurion Sub as surviving the merger as a wholly-owned subsidiary of Western. In addition, in connection with the consummation of the Business Combination, Western was renamed "Cycurion, Inc."

As a result of the Business Combination, each common share of Cycurion Sub was cancelled and converted into shares of Company common stock, on the terms set forth in the Merger Agreement. Pursuant to the terms of the Merger Agreement, the aggregate number of shares of Company common stock that was delivered as consideration in the Business Combination was capped at 500,000 shares. Concurrently with the completion of the Business Combination, the Company issued an aggregate of 218,102 shares of common stock, 106,816 shares of Series A convertible preferred stock ("Class A Convertible Preferred Stock"), 3,000 shares of Series B convertible preferred stock ("Class B Convertible Preferred Stock"), 4,851 shares of Series C convertible preferred stock ("Class C Convertible Preferred Stock"), 6,666,666 shares of Series D convertible preferred stock ("Class D Convertible Preferred Stock"), 22,696 Series A warrants, 200,000 Series B warrants, 242,424 Series D warrants , 9,006 common stock warrants, 15,760 shares of common stock issued in connection with the Series D private placement, 16,667 shares of common stock issued to A.G.P./Alliance Global Partners ("A.G.P."), 8,333 shares of common stock issued to Seward & Kissel LLP and 2,627 shares of common stock issued to Baker & Hostetler LLP.

The Business Combination has been accounted for as a reverse recapitalization in accordance with U.S. GAAP because Cycurion is the operating company and has been determined to be the accounting acquirer under Financial Accounting Standards Board's Accounting Standards Codification Topic 805, Business Combinations ("ASC 805"), while Western is a blank check company.

Under the reverse recapitalization model, the Business Combination was treated as Cycurion issuing equity for the net assets of Western, with no goodwill or intangible assets recorded.

While Western was the legal acquirer in the Business Combination, because Cycurion Sub, prior to the Business Combination, was deemed the accounting acquirer, the historical financial statements of Cycurion Sub became the historical financial statements of the combined company upon the consummation of the Business Combination. As a result, the financial statements reflect (i) the historical operating results of Cycurion Sub prior to the Business Combination; (ii) the combined results of Western and Cycurion Sub following the closing of the Business Combination; (iii) the assets and liabilities of Cycurion Sub at their historical cost; and (iv) Cycurion's equity structure for all periods presented.

------

**<u>[Table of Content](#i20cde463f9bc41bd8d781febc1d65735_7)[s](#i20cde463f9bc41bd8d781febc1d65735_7)</u>**

In accordance with the applicable guidance, the equity structure has been retroactively restated in all comparative periods up to the Closing Date, to reflect the number of shares of the Company's common stock issued to Cycurion Sub common stockholders in connection with the Business Combination. As such, the shares and corresponding capital amounts and earnings per share related to Cycurion Sub prior to the Business Combination have been retroactively restated as shares reflecting the exchange ratio established in the Business Combination.

*Going Concern*

The accompanying financial statements have been prepared in conformity with generally accepted accounting principles ("GAAP") in the United States, which contemplates continuation of the Company on a going concern basis. The going concern basis assumes that assets are realized, and liabilities are settled in the ordinary course of business at amounts disclosed in the financial statements. As of September 30, 2025, there was substantial doubt regarding the Company's ability to continue as a going concern, as the Company had a net working capital deficit and an accumulated deficit resulting from substantial losses incurred during the three and nine months ended September 30, 2025 and from prior periods. The Company's ability to continue as a going concern depends upon its ability to market and sell its products to generate positive operating cash flows. As of September 30, 2025, the Company had an accumulated deficit of $21.8 million and a working capital deficit of $9.6 million. In addition, the Company had a net cash outflow of $8.8 million from operating activities during the nine months ended September 30, 2025. These circumstances continued to give rise to substantial doubt as to whether the Company will be able to continue as a going concern and did not alleviate the doubt outstanding from 2024.

Management's plan is to continue improving operations to generate positive cash flows and register shares of its common stock in order to undertake a public offering to raise additional capital. Management believes that the valuation and liquidity brought by a public offering of its securities will allow holders of convertibles notes, and convertible preferred stockholders the mechanism to convert their securities into common stock that will reduce the Company's overall leverage and debt service requirement. If the Company is not able to continue generating positive operating cash flows, and raise additional capital, there is the risk that the Company may become insolvent.

*Nasdaq Communications*

On August 21, 2025, the Company announced that we received formal notification on August 19, 2025 and August 20, 2025 from the Nasdaq Stock Market ("Nasdaq") regarding its previous deficiencies. On August 19, 2025, Nasdaq determined that we comply with Nasdaq Listing Rule 5450(b)(1)(A), which requires a minimum of $10,000,000 in stockholders' equity ("Equity Rule"), based on our Form 10-Q for the period ended June 30, 2025, evidencing stockholders' equity of $10,448,853. Reference is made to the April 11, 2025 notification for failure to maintain a minimum market value of listed securities of $50,000,000 over the previous 30 consecutive business days as set forth in Listing Rule 5450(b)(2)(A) ("MVLS Rule"). As we are in compliance with the Equity Rule, Nasdaq notified us that the matter regarding the MVLS Rule is now closed. Additionally, on August 20, 2025, we received formal notification from Nasdaq, determining that for the last 10 consecutive business days, from August 5, 2025 to August 18, 2025, our market value of publicly held shares ("MVPHS") has been $5,000,000 or greater set forth in Nasdaq Listing Rule 5450(b)(1)(C) ("MVPHS Rule"), and that we have regained compliance with the MVPHS Rule.

On October 14, 2025, we received written notice from the staff of Nasdaq Listing Qualifications (the "Staff") that it has determined to commence proceedings to delist our common stock from the Nasdaq Global Market. As previously announced in a Current Report filed with the U.S. Securities and Exchange Commission ("SEC"), on April 15, 2025, the Staff notified the Company on April 9, 2025 that, for the prior 30 consecutive business days, the closing bid price of our common stock had been below the minimum of $1.00 per share required for continued listing on The Nasdaq Global Market under Nasdaq Listing Rule 5550(a)(2) (the "Bid Price Rule"). The notification letter stated that we would be afforded 180 calendar days, or until October 6, 2025, to regain compliance. The Company did not regain compliance with the Bid Price Rule by October 6, 2025, and the listed security was subject to delisting from The Nasdaq Global Market.

On October 20, 2025, the Company submitted its request to the Nasdaq Global Market to appeal the Staff's determination to a Hearings Panel (the "Panel") pursuant to the procedures set forth in the Nasdaq Listing Rule 5800 Series, which stayed the suspension of the Company's securities and the filing of a Form 25-NSE with the SEC that would remove the Company's shares of common stock from listing and registration on The Nasdaq Stock Market. The Company's hearing was scheduled for November 20, 2025.

On November 11, 2025, the Company announced that it received a letter Nasdaq stating that Nasdaq has determined that the Company has regained compliance with Nasdaq's Bid Price Rule requirement under Listing Rule 5450(a)(1). The

------

**<u>[Table of Content](#i20cde463f9bc41bd8d781febc1d65735_7)[s](#i20cde463f9bc41bd8d781febc1d65735_7)</u>**

Company is now in compliance with Nasdaq Global Market's listing requirements. Additionally, Nasdaq confirmed that the previously scheduled hearing before the Nasdaq Hearings Panel on November 20, 2025 has been canceled. The Company's securities will continue to be listed and traded on The Nasdaq Stock Market without interruption.

*Reverse Stock Split*

On October 27, 2025, the Company announced a one-for-thirty reverse stock split of the Company's shares of common stock, par value $0.0001 per share (the "Reverse Stock Split") that took effect with the commencement of business on October 27, 2025.

The Company effected the Reverse Stock Split by filing the Second Amendment to the Second Amended and Restated Certificate of Incorporation with the Secretary of State of the State of Delaware. The Company's shares of common stock began trading on a split-adjusted basis on The Nasdaq Global Market, when the market opened on October 27, 2025, under the existing trading symbol "CYCU" and new CUSIP number 95758L305.

As a result of the Reverse Stock Split, every thirty of the Company's issued shares of common stock was combined into one issued share of common stock, without any change to the par value per share and without any change in the total number of authorized shares of common stock. The number of outstanding shares of common stock was reduced from approximately 86,533,435 shares to approximately 2,884,447 shares. All disclosures affected in this report on Form 10-Q, including share counts and warrant counts have been retroactively adjusted to give effect to the Reverse Stock Split.

No fractional shares were issued in connection with the Reverse Stock Split. Stockholders who otherwise held a fraction of a share of common stock of the Company will receive a cash payment (without interest and subject to withholding taxes, as applicable) in lieu thereof at a price equal to that fraction of a share to which the stockholder would otherwise be entitled, multiplied by the closing price of the Company's shares on The Nasdaq Global Market on the trading day immediately preceding the effective date of the Reverse Stock Split.

*Restricted Cash*

In accordance with the trust agreement between Western and Equiniti Trust Company, LLC, dated January 11, 2022, the Company is permitted to withdraw interest from the trust account (the "Trust Account") to pay its tax obligations, including federal income taxes and state franchise taxes. The balance of this withdrawal would be presented in restricted cash, but as of September 30, 2025 there are no amounts in restricted cash.

2. SIGNIFICANT ACCOUNTING POLICIES

&nbsp;&nbsp;&nbsp;&nbsp;(a)Basis of Presentation and Principles of Consolidation

The accompanying unaudited consolidated financial statements for the Company have been prepared in accordance with accounting principles generally accepted in the United States ("U.S. GAAP") and pursuant to the rules and regulations of the SEC. The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries.

These financial statements include the accounts of Cycurion, Inc. (f/k/a KAE Holdings, Inc.; f/k/a Cyber Secure Solutions, Inc.) and its wholly owned subsidiaries: Axxum, Cloudburst and Cycurion Innovation. Additionally, the financial statements include the accounts of SLG Innovation Inc. ("SLG") as a result of the master service agreement entered into between the Company and SLG. The Company has determined that the SLG transaction constitutes a business combination as defined by ASC 805, Business Combinations ("ASC 805"). ASC 805 establishes principles and requirements as to how the acquirer of a business recognizes and measures in its financial statements the identifiable assets acquired, the liabilities assumed and any non-controlling interest in the acquiree. The assets acquired and liabilities assumed were recognized provisionally in the accompanying consolidated balance sheets at their estimated fair values as of March 31, 2025, and adjusted in the second and third quarter of 2025. All significant inter-company balances, fees, and expenses have been eliminated in consolidation.

The accompanying unaudited consolidated financial statements should be read in conjunction with the Company's audited financial statements and notes thereto, included in the Annual Report on Form 10-K filed with the SEC on April 17, 2025.

&nbsp;&nbsp;&nbsp;&nbsp;(b)Basis of Presentation for Interim Periods

------

**<u>[Table of Content](#i20cde463f9bc41bd8d781febc1d65735_7)[s](#i20cde463f9bc41bd8d781febc1d65735_7)</u>**

Certain information and footnote disclosures normally included for the annual financial statements prepared in accordance with U.S. GAAP have been omitted for the interim periods presented and accordingly, they do not include all of the information and footnotes required by GAAP for audited financial statements. Management believes that the unaudited interim financial statements include all adjustments (which are normal and recurring in nature) necessary to present fairly the financial position of the Company and the results of operations and cash flows for the periods presented.

The results of operations for the periods presented are not necessarily indicative of the results that may be expected for the year ending December 31, 2025. Seasonal changes, political and other conditions can affect the sales volumes of the Company's products. Therefore, the financial results for any interim period do not necessarily indicate the expected results for the year.

&nbsp;&nbsp;&nbsp;&nbsp;(c)Reclassification

Certain amounts have been reclassified to improve the clarity and comparability of the financial statements. These reclassifications had no impact on previously reported total assets, liabilities, equity, net income (loss), or cash flows for any periods presented.

&nbsp;&nbsp;&nbsp;&nbsp;(d)Emerging Growth Company

The Company is an emerging growth company as defined in Section 102(b)(1) of the Jumpstart Our Business Start-ups Act of 2012 (the "JOBS Act") which exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies, but any such an election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised, and it has different application dates for public or private companies. The Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard.

This may make comparison of the Company's financial statements with another public company that is neither an emerging growth company nor an emerging growth company that has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.

&nbsp;&nbsp;&nbsp;&nbsp;(e)Use of estimates

The preparation of financial statements in conformity with GAAP, requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, and disclosures regarding contingent liabilities at the date of the financial statements. These estimates may affect the reported amounts for certain revenues and expenses incurred during the reporting period; actual results may materially differ from these estimates.

&nbsp;&nbsp;&nbsp;&nbsp;(f)Commitments and contingencies

Liabilities for loss contingencies arising from claims, assessments, litigation, fines and penalties and other sources are recorded when it is probable that a liability has been incurred and the amount of the assessment can be reasonably estimated.

&nbsp;&nbsp;&nbsp;&nbsp;(g)Recently Issued Accounting Pronouncements

In November 2024, the FASB issued ASU 2024-03, Income Statement-Reporting Comprehensive Income-Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses, requiring public entities to disclose additional information about specific expense categories in the notes to the financial statements on an interim and annual basis. ASU 2024-03 is effective for fiscal years beginning after December 15, 2026, and for interim periods beginning after December 15, 2027, with early adoption permitted. The Company is currently evaluating the impact of adopting ASU 2024-03.

In March 2024, the FASB issued ASU 2024-02 "Codification Improvements – Amendments to Remove References to the Concepts Statements" ("ASU 2024-02"), which contains amendments to the codification to remove references to various

------

**<u>[Table of Content](#i20cde463f9bc41bd8d781febc1d65735_7)[s](#i20cde463f9bc41bd8d781febc1d65735_7)</u>**

FASB Concepts Statements. In most instances, the references are extraneous and not required to understand or apply the guidance. Generally, ASU 2024-02 is not intended to result in significant accounting changes for most entities. ASU 2024-02 is effective for the Company for fiscal years beginning after December 15, 2024. The Company does not expect this update to have a material impact on its financial statements.

The Company has considered all other recently issued accounting pronouncements and does not believe the adoption of such pronouncements will have a material impact on its financial statements.

3. REVENUE RECOGNITION

We recognize revenue in accordance with ASC Topic 606, "Revenue from Contracts with Customers," as, or when, we satisfy performance obligations under a contract. We account for a contract when the parties approve the contract and are committed to perform on it, the rights of each party and the payment terms are identified, the contract has commercial substance, and it is probable that we will collect substantially all of the consideration. A performance obligation is a promise in a contract to transfer a distinct good or service, or a series of distinct goods or services, to a customer. The transaction price of a contract must be allocated to each performance obligation and recognized as the performance obligation is satisfied.

In most cases, we view our performance obligations as promises to transfer a series of distinct services to our customer that are substantially the same and which have the same pattern of service. We recognize revenue over the performance period as a customer receives the benefits of our services. Typically, the performance obligations in the contract are the delivery of service hours. When the Company has obtained evidence that the service has been delivered and the performance obligations have been fulfilled, it will record revenue and recognize an asset such as accounts receivable.

*<u>Advisory Consulting</u>*

The Company enters into service agreements with customers that will set forth the responsibilities of both parties, including the type of service to be delivered, the timing of the delivery of those services, and the associated price per unit for such services. The unit of measure in the agreement is typically hours. The advisory consulting services represent a single performance obligation, as they constitute a series of distinct hourly services that are substantially the same and transferred to the customer over time. The revenue from advisory service agreement will also set forth the timing of payments by the customers which is typically between 60 and 90 days from the date that an invoice is issued to the customer. The Company issues invoices when management has received acknowledgment from the customer that it has rendered service as measured in hours to the customer. As a practical matter, the Company continuously delivers service to customers, and the customer receives benefits from those services over time. The revenue advisory consulting is recognized over time as services are rendered, based on contractual hourly rates, and when the Company has received the aforementioned acknowledgement from its customers that service has been rendered related to hours accumulated over period of time, such as a week, or two weeks, or a month, which is determined on a customer-by-customer basis. The Company's contracts do not include terms for returns, or warranties, or guarantees, or rebates, or discounts on the services rendered. The Company also enters into annual contracts with customers to provide ongoing advisory and consulting services. Services are delivered continuously over the contract term and customers are billed periodically. The annual service contract represents a single performance obligation because the services are a series of distinct, substantially similar acts that are inseparable and transferred over time. Revenue is recognized over time straight-line over the contract term.

*<u>Managed Security Service Practice (MSSP)</u>*

Management has determined that its managed security service practice is a bundle of cybersecurity software tools, and expert 24x7x365 monitoring and breach resolution service that is accounted for as a single performance obligation that is delivered over time which is typically a month. The components of the bundle have individual commercial value. However, management believes assigning stand-alone value to each component is impractical because each component would not be able to be fully implemented or utilized if not packaged with the other components. Therefore, management believes the MSSP can only be sold as a bundle package over time. At the time that the Company recognizes revenue, it is has either already received funds in advance from its customer or it is reasonably assured that it will collect funds from its customer. In the event that funds that are received in advance, they are accounted for as contract liabilities in the deferred revenue account until the Company fulfills the performance obligation. A majority of the Company's contracts call for the Company to first deliver service and collect fees thereafter. The Company typically receives payment for these contracts within thirty to ninety days of delivery of service. The Company does not sell monitoring time, security software-tools, and breach resolution as stand-alone services, as the customer would not receive the benefits of these items if they were not

------

**<u>[Table of Content](#i20cde463f9bc41bd8d781febc1d65735_7)[s](#i20cde463f9bc41bd8d781febc1d65735_7)</u>**

sold as an integrated package. The cybersecurity needs to monitor the customer cybersecurity environment regularly, stay up to date on cyberthreats and solutions, maintain its software tools, and then address threats identified, or rectify situations when customer environments have been breached. It is not practical or viable to sell these components separately, as customers expect comprehensive solutions. While the components are separately identifiable, management does not believe they could market the components individually. The Company's management does not believe their customers can benefit from the individual components alone, and there are not readily available resources in the market that can be obtained to make those components viable. The continuous monitoring allows the Company to identify and either neutralize and or rectify breaches by having up to the minute first-hand information, and the tools allow the Company to implement solutions rapidly. The absence all of the components would render the solutions and service offering significantly devalued and non-competitive in the marketplace.

The Company believes MSSP meets the criteria to combine the goods and services under a single performance obligation. The Company believes combined integrated solution is delivered continuously over a period of time. In accordance with the terms of the contract between the Company and its customers, the Company receives prepayments in advance from its customers, and recognizes those payments to revenues over a period of time, which is typically each month.

*<u>Managed Service Provider (MSP)</u>*

The Company's managed service provider (MSP) service offering is the provision of IT infrastructure support to customers, specifically in the areas of desktop support, on-site troubleshooting, and cloud-based network infrastructure troubleshooting. This service is accounted for as a single performance obligation that is delivered over time, which is typically a month; At the time that the Company recognizes revenue, it either already received funds in advance from its customer, or it is reasonably assured that it will collect funds from its customer. In the event that funds that are received in advance, they are accounted for as contract liabilities in the deferred revenue account until the Company fulfills the performance obligation. A majority of the Company's contracts call for the Company to first deliver service and collect fees thereafter. The Company typically receives payment for these contracts within thirty to ninety days of delivery of service.

MSP requires the integration of tools and labor in order for a customer to receive any benefit from the services provided. The Company refers to the guidance in ASC 606-10-25-19 to provide an analysis regarding this accounting recognition of this integrated service. Under MSP, the customer cannot receive any benefit purely from labor or individual software tools as a stand-alone service. The tools that the Company deploys require engineers to decipher results and develop solutions to problems during the service period covered in a contract.

While components can be separately identified, they must be used in conjunction with each other to serve the Company's customers. The Company must continuously make available support engineers to customers whenever they need support and troubleshooting. The service includes remote resolution of issues or going onsite to customer locations to solve problems. The Company's contracts with customers require the Company to have these resources available during the length of the contract. Therefore, these services are continuously delivered as a service over time. Accordingly, the Company recognizes revenue for such MSP contract on a monthly basis.

*<u>Software as a service (SaaS)</u>*

Management has determined that its software as a service is a suite of cybersecurity tools that are delivered either remotely or on customer premises. The service is delivered on a monthly basis. The cybersecurity tools are typically sold as a package. However, the individual components of the suite of tools can either be sold individually or bundled together. Nevertheless, if they are sold individually, or as a bundle, they are all delivered over time. Accordingly, the Company recognizes revenue over time, which is typically monthly; At the time that the Company recognizes revenue it is has either already received funds in advance from its customer, or it is reasonably assured that it will collect funds from its customer. In the event that funds that are received in advance, they are accounted for as contract liabilities in the deferred revenue account until the Company fulfills the performance obligation. A majority of the Company's contracts call for the Company to first deliver service and collect fees thereafter. The Company typically receives payment for these contracts within thirty to ninety days of delivery of service.

The Company's SaaS is delivered continuously over time. It is a subscription service where the Company provisions a suite of security software tools to its customers accessed via the internet that allows the customers to protect themselves from cyber-attacks using multiple tools within the suite. This subscription service is recognized to revenue monthly.

------

**<u>[Table of Content](#i20cde463f9bc41bd8d781febc1d65735_7)[s](#i20cde463f9bc41bd8d781febc1d65735_7)</u>**

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Table 3: Disaggregated Revenue** | **Table 3: Disaggregated Revenue** | **Table 3: Disaggregated Revenue** | **Table 3: Disaggregated Revenue** | **Table 3: Disaggregated Revenue** |
|  | For the Three Months Ended | For the Three Months Ended | For the Nine Months Ended | For the Nine Months Ended |
|  | September 30, 2025 | September 30, 2024 | September 30, 2025 | September 30, 2024 |
| Advisory consulting | $3817911 | $4382982 | $11505113 | $13433256 |
| Managed security service practice (MSSP) | 12027 | 63793 | 79095 | 250342 |
| Software as a service (Saas) | 3100 | 3672 | 6795 | 11016 |
| &nbsp;&nbsp;&nbsp;Revenue | $3833038 | $4450447 | $11591003 | $13694614 |

---

4. ACCOUNTS RECEIVABLE, NET

---

| | | |
|:---|:---|:---|
| **Table 4: Details of Accounts Receivable, Net** | **Table 4: Details of Accounts Receivable, Net** | **Table 4: Details of Accounts Receivable, Net** |
|  | September 30, 2025 | December 31, 2024 |
| Accounts receivable | $3432039 | $10353708 |
| Allowance for credit losses | (334985) | - |
| &nbsp;&nbsp;&nbsp;&nbsp;Accounts receivable, net | $3097054 | $10353708 |

---

During the three and nine months ended September 30, 2025, the Company recorded $0.3 million for provisions for credit losses. During the three and nine months ended September 30, 2024, the company had record $0 for provisions for credit losses. During both the three and nine months ended September 30, 2025 and 2024, the Company had $0 write-offs of any outstanding receivables.

5. PROPERTY AND EQUIPMENT, NET

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| **Table 5: Details of Property and Equipment, Net** | **Table 5: Details of Property and Equipment, Net** | **Table 5: Details of Property and Equipment, Net** | **Table 5: Details of Property and Equipment, Net** | **Table 5: Details of Property and Equipment, Net** | **Table 5: Details of Property and Equipment, Net** | **Table 5: Details of Property and Equipment, Net** |
|  | September 30, 2025 | September 30, 2025 | September 30, 2025 | December 31, 2024 | December 31, 2024 | December 31, 2024 |
|  | Gross Carrying Amount | Accumulated<br>Depreciation and<br>Amortization | Net Carrying Amount | Gross Carrying Amount | Accumulated<br>Depreciation and<br>Amortization | Net Carrying Amount |
| Equipment | $- | $- | $- | $125546 | $(121869) | $3677 |
| Furniture and fixtures | - | - | - | 26339 | (19396) | 6943 |
| Leasehold improvements | - | - | - | 62721 | (62721) | - |
| Capital lease | - | - | - | 23004 | (19897) | 3107 |
| Software | - | - | - | 13500 | (6906) | 6594 |
| &nbsp;&nbsp;Property and equipment, net | $- | $- | $- | $251110 | $(230789) | $20321 |

---

During the three and nine months ended September 30, 2025 and 2024, the Company recorded immaterial amounts of depreciation expense in cost of revenue and selling, general and administrative expenses. Additionally, during the three months ended September 30, 2025, as part of the annual review of property and equipment, the Company disposed of all assets categorized as property and equipment, which were fully depreciated already or had an immaterial acceleration of depreciation and amortization.

6. SOFTWARE DEVELOPMENT COSTS

In 2024, the Company reclassified software development costs from property and equipment to software development costs. The Company continues to incur costs to develop new modules, functionalities, and integrations on previous purchased SaaS platform in order to develop a new product with differentiated offering. As of September 30, 2025, the SaaS platform is still undergoing development stage and is not ready for external sales. No amortization has been recorded during the three and nine months ended September 30, 2025 and 2024.

In 2024, the Company reclassified a part of software from property and equipment to software development costs.

------

**<u>[Table of Content](#i20cde463f9bc41bd8d781febc1d65735_7)[s](#i20cde463f9bc41bd8d781febc1d65735_7)</u>**

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Table 6: Capitalized Software Development Costs** | **Table 6: Capitalized Software Development Costs** | **Table 6: Capitalized Software Development Costs** | **Table 6: Capitalized Software Development Costs** | **Table 6: Capitalized Software Development Costs** |
|  | For the Three Months Ended | For the Three Months Ended | For the Nine Months Ended | For the Nine Months Ended |
|  | September 30, 2025 | September 30, 2024 | September 30, 2025 | September 30, 2024 |
| Capitalized software development costs | $94000 | $105001 | $268000 | $343001 |

---

7. INTANGIBLE ASSETS

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| **Table 7.1: Details of Intangible Assets, Net** | **Table 7.1: Details of Intangible Assets, Net** | **Table 7.1: Details of Intangible Assets, Net** | **Table 7.1: Details of Intangible Assets, Net** | **Table 7.1: Details of Intangible Assets, Net** | **Table 7.1: Details of Intangible Assets, Net** | **Table 7.1: Details of Intangible Assets, Net** |
|  | September 30, 2025 | September 30, 2025 | September 30, 2025 | December 31, 2024 | December 31, 2024 | December 31, 2024 |
|  | Gross Carrying Amount | Accumulated<br>Depreciation and<br>Amortization | Net Carrying Amount | Gross Carrying Amount | Accumulated<br>Depreciation and<br>Amortization | Net Carrying Amount |
| Contractual relationship | $66361 | $(66361) | $- | $66361 | $(66361) | $- |
| Implementation | 28099 | (28099) | - | 28099 | (28099) | - |
| Software | 100000 | (100000) | - | 100000 | (75000) | 25000 |
| &nbsp;&nbsp;Intangible assets, net | $194460 | $(194460) | $- | $194460 | $(169460) | $25000 |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Table 7.2: Details of Intangible Asset Amortization** | **Table 7.2: Details of Intangible Asset Amortization** | **Table 7.2: Details of Intangible Asset Amortization** | **Table 7.2: Details of Intangible Asset Amortization** | **Table 7.2: Details of Intangible Asset Amortization** |
|  | For the Three Months Ended | For the Three Months Ended | For the Nine Months Ended | For the Nine Months Ended |
|  | September 30, 2025 | September 30, 2024 | September 30, 2025 | September 30, 2024 |
| Amortization expense, presented in SG&A | $7917 | $- | $25000 | $- |

---

8. BUSINESS COMBINATION

<u>SLG Innovation, Inc.</u>

SLG is a technology services firm with operations and client contracts deemed to be strategically complementary to the Company's existing business and long-term growth objectives. As of December 31, 2020, the Company had initiated discussions regarding the potential acquisition of SLG and had advanced a non-refundable deposit of $1,401,923 for cash advances, loans, capitalized transaction costs and accounts receivable arising from prior business dealings with SLG. On May 13, 2021, the Company entered into an agreement to acquire substantially all of SLG's assets and certain liabilities, which included a termination right exercisable at the Company's sole discretion prior to December 31, 2021. This agreement was subsequently amended to limit the acquisition to certain specified assets, primarily identifiable sales contracts.

As of December 31, 2024, the refundable deposit had increased to $2,000,000, comprising $561,808 in cash advances and loans, $20,000 in due diligence costs, and $1,418,192 in accounts receivable.

On April 29, 2023, the Company and SLG executed a unidirectional letter of intent ("SLG LOI"), which bound SLG to the transaction but did not obligate the Company. The SLG LOI provided that, unless terminated by the Company on or before April 30, 2024, the Company would proceed to acquire SLG or substantially all of its assets and liabilities through a structure to be finalized. The agreed-upon valuation included the $2,000,000 receivable, $2,136,445 in SLG payables to RCR Technology Corporation (excluding payables incurred within 90 days prior to closing), and 33,212 shares of the Company's capital stock.

In connection with the potential SLG transaction, the Company entered into a separate unidirectional letter of intent with RCR ("RCR LOI") on April 29, 2023, under which the Company would acquire SLG's payables owed to RCR, subject to the closing of the potential SLG transaction. Consideration for the RCR transaction was to be settled in the form of shares of common stock of the Company, as specified in the RCR LOI.

The transaction contemplated by the SLG LOI did not close and the Company does not expect that it will close. In lieu of such transaction, and consistent with the economic and business relationship between SLG and the Company for more than

------

**<u>[Table of Content](#i20cde463f9bc41bd8d781febc1d65735_7)[s](#i20cde463f9bc41bd8d781febc1d65735_7)</u>**

the past two years, on March 31, 2025, the Company and SLG entered into a Management Services Agreement (the "MSA"), pursuant to which SLG memorialized its formal engagement of the Company to provide the Management Services (as defined in the MSA) on the terms and subject to the conditions set forth therein. The parties agreed that the Company would continue to retain sole and absolute discretion to select its employees and/or independent contractors who would perform and support the Management Services; provided that the compensation paid to any such persons shall not exceed the compensation that would have been paid to a comparable, unaffiliated third party on a commercial, arms-length basis. SLG agreed to cooperate in good faith with the Company in furtherance of its continued performance of the Management Services.

In connection with the Management Services to be provided by the Company, SLG agreed to pay a fee equal to SLG's "operational cash flow" (whether or not the inbound funds included were recognized as revenue under GAAP and whether or not the outbound funds were recognized as expenses under GAAP during the relevant reporting period). For purposes of the MSA, "operational cash flow" means (i) all cash and cash-equivalencies received by, or on behalf of, SLG from any source for any reason during any reporting period *<u>minus</u>* (ii) all payments made by, or on behalf of, SLG, all in connection with SLG's business as historically operated and as managed by the Company in accordance with the provisions of the MSA. If SLG's operational cash flow during any reporting period is negative, then the Company reserves the right (in its sole and absolute discretion) to advance funds to SLG in an amount not to exceed such negative cash flow during such period with an interest rate to be determined on a case-by-case basis.

In connection with the execution and delivery of the MSA, the Company and Ed Burns entered into a Release Agreement (the "Burns Release Agreement"), pursuant to which the Company acknowledged that it has provided and will continue to provide certain services to SLG as a subcontractor and Mr. Burns agreed to release certain claims that he had, has, or may have against the Company or SLG in relation to the terms and conditions of the MSA, the transactions contemplated thereby, or the manner in which the Company and SLG became parties to the MSA, as well as the relationship between the Company and SLG prior to the date of the MSA and the Company issued to Mr. Burns 33,609 shares of common stock and 51 shares of Series E Convertible Preferred stock with a face value of $10,000 and conversion price of $1.00. The Company offered a substantially equivalent release agreement to the owner of 49% of the equity of SLG with a percentage-equivalent contingent issuance of common stock and Series E Convertible Preferred Stock. As of the date of this quarterly report, such other release has not been accepted or executed and delivered.

On March 31, 2025, the company entered into a Management Services Agreement and a Release agreement (the "Agreement") to gain control of SLG as a Variable Interest Entity ("VIE"). The total purchase consideration for the VIE contractual relationship of SLG consisted primarily of:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)prepaid deposit of $2,000,000;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)33,609 shares of common stock having par value of $0.0001 per share;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)51 shares of Series E Convertible Preferred Stock with a face value of $10,000 and conversion price of $1.00; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)$10,814,147 of accounts receivable in Cycurion owing from SLG

The Company has determined that the SLG transaction constitutes a business combination as defined by ASC 805, Business Combinations ("ASC 805"). ASC 805 establishes principles and requirements as to how the acquirer of a business recognizes and measures in its financial statements the identifiable assets acquired, the liabilities assumed and any non-controlling interest in the acquiree. The assets acquired and liabilities assumed were recognized provisionally in the accompanying consolidated balance sheets at their estimated fair values as of March 31, 2025, and adjusted in the second and third quarter of 2025. The initial accounting for the business combination is not complete as the Company is in the process of obtaining additional information for the valuation of acquired assets and liabilities, if any. The provisional amounts are subject to change to the extent that additional information is obtained about the facts and circumstances that existed as of the acquisition date. Under U.S. GAAP, the measurement period shall not exceed one year from the acquisition date and the Company will finalize these amounts no later than March 31, 2026. The estimated fair values as of the business combination date are based on information that existed as of the acquisition date. During the measurement period the Company may adjust provisional amounts recorded for assets acquired and liabilities assumed to reflect new information that the Company has subsequently obtained regarding facts and circumstances that existed as of the transaction date. The results of operations for SLG are included in the consolidated results of Cycurion, Inc. starting April 1, 2025.

------

**<u>[Table of Content](#i20cde463f9bc41bd8d781febc1d65735_7)[s](#i20cde463f9bc41bd8d781febc1d65735_7)</u>**

---

| | | | |
|:---|:---|:---|:---|
| **Table 8: SLG Valuation** | **Table 8: SLG Valuation** | **Table 8: SLG Valuation** | **Table 8: SLG Valuation** |
|  | Initial Allocation of Assets and Liabilities | Adjustments | Estimated Allocation of Assets and Liabilities as of<br> September 30, 2025 |
| ***<u>Cash consideration:</u>*** |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash consideration | $2000000 | $- | $2000000 |
| &nbsp;&nbsp;&nbsp;&nbsp;Less: cash acquired | (34983) | - | (34983) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cash consideration, net of cash acquired | 1965017 | - | 1965017 |
| <u>Noncash consideration:</u> |  |  | - |
| &nbsp;&nbsp;&nbsp;&nbsp;Common stock <sup>(1)</sup> | 254071 | 250071 | 504142 |
| &nbsp;&nbsp;&nbsp;&nbsp;Series E Convertible Preferred Stock <sup>(2)</sup> | 255000 | - | 255000 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accounts receivable in Cycurion owing from SLG <sup>(3)</sup> | 10814147 | - | 10814147 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Noncash consideration | 11323218 | 250071 | 11573289 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total consideration | $13288235 | $250071 | $13538306 |
| ***<u>Assets acquired:</u>*** |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Accounts receivable | $3066581 | $- | $3066581 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total identified assets acquired | 3066581 | - | 3066581 |
| ***<u>Liabilities assumed:</u>*** |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Accounts payable | 4317052 | - | 4317052 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accrued liabilities | 10650 | 54209 | 64859 |
| &nbsp;&nbsp;&nbsp;&nbsp;Payroll liability | 40642 | - | 40642 |
| &nbsp;&nbsp;&nbsp;&nbsp;Factoring liability | 2176922 | - | 2176922 |
| &nbsp;&nbsp;&nbsp;&nbsp;Due to related parties | 18000 | - | 18000 |
| &nbsp;&nbsp;&nbsp;&nbsp;Loans payable | 625222 | - | 625222 |
| &nbsp;&nbsp;&nbsp;&nbsp;Liabilities to Cycurion | 2982908 | - | 2982908 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total identified liabilities assumed | 10171396 | 54209 | 10225605 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net identifiable liabilities assumed | (7104815) | (54209) | (7159024) |
| &nbsp;&nbsp;&nbsp;&nbsp;Elimination of inter-company balances | 2982908 | - | 2982908 |
| &nbsp;&nbsp;&nbsp;&nbsp;Non-controlling interest | (3464218) | - | (3464218) |
| &nbsp;&nbsp;&nbsp;&nbsp;Goodwill | 13945924 | 304280 | 14250204 |
| Net assets acquired | $13288235 | $250071 | $13538306 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)Represents the fair value of 33,609 common stock issued in the SLG transaction based on the quoted stock price on the date of issuance.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2)Represents the fair value of the Series E Convertible Preferred Stock as is converted to common stock based on the quoted price common stock on the date of issuance.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3)Represents the fair value of the accounts receivable in Cycurion owing from SLG.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(4)Fair value of the noncontrolling interest based on NCI's 49% interest in the net assets acquired.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(5)Goodwill is calculated as Total Consideration paid less the net assets acquired.

9. GOODWILL

*Acquisition of Axxum Technologies, LLC.*

On November 22, 2017, the Company entered into a share transfer agreement with Axxum and the two prior members of Axxum to purchase 100% of the members' equity interest in the Company in exchange for $6,500,000 in cash and $500,000 in two subordinated convertible promissory notes for $250,000 each, payable to the two members of Axxum. Accordingly, Axxum became a wholly-owned subsidiary of the Company. The Company assessed the carrying value of Axxum's assets and liabilities at the date of acquisition and determined that the carrying value of those accounts approximated fair value. The difference between the purchase price paid for the acquisition of Axxum and the net asset value derived from the assets and liabilities of Axxum at the date of acquisition has been recognized as goodwill. Accordingly, the purchase costs of $6,500,000 in cash, $500,000 in promissory notes, and $140,005 in capitalized

------

**<u>[Table of Content](#i20cde463f9bc41bd8d781febc1d65735_7)[s](#i20cde463f9bc41bd8d781febc1d65735_7)</u>**

transaction costs, less $573,150 in adjustment in working capital that is recoverable from sellers resulted in a total purchase cost of $6,566,855. The net asset value of Axxum at the date of acquisition was $1,413,589. Accordingly, the Company recognized $5,153,266 in goodwill related to the acquisition of Axxum.

*Acquisition of Cloudburst Security, LLC.*

On April 3, 2019, the Company entered into a membership interest purchase agreement with Cloudburst and its two equity holders to purchase 100% of the issued and outstanding units in exchange for $500,000 in cash; $540,000 for a promissory note to one equity holder and $360,000 to the other; and 111,628 and 74,420 shares of the Company's common stock to the two equity holders, respectively, on a post-split basis. Accordingly, Cloudburst became a wholly-owned subsidiary of the Company. The Company assessed the carrying value of Cloudburst's assets and liabilities at the date of acquisition and determined that the carrying value of those accounts approximated fair value; the difference between the purchase price paid for the acquisition of Cloudburst and the net asset value derived from the assets and liabilities of Cloudburst at the date of acquisition has been recognized as goodwill. The purchase costs of $500,000 in cash, $900,000 in promissory notes, $300,000 in 186,048 shares of the Company's common stock, $1,400,000 in contingent earnout, $62,305 in capitalized transaction costs, resulted in a total purchase cost of $3,162,305. The net asset value of Cloudburst at the date of acquisition was $323,267. Accordingly, the Company recognized $2,839,038 in goodwill related to the acquisition of Cloudburst. On April 20, 2022, the holders of the (i) $900,000 promissory notes and (ii) 186,048 shares of the Company's common stock tendered them to the Company for cancellation.

Relevant factors to the Company's assessment of the carrying value of goodwill for both business combinations in accordance to the fair value hierarchy under the category of level 3 are as follows: estimation of the growth rate of future incoming and outgoing cash flows, certain elements that comprise the appropriate weighted average cost of capital, such as the equity of potential market participants for comparability analysis, and the Company's sensitivity to outside factors that would lead to variation in the aforementioned cash flows and weighted average cost of capital.

The Company's management reviewed the performance of Cloudburst and its manager during the year ended December 31, 2020 and determined that Cloudburst had not met the performance targets set forth at the time of acquisition. As a result, the manager of Cloudburst was dismissed. Management of the Company performed a quantitative analysis of the carrying value of the subsidiary and its related goodwill by preparing a future discounted cash flow analysis, which included variables such as expectations on future cash flows, calculation of the cost of capital, and the probability of capturing certain contracts under the framework of Cloudburst being a federal government approved service provider, and determined that the fair value as of December 31, 2020 was lower than the carrying value that was previously established at the point of acquisition; accordingly, during the year ended December 31, 2020, the Company determined that the contingent earnout should be de-recognized, and written off in its entirety in the amount of $1,400,000 to the Company's result of operations, and, as a result of the above assessment, the Company recognized an impairment of goodwill in the amount of $1,400,000 that was also recognized to the Company's results of operations. The Company's ending goodwill related to the acquisition of Cloudburst after recognizing impairment was $1,439,038.

*SLG Innovation Inc. Master Service Agreement*

The Company initiated discussions to acquire SLG in late 2020, advancing an initial non-refundable deposit of $1.4 million for loans, capitalized transaction costs, and accounts receivable. By December 31, 2024, this deposit had increased to $2.0 million. On May 13, 2021, the Company entered into an agreement to acquire substantially all of SLG's assets and certain liabilities, later amended to focus on specific sales contracts. A unidirectional letter of intent (LOI) was executed on April 29, 2023, binding SLG to the transaction while allowing the Company the option to proceed. The LOI contemplated a structure involving the $2.0 million receivable, $2.1 million in SLG payables to RCR Technology Corporation, and 33,212 shares of the Company's capital stock.

On March 31, 2025, the Company finalized the MSA and Burns Release Agreement for SLG. The total purchase consideration included the $2.0 million prepaid deposit, 33,609 shares of common stock (par value $0.0001), 51 shares of Series E Convertible Preferred Stock (face value $10,000 each, conversion price $1.00) and $10,814,147 of accounts receivable in Cycurion owing from SLG. Additionally, the Company issued 16,667 shares of common stock to assume SLG's share-based payment obligations.

The transaction was accounted for as a business combination under ASC 805. As of the transaction date, the fair value of assets acquired totaled $3.1 million, excluding cash of $34,983 that was netted against cash consideration paid. Liabilities assumed amounted to $10.2 million, including accounts payable, accrued liabilities, payroll liabilities, and loans. After

------

**<u>[Table of Content](#i20cde463f9bc41bd8d781febc1d65735_7)[s](#i20cde463f9bc41bd8d781febc1d65735_7)</u>**

recognizing a non-controlling interest of $3.5 million, the net assets acquired were negative $7.1 million. The total consideration transferred exceeded the net assets acquired, resulting in the recognition of goodwill amounting to $14.3 million. This goodwill reflects the strategic value of SLG's operations, expected synergies, and future growth potential.

---

| | | |
|:---|:---|:---|
| **Table 9: Details of Goodwill** | **Table 9: Details of Goodwill** | **Table 9: Details of Goodwill** |
|  | September 30, 2025 | December 31, 2024 |
| Axxum | $5153266 | $5153266 |
| Cloudburst | 1439038 | 1439038 |
| SLG | 14250204 | - |
| &nbsp;&nbsp;&nbsp;&nbsp;Goodwill | $20842508 | $6592304 |

---

10. BANK LOANS

*Revolving Line of Credit*

On November 22, 2017, Axxum procured from Main Street Bank a revolving line of credit with a maximum of up to $1,000,000 ("Revolving Line of Credit"), subject to certain restrictions based on available collateral pledged to the bank in the form of accounts and trade receivables owed by the Company's customers. This Revolving Line of Credit is available for one year, at which point it may be renewed by Axxum. Axxum incurred origination and closing costs for this line of credit in the amount of $10,000, which Axxum has recognized a prepaid expense that will amortize over one year as interest expense. The stated rate of interest of the Revolving Line of Credit is the prime rate plus 100 basis points, which at the time of the loan, was 4.50%.

On April 18, 2019, Axxum, Cloudburst, and the Company collectively renewed the Revolving Line of Credit with a maximum aggregate principal sum of $2,000,000 with Main Street Bank. The stated rate of interest of the Revolving Line of Credit increased to 5.75% at the time of the renewal.

On June 29, 2020 and again on June 30, 2021, the Company amended the Revolving Line of Credit with an extension of the maturity date to March 31, 2024. The stated rate of interest of the Revolving Line of Credit decreased to 5.25% at the time of the first amendment and an additional 5% default interest on the second amendment.

As of September 30, 2025, the stated rate of interest of the Revolving Line of Credit was 8.50%. The outstanding balance of the Revolving Line of Credit was $3,231,067 and $3,249,067, respectively, as of September 30, 2025 and December 31, 2024.

*Loan and Security Agreement*

On November 22, 2017, concurrent with the above-mentioned Revolving Line of Credit, Axxum procured a bank term loan from Main Street Bank in the amount of $5,250,000 with an expiration of December 31, 2024 (the "Loan and Security Agreement"). The Loan and Security Agreement is subject to a monthly repayment of principal in the amount of $109,375. The loan carries a stated adjustable interest rate of the prime rate plus 200 basis points, which, at the time of the loan, was 5.50%. Axxum incurred closing and origination costs totaling $211,729. The imputed interest rate after giving effect for the closing and origination costs was 7.82%.

Under the Loan and Security Agreement, Axxum is subject to the following affirmative loan covenants: (i) on or after December 31, 2017 but prior to June 30, 2018, minimum tangible net worth (net liability) of $2,250,000; on or after June 30, 2018 but prior to June 30, 2019, minimum tangible net worth (net liability) of $1,250,000; on or after June 30, 2019 but prior to December 31, 2019, minimum tangible net worth (net liability) of $950,000; on or after December 31, 2019 but prior to June 30, 2020, minimum tangible net worth (net asset) of $1,750,000; on or after June 30, 2020 but prior to December 31, 2020, minimum tangible net worth (net asset) of $2,500,000; on or after December 31, 2020 but prior to June 30, 2021, minimum tangible net worth (net asset) of $3,000,000; on or after June 30, 2021 but prior to December 31, 2021, minimum tangible net worth (net asset) of $3,500,000; on or after December 31, 2021, minimum tangible net worth (net asset) of $5,000,000, (ii) interest coverage ratios must be greater than 1.25-to-1, measured on quarterly basis, using a rolling four-quarter basis, beginning with the fiscal quarter ending December 31, 2017, (iii) the Company and Axxum must achieve minimum consolidated earnings before tax interest, tax, depreciation and amortization of ("EBITDA") greater than $300,000 per quarter, and (iv) annual capital expenditures must be less than $50,000. Management conferred with the bank

------

**<u>[Table of Content](#i20cde463f9bc41bd8d781febc1d65735_7)[s](#i20cde463f9bc41bd8d781febc1d65735_7)</u>**

regarding the covenants and determined that the Company was in compliance after giving effect to clarification in the definitions and formulas set forth by the bank in regard to the calculation of the above covenants.

On April 18, 2019, Axxum, Cloudburst, and the Company collectively amended the Loan and Security Agreement, including the addition of Cloudburst as a borrower. The stated interest rate increased to 6.75% and the loan covenants remained the same.

On June 29, 2020, the Company amended and restated the Loan and Security Agreement ("Amended and Restated Loan and Security Agreement") by extending the maturity date to March 22, 2024 with a monthly repayment of principal in the amount of $62,500 on or after June 22, 2020. The stated interest rate decreased to 6.25%.

Under the Amended and Restated Loan and Security Agreement, the loan covenants were replaced as follows: (i) on or after June 30, 2020 but prior to December 31, 2020, minimum tangible net worth (net liability) of $2,750,000; on or after December 31, 2020 but prior to June 30, 2021, minimum tangible net worth (net liability) of $2,250,000; on or after June 30, 2021 but prior to December 31, 2021, minimum tangible net worth (net liability) of $1,750,000; on or after December 31, 2021, but prior to June 30, 2022, minimum tangible net worth (net liability) of $1,250,000; on or after June 30, 2022 but prior to December 31, 2022, minimum tangible net worth (net asset) of $500,000; on or after December 31, 2022, but prior to June 30, 2023, minimum tangible net worth (net asset) of $1,250,000; on or after June 30, 2023 but prior to December 31, 2023, minimum tangible net worth (net asset) of $2,000,000; on or after December 31, 2023, minimum tangible net worth (net asset) of $2,500,000, (ii) interest coverage ratios must be greater than 1.20-to-1, measured on quarterly basis, using a rolling four-quarter basis, beginning with the fiscal quarter ending June 30, 2020 (iii) the Company must achieve minimum consolidated EBITDA greater than $300,000 per quarter, and (iv) annual capital expenditures must be less than $50,000.

As of September 30, 2025, the stated rate of interest of the loan was 9.5%.

The Company has categorized balances due within one operating period as current and those payments due after one operating period as long-term. As of September 30, 2025 and December 31, 2024, the Company recorded bank loan-current portion of $276,012, net of debt discount of $0 and $774,095, net of debt discount of $1,097, respectively.

*Pledge agreement*

On November 22, 2017, concurrent with Axxum's procurement of the above-mentioned Revolving Line of Credit and Loan and Security Agreement, Axxum entered into a pledge agreement (the "Pledge Agreement"). The following pledges of collateral and credit enhancement were made by Axxum and the Company as the sole member of Axxum: (i) the Company equity ownership in Axxum and (ii) all of Axxum's assets, such as accounts, instruments, equipment, fixtures, deposit accounts, letter of credit rights, and any other assets. All future debt is subordinated to the bank term loan until the term loan is repaid in full. Personal guarantees have also been made by Emmit McHenry, Kurt McHenry, and Alvin McCoy III, as officers and stockholders of the Company in support of the term loan.

On April 18, 2019, Axxum, Cloudburst, and the Company collectively amended the Pledge Agreement, including the addition of Cloudburst as a pledgor. The following pledges of collateral and credit enhancement were made by Axxum, Cloudburst, and the Company: (i) all of the equity of Axxum, Cloudburst and each other subsidiary of the Company then owned or hereafter acquired by the Company and (ii) all rights to which the owner of the pledged equity then or may thereafter become entitled by virtue of owning such pledged equity and being a member of Axxum, Cloudburst, and each other subsidiary of the Company.

------

**<u>[Table of Content](#i20cde463f9bc41bd8d781febc1d65735_7)[s](#i20cde463f9bc41bd8d781febc1d65735_7)</u>**

11. LOANS PAYABLE

---

| | | |
|:---|:---|:---|
| **Table 11: Details of Loans Payable** | **Table 11: Details of Loans Payable** | **Table 11: Details of Loans Payable** |
|  | September 30, 2025 | December 31, 2024 |
| Loan payable | $405314 | $405314 |
| Loan payable - SLG | 264379 | - |
| Economic injury disaster loan - Cycurion | 150000 | 150000 |
| Economic injury disaster loan - SLG | 157220 | - |
| Private loan payable | 203623 | - |
| &nbsp;&nbsp;&nbsp;Funded loans payable | 1180536 | 555314 |
| Less: Unamortized debt-issuance costs and discounts | - | - |
| &nbsp;&nbsp;&nbsp;Total loans payable | 1180536 | 555314 |
| Less: Current portion of long-term debt | 885240 | 408516 |
| &nbsp;&nbsp;&nbsp;Long-term debt | $295296 | $146798 |

---

*<u>Loan payable</u>*

On March 20, 2023, the Company entered into a receivable purchase agreement (the "RPA Loan") for cash received of $0.3 million, with a specified interest rate of 8.00%, due January 20, 2024. The RPA Loan requires weekly payments of $15,302, until $0.5 million is repaid. As of September 30, 2025 and December 31, 2024, the Company recognized a balance owing of $0.4 million, respectively, and the loan is in default.

*<u>EIDL Cycurion Loan</u>*

On July 16, 2020, the Company executed the standard loan documents required for securing loans (the "EIDL Loan - Cycurion") offered by the U.S. Small Business Administration (the "SBA") under its Economic Injury Disaster Loan ("EIDL") assistance program in light of the impact of the COVID-19 pandemic on the Company's business. The principal amount of the EIDL Cycurion Loan is $150,000, with proceeds to be used for working capital purposes. Interest accrues at the rate of 3.75% per annum and will accrue from the date of the EIDL Cycurion Loan. Installment payments, including principal and interest, are due monthly beginning July 16, 2021 (twelve months from the date of the EIDL Cycurion Loan) in the amount of $731. The balance of principal and interest is payable 30 years from the date of the EIDL Cycurion Loan.

*<u>EIDL SLG Loan</u>*

On September 30, 2020, the Company executed the standard loan documents required for securing loans (the "EIDL SLG Loan") offered by the SBA under its EIDL assistance program in light of the impact of the COVID-19 pandemic on the Company's business. The principal amount of the EIDL SLG Loan is $150,000, with the proceeds to be used for working capital purposes. Interest accrues at the rate of 3.75% per annum and will accrue from the date of the EIDL SLG Loan. Installment payments, including principal and interest, are due monthly beginning January 1, 2023 in the amount of $731. The balance of principal and interest is payable 30 years from the date of the EIDL SLG Loan (June 30, 2050). As of September 30, 2025, the balance of the EIDL SLG Loan including interest is $157,220.

*<u>Loan Payable-SLG</u>*

In 2022 and 2023, the Company entered into non-recourse agreements with a lender to sell future receipts. Under the agreement, the Company was required to make daily payments. The terms were renegotiated to monthly payments in 2023. As of September 30, 2025, the balance on the loan is $264,379 and it is currently in default.

*<u>Private Loan payable</u>*

In 2017, the Company entered into a loan agreement with a third party to provide up to $500,000. The funds can be requested on an as-needed basis based on a 10-30% interest rate. As of September 30, 2025, the balance on the loan is $203,623 and is currently in default.

------

**<u>[Table of Content](#i20cde463f9bc41bd8d781febc1d65735_7)[s](#i20cde463f9bc41bd8d781febc1d65735_7)</u>**

12. CONVERTIBLE NOTES

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Table 12: Details of Convertible Notes** | **Table 12: Details of Convertible Notes** | **Table 12: Details of Convertible Notes** | **Table 12: Details of Convertible Notes** | **Table 12: Details of Convertible Notes** | **Table 12: Details of Convertible Notes** |
|  | Principal Value | Unamortized Discount and<br>Issuance Costs | Convertible Notes Carrying<br>Balance | Weighted Average Interest Rate | Maturity<br> (Calendar Year) |
| **Balance as of December 31, 2024** | - | - | - |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Issuance | 440217 | (53717) | 386500 | 18.0% | 2026 |
| &nbsp;&nbsp;&nbsp;&nbsp;Amortization | - | 4476 | 4476 |  |  |
| **Balance as of March 31, 2025** | $**440217** | $**(49241)** | $**390976** | **18.0%** | **2026** |
| &nbsp;&nbsp;&nbsp;&nbsp;Issuance | 2050000 | (60000) | 1990000 | 15.1% | 2026 |
| &nbsp;&nbsp;&nbsp;&nbsp;Conversion to equity | (2490217) | 82465 | (2407752) | 18.0% | 2026 |
| &nbsp;&nbsp;&nbsp;&nbsp;Amortization | - | 26776 | 26776 |  |  |
| **Balance as of September 30, 2025** | $**-** | $**-** | $**-** |  |  |

---

On June 30, 2025, the Company converted all outstanding convertible notes to Series G Convertible Preferred Stock. See Note 15 – Equity.

13. PROMISSORY NOTES

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Table 13.1: Details of Promissory Notes** | **Table 13.1: Details of Promissory Notes** | **Table 13.1: Details of Promissory Notes** | **Table 13.1: Details of Promissory Notes** | **Table 13.1: Details of Promissory Notes** |
|  | Principal Value | Unamortized Discount and Issuance<br>Costs | Convertible Notes Carrying Balance | Weighted Average Interest Rate |
| **Balance as of December 31, 2024** | **2498369** | **(11380)** | **2486989** | **16.6%** |
| &nbsp;&nbsp;&nbsp;&nbsp;Issuance | 690558 | (77358) | 613200 | 13.5% |
| &nbsp;&nbsp;&nbsp;&nbsp;Repayment | (20000) | - | (20000) | 35.0% |
| &nbsp;&nbsp;&nbsp;&nbsp;Amortization | 36667 | 21297 | 57964 |  |
| **Balance as of March 31, 2025** | $**3205594** | $**(67441)** | $**3138153** | **15.8%** |
| &nbsp;&nbsp;&nbsp;&nbsp;Conversion to equity | (456500) | - | (456500) | 24.0% |
| &nbsp;&nbsp;&nbsp;&nbsp;Repayment | (50000) | - | (50000) | 24.0% |
| &nbsp;&nbsp;&nbsp;&nbsp;Amortization | - | 37973 | 37973 |  |
| **Balance as of June 30, 2025** | $**2699094** | $**(29468)** | $**2669626** | **14.3%** |
| &nbsp;&nbsp;&nbsp;&nbsp;Repayment | (31579) | - | (31579) | 12.0% |
| &nbsp;&nbsp;&nbsp;&nbsp;Amortization | - | 20616 | 20616 |  |
| **Balance as of September 30, 2025** | $**2667515** | $**(8852)** | $**2658663** | **14.3%** |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Table 13.2: Details of Loans Payable** | **Table 13.2: Details of Loans Payable** | **Table 13.2: Details of Loans Payable** | **Table 13.2: Details of Loans Payable** | **Table 13.2: Details of Loans Payable** |
|  | September 30, 2025 | December 31, 2024 | Weighted Average Interest Rate | Maturity<br> (Calendar Year) |
| Note issued in 2017 | $250000 | $250000 | 4.0% | 2020 |
| Note issued in 2020 | 300000 | 300000 | 24.0% | 2021 |
| Note issued in 2021 | 400000 | 400000 | 24.0% | 2021 - 2022 |
| Notes issued in 2023 | 611111 | 1067611 | 24.0% | 2023 |
| Notes issued in 2024 | 485846 | 480758 | 11.5% | 2025 |
| Notes issued in 2025 | 620558 | - | 12.0% | 2025 -2026 |
| &nbsp;&nbsp;&nbsp;&nbsp;Funded loans payable | 2667515 | 2498369 | 14.3% |  |
| Less: Unamortized debt-issuance costs and discounts | (8852) | (11380) |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Total loans payable | $2658663 | $2486989 |  |  |

---

------

**<u>[Table of Content](#i20cde463f9bc41bd8d781febc1d65735_7)[s](#i20cde463f9bc41bd8d781febc1d65735_7)</u>**

*<u>Subordinated Convertible Promissory notes payable</u>*

On March 22, 2022, the Company issued subordinated convertible promissory notes with principal value of $526,315 to six investors. While subordinate to bank lender the notes are secured by The Company's assets. The Company issued to an independent director a $236,842 subordinated convertible note. The Company issued to an otherwise unaffiliated investors of subordinated convertible notes in principal amounts of $52,631 to three investors, $105,263 to a fifth investor and $26,315 to a sixth investor. The notes carry annual interest rate of 8% that commenced upon funding date through the date of repayment.

On November 22, 2022, the Company issued to three otherwise unaffiliated investors $2,777,778 in promissory notes, 13,134 shares of common stock and 32,819 warrants for $2,500,000 in gross proceeds.

The Company entered into the Merger Agreement with Western and Merger Sub, on November 21, 2022, as amended. As a result of the Business Combination, Cycurion raised $3,333,335 of debt capital on November 21, 2022, from nine unaffiliated investors who were issued for convertibles notes, warrants and shares of common stock. The convertible notes had a maturity date of November 21, 2023, and an interest rate of 8%. They were also issued to convert to equity upon completion of the Business Combination between Cycurion and Western.

During the first quarter of 2025, the Company issued shares of preferred stock and warrants in exchange of the outstanding convertible promissory notes which had an aggregate principal amount of $3,333,335 and accrued interest of $299,259. As a part of this conversion, the Company issued 222,222 shares of Series D Convertible Preferred Stock and 242,424 Series D warrants to seven unaffiliated noteholders. As a result, the Company recorded gain on settlement of debt of $299,259, which is presented on the consolidated statements of operations and the consolidated statements of cash flows within 'Loss on debt settlement, net.

14. FACTORING LIABILITY

On July 12, 2022, the Company entered into agreement with a lender, whereby the lender would loan proceeds against certain accounts receivable up to 90% of the total value of the invoice, which is paid to the Company in the form of a cash advance. A factoring cost of 1.5% is applied for days 1-30 after the loan is funded, and an additional 0.5% fee charge is applied for each additional 10 days period thereafter. The maximum facility is $3.0 million.

Accordingly, pursuant to ASC 860-20-55-24, the Company recognized a factoring liability to the lenders until the accounts receivables are collected. As of September 30, 2025 the factoring liability was $1.7 million.

15. SERIES A CONVERTIBLE PREFERRED STOCK

As of December 31, 2024, the Company has authorized 16,667 shares of Series A Convertible Preferred Stock with a par value of $0.001 per share. The Series A Convertible Preferred Stock had voting rights on an as-if-converted to common stock basis. The holders were entitled to a 12% dividend and convert at any time into shares of common stock at a ratio of 1 to 25.6938 shares of common stock, subject to adjustment.

As a part of the Business Combination with Western, the Company issued 106,816 shares of Series A Convertible Preferred Stock, par value $0.0001 per share, in connection with the conversion and settlement of previously outstanding securities mentioned above. Refer to Note 16 for the characteristic of newly issued Series A Convertible Preferred stock.

16. EQUITY

*<u>Preferred Stock</u>*

The Company has authorized 20,000,000 shares of preferred stock, par value of $0.0001 per share, issuable from time to time in one or more series.

The Second Amended and Restated Certificate of Incorporation authorizes the board of directors to establish one or more series of preferred stock. Unless required by law or by any stock exchange, and subject to the terms of the Second Amended and Restated Certificate of Incorporation, the authorized shares of preferred stock will be available for issuance without further action by holders of common stock. The board of directors is able to determine, with respect to any series

------

**<u>[Table of Content](#i20cde463f9bc41bd8d781febc1d65735_7)[s](#i20cde463f9bc41bd8d781febc1d65735_7)</u>**

of preferred stock, designations, powers, preferences and relative, participating, optional or other rights, if any, and the qualifications, limitations, or restrictions thereof, if any.

The Company could issue a series of preferred stock that could, depending on the terms of the series, impede or discourage an acquisition attempt or other transaction that some, or a majority, of the stockholders might believe to be in their best interests or in which the stockholders might receive a premium over the market price of the common stock. Additionally, the issuance of preferred stock may adversely affect the rights of stockholders by restricting dividends on the common stock, diluting the voting power of the common stock or subordinating the rights of stockholders to distributions upon a liquidation, dissolution or winding up, or other event. As a result of these or other factors, the issuance of preferred stock could have an adverse impact on the market price of our common stock.

*<u>Mezzanine Equity</u>*

As of September 30, 2025 and December 31, 2024, there are 0 and 5,796 shares of common stock subject to possible redemption, respectively.

**Stockholders' Equity**

*<u>Series A Convertible Preferred Stock</u>*

The Company has authorized 110,000 shares of Series A Convertible Preferred Stock, par value $0.0001 per share.

<u>Voting Rights:</u> The holders of our Cycurion's Series A Convertible Preferred Stock have voting rights on an as-if-converted-to-common-stock basis and as required by law (including without limitation, the DGCL) and as expressly provided in the Certificate of Designation of Preferences, Rights and Limitations for our Series A Convertible Preferred Stock.

<u>Dividend Rights:</u> Holders of shares of our Series A Convertible Preferred Stock shall be entitled to receive dividends at the rate of twelve percent (12%) per annum of the per-share Stated Value ($1.45 per share). The dividends shall be paid payable quarterly in arrears in shares of common stock, calculated for each dividend payment on an as-if-converted-to-Common-Stock basis. No other dividends shall be paid on shares of Preferred Stock.

<u>Conversion Rights:</u> Shares of Cycurion's Series A Convertible Preferred Stock shall be convertible, at any time and from time to time at the option of the holder thereof, into shares of common stock (subject to certain 4.99% or 9.99% blocker limitations) at the conversion ratio of one share of Series A Convertible Preferred Stock-for-one share of common stock, subject to adjustment.

<u>Liquidation Preference:</u> Holders of shares of Cycurion's Series A Convertible Preferred Stock, upon any liquidation, dissolution, or winding-up of Cycurion, whether voluntary or involuntary, shall be entitled to receive out of the assets, whether capital or surplus, of Cycurion an amount equal to the Stated Value, plus any accrued and unpaid dividends thereon, for each share of Series A Convertible Preferred Stock before any distribution or payment shall be made to the holders of common stock, and, if the assets of Cycurion shall be insufficient to pay in full such amounts, then the entire assets to be distributed to the holders of shares of Series A Convertible Preferred Stock shall be ratably distributed among them in accordance with the respective amounts that would have been payable on such shares if all amounts payable thereon had been paid in full.

<u>Protective Provisions:</u> As long as any shares of Series A Convertible Preferred Stock are outstanding, Cycurion shall not, without the affirmative vote of the holders of a majority of the then-outstanding shares of Series A Convertible Preferred Stock, (a) alter or change adversely the powers, preferences, or rights given to the holders of Series A Convertible Preferred Stock or alter or amend the Certificate of Designation of Preferences, Rights and Limitations for Cycurion's Series A Convertible Preferred Stock, (b) amend its certificate of incorporation or other charter documents in any manner that adversely affects any rights of the holders of shares of Series A Convertible Preferred Stock, (c) increase the number of authorized shares of Series A Convertible Preferred Stock, or (d) enter into any agreement with respect to any of the foregoing.

As part of the Business Combination with Western during the first quarter of calendar year 2025, the Company issued to unaffiliated investors a total of 106,816 preferred shares, which were converted into common stock during the third quarter 2025.

------

**<u>[Table of Content](#i20cde463f9bc41bd8d781febc1d65735_7)[s](#i20cde463f9bc41bd8d781febc1d65735_7)</u>**

As of both September 30, 2025 and December 31, 2024, there were 0 Series A Convertible Preferred Stock issued and outstanding.

*<u>Series B Convertible Preferred Stock</u>*

The Company has authorized 3,000 shares of Series B Convertible Preferred Stock, par value $0.0001 per share.

<u>Voting Rights:</u> Holders of shares of Cycurion's Series B Convertible Preferred Stock shall not have any voting rights except as required by law (including without limitation, the DGCL) and as expressly provided in the Certificate of Designation of Preferences, Rights and Limitations for our Series B Convertible Preferred Stock.

<u>Dividend Rights:</u> Holders of our Series B Convertible Preferred Stock shall be entitled to receive dividends (on an as-if-converted-to-Common-Stock basis) to and in the same form as dividends actually paid on shares of common stock when, as, and if such dividends are paid on shares of common stock.

<u>Conversion Rights:</u> Shares of our Series B Convertible Preferred Stock shall be convertible, at any time and from time to time at the option of the holder thereof, into common stock (subject to certain 4.99% or 9.99% blocker limitations) at the conversion ratio of one share of Series B Convertible Preferred Stock-for-one share of common stock, subject to adjustment.

<u>Liquidation Preference:</u> Holders of shares of our Series B Convertible Preferred Stock, upon any liquidation, dissolution, or winding-up, whether voluntary or involuntary, shall be entitled to receive out of the assets, whether capital or surplus, an amount equal to the Stated Value, plus any accrued and unpaid dividends thereon, for each share of Series B Convertible Preferred Stock before any distribution or payment shall be made to the holders of common stock, and, if our assets are insufficient to pay in full such amounts, then the entire assets to be distributed to the holders of shares of Series B Convertible Preferred Stock shall be ratably distributed among them in accordance with the respective amounts that would have been payable on such shares if all amounts payable thereon had been paid in full.

<u>Protective Provisions:</u> As long as any shares of Series B Convertible Preferred Stock are outstanding, we will not, without the affirmative vote of the holders of a majority of the then-outstanding shares of Series B Convertible Preferred Stock, (a) alter or change adversely the powers, preferences, or rights given to the holders of Series B Convertible Preferred Stock or alter or amend the Certificate of Designation of Preferences, Rights and Limitations for our Series B Convertible Preferred Stock, (b) amend our certificate of incorporation or other charter documents in any manner that adversely affects any rights of the holders of shares of Series B Convertible Preferred Stock, (c) increase the number of authorized shares of Series B Convertible Preferred Stock, or (d) enter into any agreement with respect to any of the foregoing.

As part of the Business Combination with Western during the first quarter of 2025, the Company issued to unaffiliated investors a total of 3,000 preferred shares of series B Convertible Preferred Stock in exchange of existing 3,000 Series B Convertible Preferred Stock.

During the nine months ended September 30, 2025, a total of 2,999 Series B Convertible Preferred Stock were converted into 199,955 shares of common stock.

As of September 30, 2025 and December 31, 2024, there were 1 and 3,000 shares of Series B Convertible Preferred Stock issued and outstanding, respectively.

***Series C Convertible Preferred Stock***

The Company has authorized 5,000 shares of Series C Convertible Preferred Stock, par value $0.0001 per share.

<u>Voting Rights:</u> The holders of our Series C Convertible Preferred Stock have voting rights on an as-if-converted-to-Common-Stock basis, as required by law, and as expressly provided in its Certificate of Designation, as follows. As long as any shares of our Series C Convertible Preferred Stock are outstanding, we shall not, without the affirmative vote of the holders of a majority of the then-outstanding shares of our Series C Convertible Preferred Stock, (a) alter or change adversely the powers, preferences, or rights given to our Series C Convertible Preferred Stock or alter or amend its Certificate of Designation, (b) amend our Certificate of Incorporation or other charter documents in any manner that adversely affects any rights of the holders of our Series C Convertible Preferred Stock, (c) increase the number of

------

**<u>[Table of Content](#i20cde463f9bc41bd8d781febc1d65735_7)[s](#i20cde463f9bc41bd8d781febc1d65735_7)</u>**

authorized shares of our Series C Convertible Preferred Stock, or (d) enter into any agreement with respect to any of the foregoing.

<u>Dividend Rights:</u> We shall pay dividends on our Series C Convertible Preferred Stock at the rate of 12% per annum of the per-share Stated Value ($82.46 per share). The dividends are payable quarterly in arrears not in cash, but in shares of our common stock, calculated for each dividend payment on an as-if-converted-to-Common-Stock basis. No other dividends are payable on shares of our Series C Convertible Preferred Stock.

<u>Conversion Rights:</u> The shares of our Series C Convertible Preferred Stock may be converted into shares of our common stock at a ratio of approximately 20 shares of common stock for every one share of our Series C Convertible Preferred Stock, or an aggregate of 99,077 shares of our common stock, assuming full conversion. In connection with conversions, each holder of our Series C Convertible Preferred Stock is subject to a "beneficial ownership limitation" of 4.99% of the number of shares of our common stock outstanding immediately after giving effect to that conversion, which limitation may be increased by the holder to not more than 9.99% on 61 days' advanced notice to us.

<u>Liquidation Preference:</u> Our Series C Convertible Preferred Stock has a liquidation preference in an amount equal to its per-share Stated Value ($82.46 per share), plus any accrued and unpaid dividends thereon, for each share of our Series C Convertible Preferred Stock before we can make any distribution or payment to the holders of our common stock. If our assets are insufficient to pay in full such liquidation preference, then our entire assets are to be distributed to the holders of our Series C Convertible Preferred Stock, ratably distributed among them in accordance with the respective amounts that would be payable on such shares if all amounts payable thereon were paid in full.

<u>Protective Provisions:</u> As long as any shares of Series C Convertible Preferred Stock are outstanding, we will not, without the affirmative vote of the holders of a majority of the then-outstanding shares of Series C Convertible Preferred Stock, (a) alter or change adversely the powers, preferences, or rights given to the holders of Series C Convertible Preferred Stock or alter or amend the Certificate of Designation of Preferences, Rights and Limitations for our Series C Convertible Preferred Stock, (b) amend our certificate of incorporation or other charter documents in any manner that adversely affects any rights of the holders of shares of Series C Convertible Preferred Stock, (c) increase the number of authorized shares of Series C Convertible Preferred Stock, or (d) enter into any agreement with respect to any of the foregoing.

As part of the Business Combination with Western during the first quarter of 2025, the Company issued a total of 4,851 preferred shares of series C Convertible Preferred Stock in exchange of existing 1,356,586 shares of Cycurion common stock and 406,969 Warrants. No conversions occurred during the nine months ended September 30, 2025.

As of September 30, 2025 and December 31, 2024, there were 4,851 shares of Series C Convertible Preferred Stock issued and outstanding.

***Series D Convertible Preferred Stock***

The Company has authorized 6,666,700 shares of Series D Convertible Preferred Stock, par value $0.0001 per share.

*Voting Rights*: Holders of shares of Cycurion's Series D Convertible Preferred Stock shall not have any voting rights except as required by law (including without limitation, the DGCL) and as expressly provided in the Certificate of Designation of Preferences, Rights and Limitations for Cycurion's Series D Convertible Preferred Stock.

*Dividend Rights*: Holders of shares of Cycurion's Series D Convertible Preferred Stock shall be entitled to receive, and Cycurion shall pay, dividends on shares of Series D Convertible Preferred Stock (on an as-if-converted-to-Common-Stock basis) to and in the same form as dividends actually paid on shares of common stock when, as, and if such dividends are paid on shares of common stock.

*Conversion Rights*: Shares of Cycurion's Series D Convertible Preferred Stock shall be convertible, at any time and from time to time at the option of the holder thereof, into shares of common stock (subject to certain 4.99% or 9.99% blocker limitations) at the conversion ratio of one share of Series D Convertible Preferred Stock-for-one share of common stock, subject to adjustment.

*Liquidation Preference*: Holders of shares of Cycurion's Series D Convertible Preferred Stock, upon any liquidation, dissolution, or winding-up of Cycurion, whether voluntary or involuntary, shall be entitled to receive out of the assets, whether capital or surplus, of Cycurion an amount equal to the Stated Value, plus any accrued and unpaid dividends

------

**<u>[Table of Content](#i20cde463f9bc41bd8d781febc1d65735_7)[s](#i20cde463f9bc41bd8d781febc1d65735_7)</u>**

thereon, for each share of Series D Convertible Preferred Stock before any distribution or payment shall be made to the holders of common stock, and, if the assets of Cycurion shall be insufficient to pay in full such amounts, then the entire assets to be distributed to the holders of shares of Series D Convertible Preferred Stock shall be ratably distributed among them in accordance with the respective amounts that would have been payable on such shares if all amounts payable thereon had been paid in full.

*Protective Provisions*: As long as any shares of Series D Convertible Preferred Stock are outstanding, Cycurion shall not, without the affirmative vote of the holders of a majority of the then-outstanding shares of Series D Convertible Preferred Stock, (a) alter or change adversely the powers, preferences, or rights given to the holders of Series D Convertible Preferred Stock or alter or amend the Certificate of Designation of Preferences, Rights and Limitations for Cycurion's Series D Convertible Preferred Stock, (b) amend its certificate of incorporation or other charter documents in any manner that adversely affects any rights of the holders of shares of Series D Convertible Preferred Stock, (c) increase the number of authorized shares of Series D Convertible Preferred Stock, or (d) enter into any agreement with respect to any of the foregoing.

As part of the Business Combination with Western, during the first quarter of calendar year 2025, the Company issued to unaffiliated investors a total of 6,666,666 preferred shares of series D Convertible Preferred Stock.

During the three months ended March 31, 2025, a total of 6,516,666 Series D Convertible Preferred Stock were converted into 217,220 shares of common stock. No conversions occurred during the six months ended September 30, 2025.

As of September 30, 2025 and December 31, 2024, there were 150,000 and 0 shares of Series D Convertible Preferred Stock issued and outstanding, respectively.

***Series E Convertible Preferred Stock***

The Company has authorized 100 shares of Series E Convertible Preferred Stock, par value $0.0001 per share.

*Voting Rights*: Holders of shares of Cycurion's Series E Convertible Preferred Stock shall have voting rights on an as-if-converted-to-common stock basis and as required by law (including without limitation, the DGCL) and as expressly provided in the Certificate of Designation of Preferences, Rights and Limitations for Cycurion's Series E Convertible Preferred Stock.

*Dividend Rights*: Holders of shares of Cycurion's Series E Convertible Preferred Stock shall be entitled to receive, and Cycurion shall pay, dividends on shares of Series E Convertible Preferred Stock (on an as-if-converted-to-Common-Stock basis) to and in the same form as dividends actually paid on shares of common stock when, as, and if such dividends are paid on shares of common stock.

*Conversion Rights*: Shares of Cycurion's Series E Convertible Preferred Stock shall be convertible, at any time and from time to time at the option of the holder thereof, into shares of common stock (subject to certain 4.99% or 9.99% blocker limitations) at the conversion ratio of one share of Series E Convertible Preferred Stock-for-one share of common stock, subject to adjustment.

*Liquidation Preference*: Holders of shares of Cycurion's Series E Convertible Preferred Stock, upon any liquidation, dissolution, or winding-up of Cycurion, whether voluntary or involuntary, shall be entitled to receive out of the assets, whether capital or surplus, of Cycurion an amount equal to the Stated Value, plus any accrued and unpaid dividends thereon, for each share of Series E Convertible Preferred Stock before any distribution or payment shall be made to the holders of common stock, and, if the assets of Cycurion shall be insufficient to pay in full such amounts, then the entire assets to be distributed to the holders of shares of Series E Convertible Preferred Stock shall be ratably distributed among them in accordance with the respective amounts that would have been payable on such shares if all amounts payable thereon had been paid in full.

*Protective Provisions*: As long as any shares of Series E Convertible Preferred Stock are outstanding, Cycurion shall not, without the affirmative vote of the holders of a majority of the then-outstanding shares of Series E Convertible Preferred Stock, (a) alter or change adversely the powers, preferences, or rights given to the holders of Series E Convertible Preferred Stock or alter or amend the Certificate of Designation of Preferences, Rights and Limitations for Cycurion's Series E Convertible Preferred Stock, (b) amend its certificate of incorporation or other charter documents in any manner that adversely affects any rights of the holders of shares of Series E Convertible Preferred Stock, (c) increase the number of

------

**<u>[Table of Content](#i20cde463f9bc41bd8d781febc1d65735_7)[s](#i20cde463f9bc41bd8d781febc1d65735_7)</u>**

authorized shares of Series E Convertible Preferred Stock, or (d) enter into any agreement with respect to any of the foregoing.

As part of the Management Services Agreement and a Release agreement in March 2025 with Ed Burns, the Company issued to the majority shareholder a total of 51 preferred shares of Series E Convertible Preferred Stock as consideration for the transaction. No issuances occurred during the three months ended September 30, 2025.

***Series F Convertible Preferred Stock***

The Company has authorized 10,000 shares of Series F Convertible Preferred Stock, par value $0.0001 per share.

*Voting Rights*: Holders of shares of our Series F Convertible Preferred Stock shall have voting rights on an as-if-converted-to-common-stock basis and as required by law (including without limitation, the DGCL) and as expressly provided in the Certificate of Designation of Preferences, Rights and Limitations for our Series F Convertible Preferred Stock.

*Dividend Rights*: Holders of shares of our Series F Convertible Preferred Stock shall be entitled to receive, and we shall pay, dividends on shares of our Series F Convertible Preferred Stock at the rate of twelve percent (12%) per annum of the $0.0001 per-share Stated Value of the Series F Convertible Preferred Stock. The dividends shall be paid payable quarterly in arrears in shares of common stock, calculated for each dividend payment on an as-if-converted-to-common-stock basis.

*Conversion Rights*: Shares of our Series F Convertible Preferred Stock shall be convertible, at any time and from time to time at the option of the holder thereof, into shares of Common Stock (subject to certain 4.99% or 9.99% blocker limitations) at the conversion ratio of one share of Series F Convertible Preferred Stock-for-1,000 shares of Common Stock, subject to adjustment.

*Liquidation Preference*: Holders of shares of our Series F Convertible Preferred Stock, upon any liquidation, dissolution, or winding-up, whether voluntary or involuntary , shall be entitled to receive out of the assets, whether capital or surplus, an amount equal to the Stated Value, plus any accrued and unpaid dividends thereon, for each share Series F Convertible Preferred Stock before any distribution or payment shall be made to the holders of common stock, and, if the assets shall be insufficient to pay in full such amounts, then the entire assets to be distributed to the holders of shares of our Series F Convertible Preferred Stock shall be ratably distributed among them in accordance with the respective amounts that would have been payable on such shares if all amounts payable thereon had been paid in full.

*Protective Provisions*: As long as any shares of Series F Convertible Preferred Stock are outstanding, we shall not, without the affirmative vote of the holders of a majority of the then-outstanding shares of Series F Convertible Preferred Stock, (a) alter or change adversely the powers, preferences, or rights given to the holders of Series F Convertible Preferred Stock or alter or amend the Certificate of Designation of Preferences, Rights and Limitations for our Series F Convertible Preferred Stock, (b) amend its certificate of incorporation or other charter documents in any manner that adversely affects any rights of the holders of shares of Series F Convertible Preferred Stock, (c) increase the number of authorized shares of Series F Convertible Preferred Stock, or (d) enter into any agreement with respect to any of the foregoing.

***Series G Convertible Preferred Stock***

The Company has designated 10,000 shares of Series G Convertible Preferred Stock, par value $0.0001 per share.

*Voting Rights*: Holders of shares of Series G Convertible Preferred Stock shall have voting rights on an as-if-converted-to-Common-Stock basis and as required by law (including without limitation, the DGCL) and as expressly provided in the Certificate of Designation of Preferences, Rights and Limitations for our Series G Convertible Preferred Stock.

*Dividend Rights*: Holders of shares of our Series G Convertible Preferred Stock shall be entitled to receive, and we shall pay, dividends on shares of our Series G Convertible Preferred Stock at the rate of twelve percent (12%) per annum of the $0.0001 per-share Stated Value of the Series G Convertible Preferred Stock. The dividends shall be paid payable quarterly in arrears in shares of common stock, calculated for each dividend payment on an as-if-converted-to-Common-Stock basis.

*Conversion Rights*: Shares of our Series G Convertible Preferred Stock shall be convertible, at any time and from time to time at the option of the holder thereof, into shares of common stock (subject to certain 4.99% or 9.99% blocker limitations) at the conversion ratio of one share of Series G Convertible Preferred Stock-for-1,000 shares of common stock, subject to adjustment.

------

**<u>[Table of Content](#i20cde463f9bc41bd8d781febc1d65735_7)[s](#i20cde463f9bc41bd8d781febc1d65735_7)</u>**

*Liquidation Preference*: Holders of shares of our Series G Convertible Preferred Stock, upon any liquidation, dissolution, or winding-up, whether voluntary or involuntary , shall be entitled to receive out of the assets, whether capital or surplus, an amount equal to the Stated Value, plus any accrued and unpaid dividends thereon, for each share Series G Convertible Preferred Stock before any distribution or payment shall be made to the holders of common stock, and, if the assets shall be insufficient to pay in full such amounts, then the entire assets to be distributed to the holders of shares of our Series G Convertible Preferred Stock shall be ratably distributed among them in accordance with the respective amounts that would have been payable on such shares if all amounts payable thereon had been paid in full.

*Protective Provisions*: As long as any shares of Series G Convertible Preferred Stock are outstanding, we shall not, without the affirmative vote of the holders of a majority of the then-outstanding shares of Series G Convertible Preferred Stock, (a) alter or change adversely the powers, preferences, or rights given to the holders of Series G Convertible Preferred Stock or alter or amend the Certificate of Designation of Preferences, Rights and Limitations for our Series G Convertible Preferred Stock, (b) amend its certificate of incorporation or other charter documents in any manner that adversely affects any rights of the holders of shares of Series G Convertible Preferred Stock, (c) increase the number of authorized shares of Series G Convertible Preferred Stock, or (d) enter into any agreement with respect to any of the foregoing.

***Common Stock***

The Company has authorized 300,000,000 shares of common stock, par value of $0.0001 per share. Each share of common stock entitles the holder to one vote, in person or proxy, on any matter on which an action of the stockholders of the Company is sought.

• 578,863 shares for conversion of Series A, B and D Convertible Preferred Stock

• 258,464 shares for exercise of other warrant, Warrant A, B and D for $3,309,921

• 25,000 shares valued at $9,000,000 for business acquisition costs

• 10,894 shares valued at $1,193,634 for a settlement of debt of $2,925,803, as a result, the Company recorded loss on settlement of debt of $2,174,075, which is presented on the consolidated statements of operations and the consolidated statements of cash flows within 'gain of debt settlement, net'

• 330,869 shares valued at $5,916,777 for an employment agreement

• 33,609 shares valued at $764,020 for consideration in the Management Services Agreement and a Release agreement with Ed Burns

• 2,633 shares for a release of common stock subject to redemption

As of September 30, 2025 and December 31, 2024, there were 2,662,489 and 353,087 shares of common stock issued and outstanding, respectively. The 2,662,489 shares of common stock include 33,609 shares of common stock to be issued to SLG and under certain equity plans.

------

**<u>[Table of Content](#i20cde463f9bc41bd8d781febc1d65735_7)[s](#i20cde463f9bc41bd8d781febc1d65735_7)</u>**

**Warrants**

---

| | | | |
|:---|:---|:---|:---|
| **Table 16.1: Details of Warrants** | **Table 16.1: Details of Warrants** | **Table 16.1: Details of Warrants** | **Table 16.1: Details of Warrants** |
|  | Number of Warrants | Weighted Average Exercise Price | Weighted Average Life (years) |
| Outstanding warrants, December 31, 2024 | 315028 | $20.64 | 3.0 |
| &nbsp;&nbsp;Granted | 869992 | 164.96 | 4.7 |
| &nbsp;&nbsp;Replacement of old warrants | (315028) | 20.64 | 2.9 |
| &nbsp;&nbsp;Exercised | (234831) | 14.27 | 4.3 |
| Outstanding warrants, March 31, 2025 | 635161 | 220.67 | 4.7 |
| &nbsp;&nbsp;Issued - Prefunded (equity line) | 150000 | - | 1.0 |
| &nbsp;&nbsp;Exercised - Prefunded (equity line) | (83333) | - | 1.0 |
| &nbsp;&nbsp;Exercised | (23633) | 15.00 | 5.0 |
| Outstanding warrants, June 30, 2025 | 678195 | 206.15 | 4.8 |
| &nbsp;&nbsp;Exercised - Prefunded (equity line) | (66667) | - | 1.0 |
| Outstanding warrants, September 30, 2025 | 611528 | 228.62 | 4.8 |
| Exercisable warrants, September 30, 2025 | 611528 | $228.62 | 4.8 |

---

The Company has accounted for the issuance of common stock and warrants issued for cash proceeds in the private placements as equity instruments. Management believes that the warrants are indexed to and are settled in the Company's own common stock; therefore, they should be accounted for as permanent equity.

***Public Warrants***

As of September 30, 2025 and December 31, 2024, there were 383,333 public warrants ("Public Warrants") outstanding. The Company accounts for the Public Warrants as equity instruments. The Public Warrants will become exercisable on the later of (a) 30 days after the completion of a Business Combination or (b) 12 months from the closing of the initial public offering. No warrants will be exercisable for cash unless the Company has an effective and current registration statement covering the shares of common stock issuable upon exercise of the warrants and a current prospectus relating to such shares of common stock. Notwithstanding the foregoing, if a registration statement covering the shares of common stock issuable upon exercise of the Public Warrants is not effective within a specified period following the consummation of a Business Combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company shall have failed to maintain an effective registration statement, exercise warrants on a cashless basis pursuant to the exemption provided by Section 3(a)(9) of the Securities Act, provided that such exemption is available. If neither that exemption nor another exemption is available, holders will not be able to exercise their warrants on a cashless basis.

The Public Warrants will expire on February 14, 2030, five years after the completion of the Business Combination with Cycurion or earlier upon redemption or liquidation.

Once the Public Warrants become exercisable, the Company may redeem the Public Warrants:

• in whole and not in part

• at a price of $0.30 per Public Warrant;

• upon not less than 30 days' prior written notice of redemption;

• if, and only if, the reported last sale price of the shares of common stock equals or exceeds $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations and recapitalizations), for any 20 trading days within a 30 trading day period commencing at any time after the Public Warrants become exercisable and ending on the third business day prior to the notice of redemption to warrant holders; and

------

**<u>[Table of Content](#i20cde463f9bc41bd8d781febc1d65735_7)[s](#i20cde463f9bc41bd8d781febc1d65735_7)</u>**

• if, and only if, there is a current registration statement in effect with respect to the shares of common stock underlying the Public Warrants.

If the Company calls the Public Warrants for redemption, management will have the option to require all holders that wish to exercise the Public Warrants to do so on a "cashless basis," as described in the warrant agreement.

The exercise price and number of shares of common stock issuable on exercise of the Public Warrants may be adjusted in certain circumstances including in the event of a stock dividend, extraordinary dividend or recapitalization, reorganization, merger, or consolidation. However, the warrants will not be adjusted for issuances of shares of common stock at a price below their respective exercise prices. Additionally, in no event will the Company be required to net cash settle the Public Warrants. If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of Public Warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company's assets held outside of the Trust Account with respect to such Public Warrants. Accordingly, the Public Warrants may expire and become worthless.

In addition, if (a) the Company issues additional shares of common stock or equity-linked securities for capital raising purposes in connection with the closing of a Business Combination at an issue price or effective issue price of less than $9.20 per share of common stock (with such issue price or effective issue price to be determined in good faith by the Company's board of directors, and in the case of any such issuance to the initial stockholders or their affiliates, without taking into account any Founder Shares held by them prior to such issuance), (b) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of a Business Combination on the date of the consummation of a Business Combination (net of redemptions), and (c) the volume weighted average trading price of the Company's common stock during the 20 trading day period starting on the trading day prior to the day on which the Company consummates Business Combination (such price, the "Market Value") is below $9.20 per share, the exercise price of the Public Warrants will be adjusted (to the nearest cent) to be equal to 115% of the greater of (i) the Market Value or (ii) the price at which the Company issues the additional shares of common stock or equity-linked securities.

***Private Placement Warrants***

As of September 30, 2025 and December 31, 2024, there were 12,533 private placement warrants ("Private Placement Warrants") outstanding. The Company accounts for the Private Placement Warrants as equity instruments. The Private Placement Warrants sold in the private placement are identical to the Public Warrants underlying the Units sold in the IPO, except that such warrants, and the shares of common stock issuable upon the exercise of such warrants, will not be transferable, assignable, or salable until after February 14, 2025, the date of completion of a Business Combination, subject to certain limited exceptions.

***Series A Warrants***

On November 17, 2017, the Company had issued 44,445 Series A Warrants at exercise price of $13.50 with an expiration date of November 22, 2025. As part of the Business Combination with Western, during the first quarter of 2025, the Company issued to unaffiliated investors a total of 22,696 Series A Warrants in exchange of existing 44,445 Series A Warrants having expiry on February 19, 2029 and exercise price of $9.59121

***Series B Warrants***

On August 1, 2023, the Company issued 133,333 Series B Warrants with an exercise price of $15.00 with an expiration date of August 1, 2028.

On April 12, 2024, the Company issued 66,667 Series B Warrants with an exercise price of $15.00 with an expiration date of April 12, 2029.

As part of the Business Combination with Western, during the first quarter of 2025, the Company issued to unaffiliated investors a total of 200,000 Series B Warrants in exchange of existing 200,000 Series B Warrants having and expiration date of February 19, 2030 and an exercise price of $15.00.

------

**<u>[Table of Content](#i20cde463f9bc41bd8d781febc1d65735_7)[s](#i20cde463f9bc41bd8d781febc1d65735_7)</u>**

***Series D Warrants***

On March 22, 2022, the Company issued 6,564 Series D Warrants with a subordinated convertible promissory note at an exercise price of $42.30 and an expiration date of September 22, 2027.

On November 22, 2022, the Company had issued 32,819 warrants with subordinated convertible promissory note at an exercise price of $42.30 and an expiration date of April 21, 2028.

As part of the Business Combination with Western, during the first quarter of 2025, the Company issued to unaffiliated investors a total of 242,424 Series D Warrants in exchange of existing 39,382 Series D Warrants having an exercise price of $15.00 and an expiration date of February 19, 2029.

***Other Warrants***

On March 8, 2022, the Company issued 17,636 warrants to the originators of $700,000 of investor notes at exercise price of $0.92 with the expiry on March 8, 2026.

As part of the Business Combination with Western, during the first quarter of 2025, the Company issued to unaffiliated investors a total of 9,006 warrants in exchange of existing 17,636 warrants having an expiration date of February 19, 2029 and an exercise price of $9.59121

*<u>Common Stock Subject to Possible Redemption</u>*

The Company accounts for its common stock subject to possible redemption in accordance with the guidance in ASC 480. Shares of common stock subject to mandatory redemption (if any) are classified as a liability instrument and are measured at fair value. Conditionally redeemable common stock (including common stock that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company's control) is classified as temporary equity. At all other times, common stock is classified as stockholders' equity. The Company's shares of common stock sold in the initial public offering of Western feature certain redemption rights that are considered to be outside of the Company's control and subject to occurrence of uncertain future events.

---

| | | |
|:---|:---|:---|
| **Table 16.2: Details of Common Stock Subject to Possible Redemption** | **Table 16.2: Details of Common Stock Subject to Possible Redemption** | **Table 16.2: Details of Common Stock Subject to Possible Redemption** |
|  | Number of Shares | Amount |
| Common stock subject to possible redemption as of December 31, 2024 | 5796 | $1917309 |
| &nbsp;&nbsp;&nbsp;Less: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Redemption | (3163) | (1001216) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Release of common stock subject to redemption | (2633) | (916093) |
| Common stock subject to possible redemption as of September 30, 2025 | - | $- |

---

17. CONCENTRATIONS, RISKS AND UNCERTAINTIES

*<u>Credit risk</u>*

The Company's primary bank deposits are located in the United States. Those deposits are provided protection under FDIC insurance up to maximum of $250,000. Any deposits in excess of the aforementioned maximum are at risk of loss if those banks become insolvent. The Company is subject to risk borne from credit extended to customers.

*<u>Interest risk</u>*

The Company is subject to interest rate risk when its loans become due and require refinancing or if the prime rate adjusts, as the Company's loans are based on adjustable interest rates.

------

**<u>[Table of Content](#i20cde463f9bc41bd8d781febc1d65735_7)[s](#i20cde463f9bc41bd8d781febc1d65735_7)</u>**

*<u>Inflation risk</u>*

Management monitors changes in prices levels. Historically, inflation has not materially impacted the Company's financial statements; however, significant increases in the cost of labor that cannot be passed on to the Company's customers could adversely impact the Company's results of operations.

*<u>Concentration risks</u>*

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Table 17.1: Revenue Concentration by Customer - Based on % of Revenue** | **Table 17.1: Revenue Concentration by Customer - Based on % of Revenue** | **Table 17.1: Revenue Concentration by Customer - Based on % of Revenue** | **Table 17.1: Revenue Concentration by Customer - Based on % of Revenue** | **Table 17.1: Revenue Concentration by Customer - Based on % of Revenue** | **Table 17.1: Revenue Concentration by Customer - Based on % of Revenue** | **Table 17.1: Revenue Concentration by Customer - Based on % of Revenue** | **Table 17.1: Revenue Concentration by Customer - Based on % of Revenue** | **Table 17.1: Revenue Concentration by Customer - Based on % of Revenue** |
|  | For the Three Months Ended | For the Three Months Ended | For the Three Months Ended | For the Three Months Ended | For the Nine Months Ended | For the Nine Months Ended | For the Nine Months Ended | For the Nine Months Ended |
|  | September 30, 2025 | September 30, 2025 | September 30, 2024 | September 30, 2024 | September 30, 2025 | September 30, 2025 | September 30, 2024 | September 30, 2024 |
| Customer | Amount | % | Amount | % | Amount | % | Amount | % |
| A | $1131581 | 29.5% | $1183445 | 26.6% | $3382634 | 29.2% | $2488622 | 18.2% |
| B | 665813 | 17.4% | 694743 | 15.6% | 2027148 | 17.5% | 2372942 | 17.3% |
| C | 369025 | 9.6% | 614556 | 13.8% | 1101765 | 9.5% | 2206993 | 16.1% |
| D | 315240 | 8.2% | 538251 | 12.1% | 1072194 | 9.3% | 1707290 | 12.5% |

---

---

| | | |
|:---|:---|:---|
| **Table 17.2: Accounts Receivable Concentration by Customer - Based on % of Accounts Receivable, Net** | **Table 17.2: Accounts Receivable Concentration by Customer - Based on % of Accounts Receivable, Net** | **Table 17.2: Accounts Receivable Concentration by Customer - Based on % of Accounts Receivable, Net** |
|  | September 30, 2025 | September 30, 2025 |
| Customer | Amount | % |
| 1 | $768954 | 25% |
| 2 | 479151 | 15% |
| 3 | 373236 | 12% |

---

Prior to the Management Services Agreement and a Release agreement with Ed Burns of SLG on March 31, 2025, the company had combined all SLG customers as one customer for purposes of customer concentration disclosures due to the nature of the relationship. Once the acquisition was complete, the company has re-evaluated this disclosure to break out all SLG customers individually, therefore the amounts reported above are not comparable to the first quarter of 2025 amounts previously reported. As of December 31, 2024, no individual customer accounts receivable balances were 10% or greater than the total accounts receivable balance.

18. FAIR VALUE DISCLOSURES

The Company estimates the fair value of its debt by discounting the future cash flows of each instrument using estimated market rates of debt instruments with similar maturities and credit profiles. These inputs are classified as Level 3 within the fair value hierarchy. As of September 30, 2025 and December 31, 2024, the carrying value reported in the consolidated balance sheet for the Company's notes payable approximated its fair value.

There were no assets or liabilities recorded at fair value on a recurring basis as of September 30, 2025. As of December 31, 2024, the Company had recorded liabilities at fair value on a recurring basis for subordinated convertible promissory notes and Series A Convertible Preferred Stock and equity warrants at fair value on a recurring basis. The subordinated convertible promissory notes carry an interest rate that is indicative of the Company's overall borrowing cost and the length of time until maturity is not expected to significantly impact their value. The convertible preferred stock, which is akin to debt, has been discounted to its presented carrying value in accordance with the debt discounts and redemption premiums recognized.

Assets and liabilities that are measured at fair value on a non-recurring basis include intangible assets and goodwill. These items are recognized at fair value when they are considered to be impaired.

There were no fair value adjustments for assets and liabilities measured on a non-recurring basis. The Company discloses fair value information about financial instruments for which it is practicable to estimate that value.

------

**<u>[Table of Content](#i20cde463f9bc41bd8d781febc1d65735_7)[s](#i20cde463f9bc41bd8d781febc1d65735_7)</u>**

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Table 18: Fair Value Hierarchy - 2024** | **Table 18: Fair Value Hierarchy - 2024** | **Table 18: Fair Value Hierarchy - 2024** | **Table 18: Fair Value Hierarchy - 2024** | **Table 18: Fair Value Hierarchy - 2024** |
|  | As of December 31, 2024 | As of December 31, 2024 | As of December 31, 2024 | As of December 31, 2024 |
|  | Level 1 | Level 2 | Level 3 | Total |
| Liabilities: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Subordinated convertible promissory notes | $- | $- | $5490324 | $5490324 |
| &nbsp;&nbsp;&nbsp;Series A Convertible Preferred Stock | - | - | 1294117 | 1294117 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total liabilities | $- | $- | $6784441 | $6784441 |
| Equity: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Warrants | $- | $- | $2687074 | $2687074 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total equity | $- | $- | $2687074 | $2687074 |

---

19. RELATED PARTY TRANSACTIONS

***Promissory Note – Related Party***

On September 20, 2024, the Company entered into a promissory note with Western Acquisition Ventures Sponsor, LLC (the "Sponsor") for $230,000, pursuant to which the Company can borrow up to an aggregate principal amount of $230,000. The Promissory Note, with an interest rate of 10% per annum is payable upon the sooner of the consummation of the Business Combination with Cycurion. As of September 30, 2025, the Company had borrowed the full $230,000 and nothing was available for withdrawal. The Company deemed the interest on the loan to be immaterial and as such did not record any interest relating to the note as of September 30, 2025.

Personal guarantees were entered by Emmit McHenry, Kurt McHenry, and Alvin McCoy III, as officers and stockholders of the Company in support of the Main Street Bank Loan and Security Agreement.

Axxum purchased an AT&T contract relationship from Archura, LLC, a company owned by Emmit McHenry and Kurt McHenry at the end of 2018. The contract relationship includes five purchase orders to deliver networking services to AT&T and its clients. The total sales of these five purchase orders were $97,658 and $119,279, as of September 30, 2025 and December 31, 2024, respectively.

***Loans payable***

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Table 19: Details of Loans Payable - Related Party** | **Table 19: Details of Loans Payable - Related Party** | **Table 19: Details of Loans Payable - Related Party** | **Table 19: Details of Loans Payable - Related Party** | **Table 19: Details of Loans Payable - Related Party** |
|  | September 30, 2025 | December 31, 2024 | Weighted Average Interest Rate | Maturity<br> (Calendar Year) |
| Loans to two directors issued in 2023 | $103400 | $130900 | 24.0% | 2023 |
| Loan to a director issued in 2024 | 20250 | 20250 | 24.0% | 2025 |
| &nbsp;&nbsp;&nbsp;&nbsp;Funded loans payable - related party principal | 123650 | 151150 |  |  |
| Less: Unamortized debt-issuance costs and discounts | - | (3062) |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Loans payable - related party - current | $123650 | $148088 |  |  |

---

During the nine months ended September 30, 2025 and 2024, the Company record amortization of debt discount of $3,062 and $0, respectively.

------

**<u>[Table of Content](#i20cde463f9bc41bd8d781febc1d65735_7)[s](#i20cde463f9bc41bd8d781febc1d65735_7)</u>**

20. EARNINGS PER SHARE

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Table 20.1: Details of Basic and Dilutive (Loss)/Earnings Per Share** | **Table 20.1: Details of Basic and Dilutive (Loss)/Earnings Per Share** | **Table 20.1: Details of Basic and Dilutive (Loss)/Earnings Per Share** | **Table 20.1: Details of Basic and Dilutive (Loss)/Earnings Per Share** | **Table 20.1: Details of Basic and Dilutive (Loss)/Earnings Per Share** |
|  | For the Three Months Ended | For the Three Months Ended | For the Nine Months Ended | For the Nine Months Ended |
|  | September 30, 2025 | September 30, 2024 | September 30, 2025 | September 30, 2024 |
| **<u>Basic net (loss)/income per share:</u>** |  |  |  |  |
| &nbsp;&nbsp;**Numerator** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Net (loss)/income including non-controlling interests | $(3240017) | $116093 | $(18778917) | $109712 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Less: Net loss attributable to non-controlling interest | (116700) | - | (218359) | - |
| &nbsp;&nbsp;&nbsp;&nbsp;Net (loss)/income attributable to common stockholders - basic | (3123317) | 116093 | (18560558) | 109712 |
| &nbsp;&nbsp;**Denominator** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Weighted average shares outstanding - basic | 1965285 | 498941 | 1252543 | 498941 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Basic net (loss)/income per share attributable to common stockholders | $(1.59) | $0.23 | $(14.82) | $0.22 |
| **<u>Diluted net (loss)/income per share:</u>** |  |  |  |  |
| &nbsp;&nbsp;**Numerator** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Net (loss)/income attributable to common stockholders - basic | $(3123317) | $116093 | $(18560558) | $109712 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Add back interest for subordinated convertible promissory note | 2500 | 2500 | 40833 | 7500 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net (loss)/income attributable to common stockholders - diluted | $(3120817) | $118593 | $(18519725) | $117212 |
| &nbsp;&nbsp;**Denominator** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Weighted average shares outstanding - basic | 1965285 | 498941 | 1252543 | 498941 |
| &nbsp;&nbsp;&nbsp;&nbsp;Weighted-average effect of potentially dilutive securities: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Conversion of subordinated convertible promissory note | 3333 | 57884 | 3333 | 57884 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Conversion of Series A Convertible Preferred Stock | - | 70203 | - | 70203 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Conversion of Series B Convertible Preferred Stock | - | 200000 | - | 175203 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Exercise of investor and placement agent warrants | - | 292806 | - | 292806 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Weighted average shares outstanding - diluted | 1968618 | 1119834 | 1255876 | 1095037 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dilutive net (loss)/income per share attributable to common stockholders | $(1.59) | $0.11 | $(14.75) | $0.11 |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Table 20.2: Details of Potentially Dilutive Effect of Securities Excluded from Dilutive EPS due to Anti-Dilutive Effect** | **Table 20.2: Details of Potentially Dilutive Effect of Securities Excluded from Dilutive EPS due to Anti-Dilutive Effect** | **Table 20.2: Details of Potentially Dilutive Effect of Securities Excluded from Dilutive EPS due to Anti-Dilutive Effect** | **Table 20.2: Details of Potentially Dilutive Effect of Securities Excluded from Dilutive EPS due to Anti-Dilutive Effect** | **Table 20.2: Details of Potentially Dilutive Effect of Securities Excluded from Dilutive EPS due to Anti-Dilutive Effect** |
|  | For the Three Months Ended | For the Three Months Ended | For the Nine Months Ended | For the Nine Months Ended |
|  | September 30, 2025 | September 30, 2024 | September 30, 2025 | September 30, 2024 |
| Conversion of Series A Convertible Preferred Stock | 151126 | - | 114388 | 70203 |
| Conversion of Series B Convertible Preferred Stock | 45 | - | 56601 | 162637 |
| Conversion of Series C Convertible Preferred Stock | 1202 | - | 1202 | - |
| Conversion of Series D Convertible Preferred Stock | 5000 | - | 15264 | - |
| Conversion of Series E Convertible Preferred Stock | 2 | - | 1 | - |
| Exercise of investor and placement agent warrants | 613255 | - | 491652 | 315028 |

---

21. COMMITMENTS AND CONTINGENCIES

*<u>Registration Rights</u>*

The holders of Founder Shares, Private Placement Units, and units that may be issued upon conversion of working capital loans, if any, are entitled to registration rights pursuant to a registration rights agreement that was signed on the date of the IPO. These holders will be entitled to certain demand and "piggyback" registration rights. However, the registration rights agreement provides that the Company will not permit any registration statement filed under the Securities Act to become

------

**<u>[Table of Content](#i20cde463f9bc41bd8d781febc1d65735_7)[s](#i20cde463f9bc41bd8d781febc1d65735_7)</u>**

effective until the termination of the applicable lock-up period for the securities to be registered. The Company will bear the expenses incurred in connection with the filing of any such registration statements.

*<u>Business Combination Marketing Agreement</u>*

The Company entered into a business combination marketing agreement on January 11, 2022 (the "Business Combination Marketing Agreement") with Alliance Global Partners/A.G.P. ("A.G.P.") whereby A.G.P. is to act as an advisor in connection with a Business Combination to assist the Company in holding meetings with its stockholders to discuss the potential Business Combination and the target business' attributes, introduce the Company to potential investors that are interested in purchasing the Company's securities in connection with a Business Combination, assist the Company in obtaining stockholders' approval for a Business Combination, and assist the Company with its press releases and public filings in connection with a Business Combination. The Company was to pay A.G.P. a fee for such marketing services upon the consummation of a Business Combination in an amount equal to 4.5% of the gross proceeds of the IPO, or $5,175,000 in the aggregate (exclusive of any applicable finders' fees that might become payable). The Business Combination Marketing Agreement will be terminated upon entry into the Advisory Agreement (described below).

*<u>Advisory Agreement with A.G.P.</u>*

A.G.P. was a financial advisor to both Western in connection with the Business Combination transaction. Upon the completion of the Business Combination, A.G.P.: (i) received a cash fee of $500,000 shares of common stock and warrants to purchase 16,667 shares of common stock at an exercise price of $150.00 per share. Pursuant to the advisory agreement (the "Advisory Agreement"), Western shall pay A.G.P. a total transaction fee equal to $2,500,000 (the "Transaction Fee") upon the closing of the Business Combination. The Transaction Fee will be payable in the form of preferred shares of Cycurion that are convertible into 16,667 shares of common stock (such preferred shares or the common stock into which they convert, the "Transaction Fee Shares"), for a price per share of common stock equal to $5.00. A portion of the Transaction Fee Shares shall be subject to forfeiture and return to the Company for cancellation once A.G.P. converts and sells Transaction Fee Shares generating sales proceeds (excluding commissions) of $2,500,000.

The Transaction Fee Shares shall be subject to a lock-up ending on the earlier of (i) the date on which 75% of the outstanding Series B Convertible Preferred Stock is converted into shares of the Combined Company's common stock and (ii) three months from February 14, 2025, which was the closing date of the de-SPAC (the "Lock-Up Termination Date"). After the Lock-Up Termination Date, A.G.P. may convert the Transaction Fee Shares and sell them subject to a leak-out provision that limits A.G.P.'s sales of Transaction Fee Shares on any given date to 10% of the cumulative trading volume of the common stock for such date (including pre-market, market and post-market trading) as reported by Bloomberg, LP. This restriction shall remain in effect beginning on the Lock-Up Termination Date and ending on the date on which 100% of the Series B Convertible Preferred Stock outstanding as of the closing is converted into shares of our common stock.

The parties amended the Advisory Agreement (the "Amended Advisory Agreement"), pursuant to which Western shall pay A.G.P. the Transaction Fee in the form of preferred shares of Cycurion that are convertible into 166,667 shares of common stock (such preferred shares or the common stock into which they convert, the "Amended Transaction Fee Shares"), for a price per share of common stock of $0.50. A portion of the Amended Transaction Fee Shares shall be subject to forfeiture and return to the Company for cancellation once A.G.P. converts and sells Transaction Fee Shares generating sales proceeds (excluding commissions) of $2,500,000.

The Amended Transaction Fee Shares shall be subject to a lock-up ending on the earlier of (i) the date on which 75% of the outstanding Series B Convertible Preferred Stock is converted into shares of the Combined Company's common stock and (ii) six months from the Lock-Up Termination Date. After the Lock-Up Termination Date, A.G.P. may convert the Amended Transaction Fee Shares and sell them subject to a leak-out provision that limits A.G.P.'s sales of Amended Transaction Fee Shares on any given date to 10% of the cumulative trading volume of the common stock for such date (including pre-market, market and post-market trading) as reported by Bloomberg, LP. This restriction shall remain in effect beginning on the Lock-Up Termination Date and ending on the date on which 100% of the Series B Convertible Preferred Stock outstanding as of the closing is converted into shares of our common stock.

Upon the execution of the Advisory Agreement, the Business Combination Marketing Agreement, dated January 11, 2022, between Western and A.G.P. in which Western and Cycurion Sub caused the combined company to issue to A.G.P. 8,333 shares of common stock of the combined company in full satisfaction of the fees, was terminated, and such shares of common stock extinguished in their entirety.

------

**<u>[Table of Content](#i20cde463f9bc41bd8d781febc1d65735_7)[s](#i20cde463f9bc41bd8d781febc1d65735_7)</u>**

*<u>Agreements with Seward & Kissel LLP</u>*

On November 27, 2024, we entered into a revised engagement letter (the "Revised Engagement Letter") with Seward & Kissel LLP ("Seward & Kissel"), pursuant to which Western and Cycurion agreed to pay approximately $1.3 million of its outstanding legal fees and expenses ("Legal Fees") in shares of common stock in connection with the Business Combination. Following the closing of the Business Combination on February 14, 2025 and in connection with the Revised Engagement Letter, we issued to Seward & Kissel 8,333 shares of common stock and a pre-funded warrant that is exercisable for approximately $1.3 million in shares of common stock (the "Seward & Kissel Pre-Funded Warrant"); provided that once the net proceeds from the sale of the shares equals the Legal Fees, the remaining shares of common stock, including such common stock exercisable under the Seward & Kissel Pre-Funded Warrant, shall be returned to the Cycurion. We plan to enter into an exchange agreement with Seward & Kissel to exchange the Seward & Kissel Pre-Funded Warrant for a convertible promissory note that is convertible into such number of shares equal to the Legal Fees.

On February 14, 2025, Cycurion entered into pre-funded warrant with Seward & Kissel Pre-Funded Warrant that is exercisable for approximately $1.3 million in shares of Common Stock, or up to 83,333 shares of Common Stock; provided that once the net proceeds from the sale of the shares equals the $1.3 million in Legal, the remaining shares of Common Stock, including such Common Stock exercisable under the Seward & Kissel Pre-Funded Warrant, shall be returned to Cycurion.

The Seward & Kissel Pre-Funded Warrant provides that the holder may not exercise any portion of the Seward & Kissel Pre-Funded Warrant to the extent that immediately prior to or after giving effect to such exercise the holder would own more than 4.99% upon 61 days' prior notice. The exercise price for each share of Common Stock underlying the Seward & Kissel Pre-Funded Warrant is $0.0030. The Seward & Kissel Pre-Funded Warrant is immediately exercisable upon issuance and may be exercised at any time until the Seward & Kissel Pre-Funded Warrant is exercised in full.

Seward & Kissel LLP may not exercise any portion of the warrants or Seward & Kissel Pre-Funded Warrant, as applicable, to the extent that the holder would own more than 4.99% of our outstanding Common Stock immediately after exercise, as such percentage ownership is determined in accordance with the terms of the Seward & Kissel Pre-Funded Warrant.

In lieu of making the cash payment otherwise contemplated to be made to us upon exercise of the Seward & Kissel Pre-Funded Warrant in payment of the aggregate exercise price, the holder may elect instead to receive upon such exercise (either in whole or in part) the net number of shares of our Common Stock determined according to a formula set forth in the Seward & Kissel Pre-Funded Warrant.

*<u>Agreement with Baker & Hostetler LLP</u>*

In 2023, Western agreed to pay approximately $788,030 of its obligations to its counsel, Baker Hostetler LLP, in shares of common stock following the Business Combination, which will be issued at a price per share equal to $10.00, or 2,627 shares.

***<u>Equity Line of Credit</u>***

*<u>Equity Purchase Agreement</u>*

On April 7, 2025 (the "Execution Date"), we entered into the Equity Purchase Agreement with Yield Point NYC LLC ("Yield Point"). Under the Equity Purchase Agreement, we have the right, but not the obligation, to direct Yield Point to purchase up to $60.0 million (the "Maximum Commitment Amount") in shares of our common stock upon satisfaction of certain terms and conditions contained in the Equity Purchase Agreement, including, without limitation, an effective registration statement filed with the SEC registering the resale of the shares of Put Stock (defined below) and the shares of Commitment Stock (defined below) and additional shares to be sold to Yield Point from time to time under the Equity Purchase Agreement. The term of the Equity Purchase Agreement began on the Execution Date and ends on the earlier of (i) the date on which Yield Point shall have purchased shares of common stock issued, or that we shall be entitled to issue, per any applicable Put Notice in accordance with the terms and conditions of the Equity Purchase Agreement (the "Put Stock") equal to the Maximum Commitment Amount, (ii) the date that is twelve (12) months from the date the registration statement is declared effective, (iii) written notice of termination by us to Yield Point (which shall not occur at any time that Yield Point holds any of the shares of Put Stock), or (iv) written notice of termination by Yield Point to us pursuant to (the "Commitment Period").

------

**<u>[Table of Content](#i20cde463f9bc41bd8d781febc1d65735_7)[s](#i20cde463f9bc41bd8d781febc1d65735_7)</u>**

During the Commitment Period, we may direct Yield Point to purchase shares of Put Stock by delivering a notice (a "Put Notice") to Yield Point. We shall, in our sole discretion, select the number of shares of Put Stock requested in each Put Notice. However, such amount may not exceed the Maximum Put Amount (as defined in the Equity Purchase Agreement). The purchase price to be paid by Yield Point for the shares of Put Stock will be ninety percent (90%) of the lowest trade of the common stock on the Principal Market during the Valuation Period (as defined in the Equity Purchase Agreement).

In consideration for Yield Point's execution and delivery of, and performance under the Equity Purchase Agreement, on the Execution Date, we, in our discretion, either were to (i) pay to Yield Point in cash $1.8 million ("Commitment Cash") or (ii) issue the Pre-Funded Warrant to Yield Point in a form acceptable to Yield Point in its sole discretion and having an exercise price per share of $0.0030, for Yield Point's purchase of shares of common stock (the "Commitment Stock") having a value of $1.8 million based on closing price of the common stock on April 6, 2025. We chose to issue the Pre-Funded Warrant. All of the shares of Commitment Stock were fully earned as of the Execution Date, and the issuance of the shares of Commitment Stock is not contingent upon any other event or condition, including, without limitation, the effectiveness of the Initial Registration Statement (defined below) or our submission of a Put Notice to Yield Point and irrespective of any termination of the Equity Purchase Agreement.

In accordance with the Equity Purchase Agreement, a registration statement on Form S-1 (the "Initial Registration Statement") covering only the resale of the shares of Put Stock and Commitment Stock was filed with the SEC on May 7, 2025.

*<u>Pre-Funded Warrant</u>*

The pre-funded warrant with Yield Point (the "Yield Point Pre-Funded Warrant") certifies that, for value received, Yield Point is entitled to be issued up to 150,000 shares of common stock as its commitment fee ("Commitment Fee") and has an initial exercise price of $0.003 per share. The Yield Point Pre-Funded Warrant was offered for the Commitment Fee in connection with the Equity Purchase Agreement for shares of common stock, and provides that the holder may not exercise any portion of the Yield Point Pre-Funded Warrant to the extent that immediately prior to or after giving effect to such exercise the holder would own more than 4.99%, which ownership cap may be increased by the holder up to 9.99% upon 61 days' prior notice. The exercise price for each share of common stock underlying the Yield Point Pre-Funded Warrant is $0.003. The Yield Point Pre-Funded Warrant is immediately exercisable upon issuance and may be exercised at any time until the Pre-Funded Warrant is exercised in full.

A holder of the Yield Point Pre-Funded Warrant may not exercise any portion of the warrants or Yield Point Pre-Funded Warrant, as applicable, to the extent that the holder would own more than 4.99% (or, at the holder's option upon issuance, 9.99%) of our outstanding common stock immediately after exercise, as such percentage ownership is determined in accordance with the terms of the Yield Point Pre-Funded Warrant.

In lieu of making the cash payment otherwise contemplated to be made to us upon exercise of the Yield Point Pre-Funded Warrant in payment of the aggregate exercise price, the holder may elect instead to receive upon such exercise (either in whole or in part) the net number of shares of our common stock determined according to a formula set forth in the Yield Point Pre-Funded Warrant.

During the three months and nine months ended September 30, 2025, 83,333 and 150,000 of these shares have been exercised, respectively. As of September 30, 2025, all Yield Point Pre-Funded Warrants have been exercised.

*<u>Registration Rights Agreement</u>*

On April 7, 2025 (the "RRA Execution Date"), in connection with the Equity Purchase Agreement, we entered into a registration rights agreement with Yield Point (the "Registration Rights Agreement"), pursuant to which we shall, by May 7, 2025, file with the SEC the Initial Registration Statement covering the maximum number of (i) shares of Commitment Stock, (ii) shares of Put Stock, which have been, or which may, from time to time be issued, including without limitation all of the shares of common stock which have been issued or will be issued to Yield Point under the Equity Purchase Agreement (without regard to any limitation or restriction on purchases), and (iii) any and all shares of capital stock issued or issuable with respect to the Put Stock, Commitment Stock, and the Equity Purchase Agreement as a result of any stock split, combination, stock dividend, recapitalization, exchange, or similar event, or otherwise, without regard to any limitation on purchases under the Equity Purchase Agreement (the "Registrable Securities"), as shall be permitted to be included thereon in accordance with applicable SEC rules, regulations, and interpretations so as to permit the resale of the Registrable Securities by Yield Point, including, but not limited to, under Rule 415 at then-prevailing market prices (and

------

**<u>[Table of Content](#i20cde463f9bc41bd8d781febc1d65735_7)[s](#i20cde463f9bc41bd8d781febc1d65735_7)</u>**

not fixed prices). The Initial Registration Statement shall register only Registrable Securities. The Initial Registration Statement and any amendment thereto was declared effective by the SEC in May 2025.

*<u>Non-Redemption Agreement</u>*

On August 6, 2024, the Company, Western Acquisition Ventures Sponsor, LLC (the "Sponsor") and RiverNorth SPAC Arbitrage Fund, LP (the "RiverNorth") entered into a non-redemption agreement (the "Non-Redemption Agreement") whereby the Sponsor plans to transfer to RiverNorth 167 shares each month over the next three months for agreeing not to redeem the 3,327 that it currently holds prior to the business combination.

On October 9, 2024, the Company, the Sponsor and RiverNorth entered into extended non-redemption agreement whereby the Sponsor plans to transfer to RiverNorth 167 shares each month over the next three months for agreeing not to redeem the 3,327 that it currently holds prior to the business combination.

*<u>Employment Agreements</u>*

On December 27, 2023, we entered into an employment agreement with James P. McCormick whereby the Company agreed to pay a total of $125,000 of total compensation annually, including $40,000 in cash and $85,000 in stock payment. On October 30, 2024, we entered into an amendment to the employment agreement with James P. McCormick whereby the Company agreed to pay total compensation of $200,000, including $40,000 in cash at the closing of the Business Combination and the remaining $160,000 in cash from the proceeds that the Company receives from any capital raising transaction following the closing of the Business Combination, including the proceeds from an equity line of credit to be entered into by and among the Company, Cycurion and the investors named therein; provided that the Company shall only be obligated to apply up to 15% of the proceeds from each capital raise until Mr. McCormick's compensation of $200,000 has been paid in full.

On December 1, 2024, Cycurion and L. Kevin Kelly, Chief Executive Officer, entered into an employment agreement on a two-year term, commencing on December 1, 2024 and ending on December 1, 2026. During the employment period, Mr. Kelly will receive an annual base salary of $325,000, and equity compensation of $500,000 of Company common stock in the first year of the employment agreement, payable quarterly. Mr. Kelly is eligible for a performance bonus based on the Company's results. The targeted performance bonus is $325,000 for year-one, and the performance bonus will increase for subsequent years based on future financial and non-financial results

On January 1, 2025, Cycurion and Alvin McCoy, III, Chief Financial Officer, entered into an employment agreement on a two-year term, commencing on January 1, 2025 and ending on December 31, 2026. During the employment period, Mr. McCoy, III will receive an annual base salary of $325,000 and equity compensation of $500,000 of Company stock in the first year of the employment agreement, payable quarterly. Mr. McCoy, III is eligible for a performance bonus based on the Company's performance. The targeted performance bonus is $325,000 for year-one, and the performance bonus will increase for subsequent years based on future financial and non-financial results.

*<u>Retention Packages</u>*

On June 16, 2025, the Board of Directors approved a retention package for L. Kevin Kelly, Chief Executive Officer, and Alvin McCoy III, Chief Financial Officer, and issued each officer 100,000 shares of Common Stock under the Company's 2025 Equity Incentive Plan.

*<u>Inflation Reduction Act of 2022 (the "IR Act")</u>*

On August 16, 2022, the Inflation Reduction Act of 2022 (the "IR Act") was signed into federal law. The IR Act provides for, among other things, a new U.S. federal 1% excise tax on certain repurchases of stock by publicly traded U.S. domestic corporations and certain U.S. domestic subsidiaries of publicly traded foreign corporations occurring on or after January 1, 2023. The excise tax is imposed on the repurchasing corporation itself, not its shareholders from which shares are repurchased. The amount of the excise tax is generally 1% of the fair market value of the shares repurchased at the time of the repurchase. However, for purposes of calculating the excise tax, repurchasing corporations are permitted to net the fair market value of certain new stock issuances against the fair market value of stock repurchases during the same taxable year. In addition, certain exceptions apply to the excise tax. The U.S. Department of the Treasury (the "Treasury") has been given authority to provide regulations and other guidance to carry out and prevent the abuse or avoidance of the excise tax.

------

**<u>[Table of Content](#i20cde463f9bc41bd8d781febc1d65735_7)[s](#i20cde463f9bc41bd8d781febc1d65735_7)</u>**

Any redemption or other repurchase that occurs after December 31, 2022, in connection with a business combination, extension vote or otherwise, may be subject to the excise tax. Whether and to what extent the Company would be subject to the excise tax in connection with a business combination, extension vote or otherwise would depend on a number of factors, including (i) the fair market value of the redemptions and repurchases in connection with the business combination, extension or otherwise, (ii) the structure of a business combination, (iii) the nature and amount of any "PIPE" or other equity issuances in connection with a business combination (or otherwise issued not in connection with a business combination but issued within the same taxable year of a business combination) and (iv) the content of regulations and other guidance from the Treasury. In addition, because the excise tax would be payable by the Company and not by the redeeming holder, the mechanics of any required payment of the excise tax have not been determined. The foregoing could cause a reduction in the cash available on hand to complete a business combination and in the Company's ability to complete a business combination.

As of September 30, 2025 and December 31, 2024, the Company's stockholders have redeemed a total of 380,701 and 377,537 shares of common stock resulting in $1.2 million and $1.2 million of excise tax liability, calculated as 1% of the value of the shares redeemed, respectively

22. SUBSEQUENT EVENTS

The Company evaluates subsequent events that have occurred after the balance sheet date but before the financial statements are issued which is up to and through November 14, 2025. There are two types of subsequent events: (i) recognized, or those that provide additional evidence with respect to conditions that existed at the date of the balance sheet, including the estimates inherent in the process of preparing consolidated financial statements, and (ii) non-recognized, or those that provide evidence with respect to conditions that did not exist at the date of the balance sheet but arose subsequent to that date.

On October 1, 2025, the Company fully paid off the term bank loan held with Main Street Bank. As of September 30, 2025 the principal balance of this loan was $276,012.

On October 14, 2025, we received written notice from the staff of Nasdaq Listing Qualifications (the "Staff") that it has determined to commence proceedings to delist our common stock from the Nasdaq Global Market. As previously announced in a Current Report filed with the U.S. Securities and Exchange Commission ("SEC"), on April 15, 2025, the Staff notified the Company on April 9, 2025 that, for the prior 30 consecutive business days, the closing bid price of our common stock had been below the minimum of $1.00 per share required for continued listing on The Nasdaq Global Market under Nasdaq Listing Rule 5550(a)(2) (the "Bid Price Rule"). The notification letter stated that we would be afforded 180 calendar days, or until October 6, 2025, to regain compliance. The Company did not regain compliance with the Bid Price Rule by October 6, 2025, and the listed security was subject to delisting from The Nasdaq Global Market.

On October 20, 2025, the Company submitted its request to the Nasdaq Global Market to appeal the Staff's determination to a Hearings Panel (the "Panel") pursuant to the procedures set forth in the Nasdaq Listing Rule 5800 Series, which stayed the suspension of the Company's securities and the filing of a Form 25-NSE with the SEC that would remove the Company's shares of common stock from listing and registration on The Nasdaq Stock Market. The Company's hearing was scheduled for November 20, 2025.

On October 27, 2025, the Company announced a one-for-thirty reverse stock split of the Company's shares of common stock, par value $0.0001 per share (the "Reverse Stock Split") that took effect with the commencement of business on October 27, 2025. The Company effected the Reverse Stock Split by filing the Second Amendment to the Second Amended and Restated Certificate of Incorporation with the Secretary of State of the State of Delaware. The Company's shares of common stock began trading on a split-adjusted basis on The Nasdaq Global Market, when the market opened on October 27, 2025, under the existing trading symbol "CYCU" and new CUSIP number 95758L305. As a result of the Reverse Stock Split, every thirty of the Company's issued shares of common stock was combined into one issued share of common stock, without any change to the par value per share and without any change in the total number of authorized shares of common stock. The number of outstanding shares of common stock was reduced from approximately 86,533,435 shares to approximately 2,884,447 shares. No fractional shares were issued in connection with the Reverse Stock Split. Stockholders who otherwise held a fraction of a share of common stock of the Company will receive a cash payment (without interest and subject to withholding taxes, as applicable) in lieu thereof at a price equal to that fraction of a share to which the stockholder would otherwise be entitled, multiplied by the closing price of the Company's shares on The Nasdaq Global Market on the trading day immediately preceding the effective date of the Reverse Stock Split.

------

**<u>[Table of Content](#i20cde463f9bc41bd8d781febc1d65735_7)[s](#i20cde463f9bc41bd8d781febc1d65735_7)</u>**

On November 11, 2025, the Company announced that it received a letter Nasdaq stating that Nasdaq has determined that the Company has regained compliance with Nasdaq's Bid Price Rule requirement under Listing Rule 5450(a)(1). The Company is now in compliance with Nasdaq Global Market's listing requirements. Additionally, Nasdaq confirmed that the previously scheduled hearing before the Nasdaq Hearings Panel on November 20, 2025 has been canceled. The Company's securities will continue to be listed and traded on The Nasdaq Stock Market without interruption.

------

**<u>[Table of Content](#i20cde463f9bc41bd8d781febc1d65735_7)[s](#i20cde463f9bc41bd8d781febc1d65735_7)</u>**

**ITEM 2. Management's Discussion and Analysis of Financial Condition and Results of Operations**

*Throughout this section, unless otherwise noted, "we," "our," "us," "Cycurion" and the "Company" refer to Cycurion, Inc.*

The following discussion is intended to help the reader understand our business, financial condition, results of operations, liquidity and capital resources. You should read this discussion in conjunction with "Risk Factors," "Special Note Regarding Forward-Looking Statements," and our financial statements and related notes included in our Annual Report on Form 10-K for fiscal year 2024 filed with the SEC on April 17, 2025 (the "2024 Form 10-K") and elsewhere in this Quarterly Report on Form 10-Q, as applicable.

**Special Note Regarding Forward-Looking Statements**

This quarterly report on Form 10-Q contains "forward-looking statements" within the meaning of Section 27A of the Securities Act, and Section 21E of the Securities Exchange Act of 1934 (the "Exchange Act"). Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on our current beliefs, expectations, and assumptions regarding the future of our business, future plans and strategies, projections, anticipated events and trends, the economy, and other future conditions. This includes, without limitation, statements regarding the financial position and the plans and objectives of management for our future operations. Such statements can be identified by the fact that they do not relate strictly to historical or current facts. When used in this quarterly report on Form 10-Q, words such as "anticipate," "believe," "continue," "could," "estimate," "expect," "intend," "may," "might," "plan," "possible," "potential," "predict," "project," "should," "strive," "would" and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking.

These risks include the risks that are identified in the "Risk Factors" section of this quarterly report and of our Annual Report on Form 10-K for the fiscal year ended December 31, 2024, and also include, among others, risks associated with the following:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the occurrence of any event, change or other circumstances, including the outcome of any legal proceedings that may be instituted against us;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the ability to maintain the listing of our securities on The Nasdaq Stock Market, and the potential liquidity and trading of our securities;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the risk of disruption to our current plans and operations;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the ability to recognize the anticipated benefits of our business and the recently closed de-SPAC transaction, which may be affected by, among other things, competition and the ability to grow, manage growth profitably, and retain key employees;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• costs related to our business;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• changes in applicable laws or regulations;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our ability to meet our future capital requirements to fund our operations, which may involve debt and/or equity financing, and to obtain such debt and/or equity financing on favorable terms, and our sources and uses of cash;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our ability to achieve and sustain profitability of our existing lines of business and through our wholly owned subsidiaries;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our ability to raise sufficient capital to continue to acquire cybersecurity companies;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our ability to attract and retain qualified cybersecurity talent;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our ability to successfully execute acquisitions, integrate the acquired businesses, and create synergies as a global cybersecurity consolidator;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our ability to efficiently acquire customers and maintain high client retention rates;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our ability to attract and retain qualified key technology or management personnel and to expand our management team;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our ability to stay in compliance with laws and regulations currently applicable to, or which may become applicable to our business both in the United States and internationally;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our ability to maintain existing license agreements;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our estimates regarding expenses, future revenue, capital requirements, and need for additional financing;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our ability to achieve and maintain profitability in the future;

------

**<u>[Table of Content](#i20cde463f9bc41bd8d781febc1d65735_7)[s](#i20cde463f9bc41bd8d781febc1d65735_7)</u>**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our financial performance; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• other factors disclosed under the section entitled "Risk Factors" in this quarterly report on Form 10-Q.

These forward-looking statements are based on information available as of the date of this quarterly report on Form 10-Q and current expectations, forecasts, and assumptions, and involve a number of judgments, risks, and uncertainties. Accordingly, forward-looking statements should not be relied upon as representing our views as of any subsequent date, and we do not undertake any obligation to update forward-looking statements to reflect events or circumstances after the date they were made, whether as a result of new information, future events, or otherwise, except as may be required under applicable securities laws.

**General and Business Overview**

We were originally incorporated as KAE Holdings, Inc., under the laws of the State of Delaware in 2017, with the purpose of acquiring and holding operating entities in the cybersecurity industry. On July 14, 2020, we changed our corporate name from KAE Holdings, Inc. to Cyber Secure Solutions, Inc., and, on February 24, 2021, to Cycurion, Inc.

We have two first-tier wholly-owned subsidiaries, Cycurion Sub, Inc. (formerly Cycurion, Inc., until February 14, 2025) and Cycurion Crypto Inc., a Delaware corporation formed in July 2025 ("Cycurion Crypto"), and three indirectly wholly-owned second-tier subsidiaries: (i) Axxum Technologies LLC ("Axxum"), a Virginia limited liability company formed in December 2006, (ii) Cloudburst Security LLC ("Cloudburst"), a Virginia limited liability company formed in January 2007, and (iii) Cycurion Innovation, Inc., a Delaware corporation formed in September 2021, in connection with our acquisition of assets from Sabres Security Ltd. ("Sabres"), a leading Israeli-based cyber security provider.

We deliver high-quality, cybersecurity solutions to federal government civilian, defense, and judiciary agencies in addition to commercial clients across a variety of industries. Through our operating subsidiaries and strategic partnerships, we have numerous prime and subcontracts with key government agencies. Our growth engine is driven by organic business solutions and strategic acquisitions of cyber/ infrastructure service providers.

**Our Subsidiaries**

*<u>Cycurion Sub, Inc.</u>*

We own our operating subsidiaries through Cycurion Sub., Inc., a Delaware corporation that, until the closing date of the de-SPAC, was known as "Cycurion, Inc." We continue to conduct our business through the three below-described entities, which are now indirectly wholly-owned second-tier subsidiaries by virtue of the recent closing of the de-SPAC transaction.

*<u>Axxum Technologies LLC</u>*

Organized in the Commonwealth of Virginia on December 29, 2006, Axxum is a cybersecurity provider with successful assignments within the multiple sub-agencies of the Department of Homeland Security. We acquired Axxum in November 2017. Following the acquisition, we continued Axxum's core operations of providing contractor services to its existing federal government customer base while leveraging our existing processes and tools to expand its commercial footprint.

*<u>Cloudburst Security LLC</u>*

Cloudburst is a cybersecurity provider with successful assignments within highly sensitive government agencies and other commercial organizations. We acquired Cloudburst in April 2019. Following the acquisition, we continued Cloudburst's core operations of providing mission-critical and highly sensitive government agencies and other commercial organizations with high-quality, innovative cybersecurity services. Cloudburst focuses on providing tailored solutions that leverage the industry's best minds and technologies to predict, protect, detect, respond, and sustain our clients from the latest evolving cyber threats.

*<u>Cycurion Innovation, Inc.</u>*

Cycurion Innovation, Inc. was formed in connection with our acquisition of assets from Sabres, a leading Israeli-based cyber security provider. It operates our Cycurion Security Platform's line of products allows our customers to improve their cyber posture with its MDP SaaS platform. This platform efficiently bundles and easily implements the external protection of a Web Application Firewall ("WAF") and the internal protection of Bot Mitigation. Bot Mitigation is the

------

**<u>[Table of Content](#i20cde463f9bc41bd8d781febc1d65735_7)[s](#i20cde463f9bc41bd8d781febc1d65735_7)</u>**

reduction of risk to applications, Application Program Interfaces (APIs), and backend services from malicious bot traffic that fuels common automated attacks, such as Distributed Denial of Service ("DDoS") campaigns and vulnerability probing. The costs of single-layer security can be measured in terms of money, time, and risk, as well as the damage wrought by a data breach, which millions of businesses experience each year. Through this interaction of the WAF and Bot Mitigation, the MDP is able to reinforce these layers of security and generate new security layers in real time in response to emerging threats. This process is directed by our Cycurion Security Platform's proprietary, cloud-based artificial intelligence ("AI") algorithm. Crucially, the AI underpinning the MDP platform is constantly evolving to counter new threats. Through a crowdsourcing process, the cloud-based MDP learns from every threat to any protected application and uses that newly acquired knowledge to protect all MDP clients better.

**<u>Master Service Agreement with SLG Innovation, Inc.</u>**

The SLG team has an average of over 25 years of experience in the development, planning, implementation, and management of information systems. SLG's leadership team offers years of combined success in answering the needs of government agencies and healthcare organizations across the country.

The SLG team has worked nationally, as it has served over 25 Department of Health and Human Services agencies, all 50 state governments, and over 250 local governments. Since SLG's inception, it has primarily focused on customers in the middle of the country. The team of professionals has successfully delivered Information Technology, Project Management, and Subject Matter Services to key health and human service projects, including, but not limited to, state Medicaid programs in Illinois, Indiana, Nebraska, and Tennessee, the Indiana Division of Aging, Illinois Early Intervention, the University of Illinois Division of Specialized Care for Children, the Multiple Myeloma Research Foundation, and many more.

We established a subcontractor — prime contractor relationship with SLG in the fall of 2019, where we serviced several government agencies and commercial customers, State of New Mexico, Cognizant, KPMG, and the University of Illinois in support of SLG. Axxum Technologies and SLG Innovation that relationship in 2020. A subcontractor offers its specialized services to a prime contractor. Unlike prime contractors, who focus on the managerial side of the government contract, subcontractors tend to dedicate their efforts to lending subject matter expertise and delivery of service to the project. Technically strong subcontractors, along with a strong subcontractor plan are essential to boost the success of a project.

As a result of the strong technical skills and experience of the cyber teams at Cycurion and its subsidiaries, SLG Innovation entered into a Master Services Agreement (MSA) with Axxum Technologies to provide services to SLG customers. The MSA is task order driven and the number of task orders is modified periodically depending on actual customer requirements for IT and Cybersecurity services. Over the last three years, Axxum Technologies has assisted SLG Innovation in growing its revenue and customer base. As a result, SLG Innovation now represents a majority of Cycurion revenues.

**RCR Acquisition Agreement**

RCR Technology Corporation ("RCR") performs certain services for SLG in its role as an SLG subcontractor and, in that context, became a creditor of SLG. In connection with the transactions contemplated by the SLG Term Sheet, on April 25, 2023, Cycurion Sub and RCR also entered into a term sheet (the "RCR Term Sheet") for a distinct, but related transaction. The RCR Term Sheet contemplates a transaction, pursuant to which RCR will sell to Cycurion all of the accounts receivable of SLG in favor of RCR (but for those accounts that are less than 90 days old as of the date of consummation of the contemplated transaction). The consummation of the transactions contemplated by the RCR Term Sheet is contingent upon the consummation of the transactions contemplated by the SLG Term Sheet. y intend to consummate the transactions contemplated by the RCR Term Sheet in the second half of our current fiscal year. The RCR Term Sheet provides that, if, when, and as the transactions contemplated thereby are consummated, RCR will be issued shares of our common stock.

Further, as amended by the parties, initially effective as of November 29, 2023, and subsequently effective as of April 29, 2024, August 16, 2024 and December 31, 2024, the RCR Term Sheet expires on the soonest of (i) closing of the transactions contemplated thereby, (ii) April 11, 2025, if the transactions contemplated thereby have not closed by then, (iii) Cycurion's termination thereof, and (iv) the mutual termination by all of the parties thereto. Notwithstanding anything to the contrary contained therein, Cycurion may terminate its obligations under the RCR Term Sheet and the transactions contemplated hereby for any reason or for no reason without any further obligations and without any liability at any time through and including April 11, 2025. As of the date of this quarterly report, we do not currently expect to terminate the

------

**<u>[Table of Content](#i20cde463f9bc41bd8d781febc1d65735_7)[s](#i20cde463f9bc41bd8d781febc1d65735_7)</u>**

transactions contemplated by the RCR Term Sheet, as amended, and currently expect to close the transactions in the second half of our current fiscal year.

The foregoing brief summary description of certain terms and provisions of the RCR Term Sheet does not purport to be complete and is qualified in its entirety by reference to the full text of the RCR Term Sheet, a copy of which is attached to the Annual Report on Form 10-K filed with the SEC on April 17, 2025 as Exhibit 10.13 and the full text of the RCR Term Sheet Amendments, a copy of each of which are attached to the Annual Report on Form 10-K filed with the SEC on April 17, 2025 as Exhibit 10.13a, 10.13b and 10.13c. Readers are encouraged to read those Exhibits in full for a more comprehensive understanding of the transaction contemplated by the RCR Term Sheet.

**Acquisition of Technology**

On September 30, 2021, we acquired certain technology assets of Sabres, a leading Israeli-based cyber security provider. As part of the asset purchase agreement, we acquired Multi-Dimensional Protection("MDF"), Web Application Firewall ("WAF") and Bot Mitigation SaaS platforms, and their associated intellectual property.

Our Cycurion Security Platform's (formerly Sabres') line of products allows our customers to improve their cyber posture with its MDP SaaS platform. This platform efficiently bundles and easily implements the external protection of a WAF and the internal protection of Bot Mitigation. Bot Mitigation is the reduction of risk to applications, Application Program Interfaces ("APIs"), and backend services from malicious bot traffic that fuels common automated attacks, such as DDoS campaigns and vulnerability probing. The costs of single-layer security can be measured in terms of money, time, and risk, as well as the damage wrought by a data breach, which millions of businesses experience each year. Through this interaction of the WAF and Bot Mitigation, the MDP is able to reinforce these layers of security and generate new security layers in real time in response to emerging threats. This process is directed by our Cycurion Security Platform's (formerly Sabres') proprietary, cloud-based AI algorithm. We do not have AI processing in the production version of the software. That version is in the testing and evaluation phase. Crucially, the AI underpinning the MDP platform is constantly evolving to counter new threats. Through a crowdsourcing process, the cloud-based MDP learns from every threat to any protected application and uses that newly acquired knowledge to protect all MDP clients better.

Our Cycurion Security Platform's (formerly Sabres') line of products provides solutions for substantially all web application security needs. These products provide solutions, whether a client is in need of a web application firewall to comply with regulations and ensure it has a first line of defense against the hazards that the internet can present or is in need of enterprise-level products that empower Security Operations Center ("SOC") teams and security management. Our Cycurion Security Platform's constantly survey a client's data to detect security issues in need of attention, send automatic updates, and provide the client with a complete database of rules and threats.

We have integrated the technology assets that we acquired from Sabres (which now constitutes our Cycurion Security Platform) into our Managed Security Services Practice. We believe that the platform will enhance our service offerings and assist with the expansion of our commercial business. Our dedicated support team will manage the Sabres platform, provide real time reporting, response to security incidents, and will manage all data privacy needs from a single SIEM SaaS platform dashboard.

------

**<u>[Table of Content](#i20cde463f9bc41bd8d781febc1d65735_7)[s](#i20cde463f9bc41bd8d781febc1d65735_7)</u>**

**Financial Overview**

A number of factors have contributed to our third quarter of 2025 results of operations, the most significant of which are described below. More details on these changes are presented below within our "Results of Operations" section.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The execution of the SLG Innovation Inc. transaction.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The completion of the business combination with Western Acquisition Ventures Corp.

**Results of Operations**

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Table MD&A 1: Consolidated Results of Operations** | **Table MD&A 1: Consolidated Results of Operations** | **Table MD&A 1: Consolidated Results of Operations** | **Table MD&A 1: Consolidated Results of Operations** | **Table MD&A 1: Consolidated Results of Operations** |
|  | For the Three Months Ended | For the Three Months Ended | For the Nine Months Ended | For the Nine Months Ended |
|  | September 30, 2025 | September 30, 2024 | September 30, 2025 | September 30, 2024 |
| Net revenues | $3833038 | $4450447 | $11591003 | $13694614 |
| Cost of revenues | 3562559 | 3732431 | 10406824 | 11605722 |
| &nbsp;&nbsp;Gross profit | 270479 | 718016 | 1184179 | 2088892 |
| &nbsp;&nbsp;Gross profit percentage | 7.1% | 16.1% | 10.2% | 15.3% |
| Operating expenses: |  |  |  |  |
| &nbsp;&nbsp;Selling, general and administrative expenses | 2719600 | 299233 | 5244323 | 963000 |
| &nbsp;&nbsp;Stock compensation expenses | 2082000 |  | 3094443 | 10000 |
| &nbsp;&nbsp;Business combination expenses |  |  | 11240114 |  |
| &nbsp;&nbsp;Total operating expenses | 4801600 | 299233 | 19578880 | 973000 |
| Operating (loss)/income | (4531121) | 418783 | (18394701) | 1115892 |
| &nbsp;&nbsp;Interest income | 1770 |  | 1770 | 20211 |
| &nbsp;&nbsp;Interest expense | (712374) | (319666) | (1506657) | (1033496) |
| &nbsp;&nbsp;Gain on debt settlement, net | 2016469 |  | 1250139 |  |
| &nbsp;&nbsp;Other (expense)/income | (14761) | 16976 | (129468) | 7105 |
| Other expense/(income), net | 1291104 | (302690) | (384216) | (1006180) |
| &nbsp;&nbsp;(Loss)/income before income taxes | (3240017) | 116093 | (18778917) | 109712 |
| Provision for income tax |  |  |  |  |
| &nbsp;&nbsp;Net (loss)/income | (3240017) | 116093 | (18778917) | 109712 |
| Less: Net loss attributable to non-controlling interest | 116700 |  | 218359 |  |
| &nbsp;&nbsp;Net (loss)/income attributable to Cycurion | $(3123317) | $116093 | $(18560558) | $109712 |

---

*<u>Revenue</u>*

Revenues for the three months ended September 30, 2025 decreased $0.6 million or 13.9% compared to the three months ended September 30, 2024. For the nine months ended September 30, 2025, revenues decreased by $2.1 million or 15.4% compared to same period in 2024.

We attribute this decrease in the revenues in 2025 compared to 2024 to delayed start dates of new federal, state and local contracts and the company's focus on more profitable business.

*<u>Cost of Revenue</u>*

The cost of revenue for the three and nine months ended September 30, 2025, was approximately $3.6 million and $10.4 million, respectively, compared to $3.7 million and $11.6 million for the same periods in 2024, respectively. The cost of revenue is driven by the costs incurred while delivering services to our customers.

------

**<u>[Table of Content](#i20cde463f9bc41bd8d781febc1d65735_7)[s](#i20cde463f9bc41bd8d781febc1d65735_7)</u>**

*<u>Selling, general and administrative ("SG&A") expenses</u>*

Our selling, general and administrative ("SG&A") expenses increased in 2025 compared to 2024 due to additional expenses being recognized in 2025 due to increased costs associated with being a publicly traded company and the addition key individuals for the company's growth strategy.

*<u>Stock compensation expenses</u>*

Stock compensation expenses increased in 2025 compared to 2024 as a result of new compensation agreements with executives.

*<u>Business combination expenses</u>*

Business combination expenses in 2025 are a result of the business combination with Western in Q1 2025.

*<u>Interest income</u>*

Interest income for both the three and nine months ended September 30, 2025 was $1,770, compared to $0 and $20,211 for the three and nine months ended September 30, 2024. The change in interest income is a result of the balance of the underlying interesting earning assets.

*<u>Interest expense</u>*

Interest expense for the three and nine months ended September 30, 2025 was $0.7 million and $1.5 million, respectively, compared to $0.3 million and $1.0 million for the three and nine months ended September 30, 2024. The change in interest expense is a result of a the underlying debt instruments. For further information refer to debt footnotes.

**Liquidity and Capital Resources**

Our primary sources of liquidity are cash on hand, cash from operations, borrowings under our debt financing arrangements and equity raises through our equity line. As of September 30, 2025, we had $3.7 million in cash and cash equivalents. We believe that our current cash position, access to the capital markets and cash flow generated from operations should be sufficient for our operating requirements through the next several fiscal years.

***Cash Flow***

---

| | | |
|:---|:---|:---|
| **Table MD&A 2: Net Changes in Cash and Cash Equivalents** | **Table MD&A 2: Net Changes in Cash and Cash Equivalents** | **Table MD&A 2: Net Changes in Cash and Cash Equivalents** |
|  | For the Nine Months Ended | For the Nine Months Ended |
|  | September 30, 2025 | September 30, 2024 |
| Net cash used in operating activities | $(8771919) | $(1165585) |
| Net cash provided by/(used in) investing activities | 1601523 | (697001) |
| Net cash provided by financing activities | 10781680 | 1330421 |
| &nbsp;&nbsp;Net increase/(decrease) in cash and cash equivalents | $3611284 | $(532165) |

---

*<u>Net Cash Used In Operating Activities</u>*

For the nine months ended September 30, 2025, net cash used by operating activities was $8.8 million, compared to $1.2 million for the nine months ended September 30, 2024. The main driver of this increase is the additional merger expenses incurred in 2025.

*<u>Net Cash Provided By/(Used In) Investing Activities</u>*

For the nine months ended September 30, 2025, net cash provided in investing activities was approximately $1.6 million, compared to a $0.7 million use of cash for the nine months ended September 30, 2024. The cash inflow in 2025 was a result of the Trust Account for redemption and cash released from the Trust Account to the Company.

------

**<u>[Table of Content](#i20cde463f9bc41bd8d781febc1d65735_7)[s](#i20cde463f9bc41bd8d781febc1d65735_7)</u>**

*<u>Net Cash Provided by Financing Activities</u>*

For the nine months ended September 30, 2025, net cash provided by financing activities was $10.8 million. The net cash provided includes $5.9 million in proceeds from the equity line of credit, $3.7 million proceeds provided from the exercise of warrants, $2.4 million in proceeds from convertible notes payable, $0.5 million in proceeds provided from notes payable, partially offset by a cash outflow of $1.0 million cash used in redemption of common stock.

For the nine months ended September 30, 2024, net cash provided by financing activities was $1.3 million. The Company received $1.0 million from a private placement.

***Going Concern***

We have incurred operating losses since inception through the period ended September 30, 2025, having had negative cash flow from operations. As of September 30, 2025, we had an accumulated deficit of approximately $21.8 million, as compared to our accumulated deficit of approximately $3.2 million as of December 31, 2024. The increase of our accumulated deficit was a result of our net losses for the nine months ended September 30, 2025.

Furthermore, we expect continued, significant operating losses for the next few years. We also utilized cash in operations of approximately $8.8 million in the nine months ended September 30, 2025. As of September 30, 2025, we had unrestricted cash of approximately $3.7 million, an increase of $3.6 million from approximately $38,742 as of December 31, 2024. As of September 30, 2025, our total assets increased to approximately $32.3 million from approximately $25.6 million as of December 31, 2024, primarily due to increases in goodwill. Based on our current capital resources as of September 30, 2025, including our unrestricted cash and accounts receivable, net of $6.7 million, we expect to be able to continue our operations for a minimum of 12 months as of the date of this quarterly report. Nevertheless, our continuation as a going concern is dependent on our ability to obtain additional financing until we can generate sufficient, consistent cash flow from operations to meet the expected growth in our obligations. We intend to continue to seek additional debt or equity financing to continue our operations.

Our consolidated financial statements have been prepared on a going concern basis, which implies we may not continue to meet our obligations and continue our operations for the next fiscal year. The continuation of our Company as a going concern is dependent upon our ability to obtain necessary debt or equity financing to continue operations until we begin generating positive cash flow.

There is no assurance that we will ever be consistently profitable or, notwithstanding our recent financing activities, that debt or equity financing will be available to us in the amounts, on terms, and at times deemed acceptable to us, if at all. The issuance of additional equity securities by us would result in a significant dilution in the equity interests of our current stockholders. Obtaining commercial loans, assuming those loans would be available, would increase our liabilities and future cash commitments. If we are unable to obtain financing in the amounts and on terms deemed acceptable to us, we may be unable to continue our business, as planned, and as a result may be required to scale back or cease operations for our business, the result of which would be that our stockholders would lose some or all of their investment. The consolidated financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classifications of liabilities that may result should we be unable to continue as a going concern.

***Off-balance sheet arrangements***

We did not have any off-balance sheet arrangements during the periods presented, and we do not currently have any off-balance sheet arrangements, as defined in the SEC rules and regulations.

**Critical Accounting Policies and Estimates**

The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires us to make estimates, judgments, and assumptions that affect the amounts reported. Actual results could differ from those estimates. The 2024 Form 10-K, as filed with the SEC on April 17, 2025, includes a summary of critical accounting policies we believe are the most important to aid in understanding our financial results. There have been no changes to those critical accounting policies that have had a material impact on our reported amounts of assets, liabilities, revenues, or expenses during the nine months ended September 30, 2025.

------

**<u>[Table of Content](#i20cde463f9bc41bd8d781febc1d65735_7)[s](#i20cde463f9bc41bd8d781febc1d65735_7)</u>**

**Item 3. Quantitative and Qualitative Disclosures about Market Risk**

As a "smaller reporting company," as that term is defined in Rule 229.10(f)(1), we are not required to provide the information required by this Item.

**Item 4. Controls and Procedures**

<u>Management's Evaluation of Disclosure Controls and Procedures.</u> 

Cycurion maintains disclosure controls and procedures designed to ensure that information required to be disclosed in its periodic filings under the Securities Exchange Act of 1934 ("Exchange Act"), including this Quarterly Report on Form 10-Q, is recorded, processed, summarized, and reported on a timely basis. These disclosure controls and procedures include controls and procedures designed to ensure that information required to be disclosed under the Exchange Act is accumulated and communicated to Cycurion's management on a timely basis to allow decisions about required disclosure. Management, including Cycurion's Chief Executive Officer and Chief Financial Officer, has evaluated the effectiveness of the design and operation of Cycurion's disclosure controls and procedures (as defined under Rules 13a-15(e) and 15d-15(e) of the Exchange Act) as of September 30, 2025.

Cycurion carried out the evaluation of the effectiveness of its disclosure controls and procedures, required by paragraph (b) of Exchange Act Rules 13a-15 and 15d-15, under the supervision and with the participation of management, including the Chief Executive Officer and Chief Financial Officer. Based upon this evaluation, the Chief Executive Officer and Chief Financial Officer concluded that Cycurion's disclosure controls and procedures were effective as of September 30, 2025.

<u>Changes in Internal Control Over Financial Reporting.</u> 

There were no changes in Cycurion's internal control over financial reporting during the quarter ended September 30, 2025 that have materially affected, or are reasonably likely to materially affect, Cycurion's internal control over financial reporting.

------

**<u>[Table of Content](#i20cde463f9bc41bd8d781febc1d65735_7)[s](#i20cde463f9bc41bd8d781febc1d65735_7)</u>**

**PART II - OTHER INFORMATION**

**Item 1. Legal Proceedings**

On July 29, 2024, Object3, LLC initiated an arbitration proceeding with the American Arbitration Association, styled *Object3, LLC, Claimant, v. Cloudburst Security, LLC, Respondent,* Case No. 01-24-0006-9906. The claimant made claims against Cloudburst for unpaid consulting services and associated costs, fees, and interest for the prior 12-month period in the aggregate amount of approximately $228,000. Defendant Cloudburst (a wholly-owned subsidiary) denies that it owes such amount to Claimant. As of the date of this Quarterly Report on Form 10-Q, the arbitration proceeding has been settled.

We know of no other material pending legal proceedings to which we or any of our subsidiaries are a party or to which any of our assets or properties, or the assets or properties of any of our subsidiaries, are subject and, to the best of our knowledge, no adverse legal activity is anticipated or threatened. In addition, we do not know of any such proceedings contemplated by any governmental authorities.

We know of no material proceedings in which any of our directors, officers, or affiliates, or any registered or beneficial stockholder is a party adverse to us or any of our subsidiaries or has a material interest adverse to us or any of our subsidiaries.

**Item 1A. Risk Factors** 

In connection with information set forth in this Form 10-Q, the factors discussed below and under "Risk Factors" in our Form 10-K for fiscal year ended December 31, 2024, should be considered. The risks included below and in the Form 10-K could materially and adversely affect our business, financial condition and results of operations.

Other than as set forth below, there have been no material changes to the factors discussed in our Annual Report on Form 10-K for the year ended December 31, 2024, which was filed with the Securities and Exchange Commission on April 17, 2025.

***Our business could be adversely affected by legislative or government budgetary and spending changes.***

The market for our services depends largely on domestic and international legislative programs and the budgetary capability to support programs, including the continuance of existing programs. Many of our contracts are not fully funded at inception and rely upon future appropriations of funds. Accordingly, a failure to receive additional anticipated funding may result in early termination of a contract. In addition, many of our contracts include clauses that allow clients to unilaterally modify or terminate contracts with little or no recompense. Decreases in funding for, or delays in contract awards and in government spending on the types of programs that we support, and terminations or price reductions on government contracts on which we are currently performing could adversely affect our future revenues and profitability.

Changes in state or federal government initiatives or in the level of government spending due to budgetary or deficit considerations may have a significant impact on our future financial performance. In recent quarters, the U.S. Federal Government has placed a significant focus on efficiency, including with respect to contracting with private companies. These efforts have and may continue to have effects on our business, including, but not limited to:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Changes in priorities may result in procurement changes, delays or cancellations, as well as changes in scope, pricing, or outright cancellations of existing contracts.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Changes in priorities may also affect the level of demand or funding for our state programs in the United States, which are typically mandated and fully or partially funded from the U.S. Federal Government.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Changes to procurement rules may result in additional competition, scrutiny and costs of compliance.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Changes in federal regulations, such as those related to the elimination of diversity, equity and inclusion initiatives, or return to office mandates may require us to change our existing business practices, may be disruptive to our business, may create a level of uncertainty within our workforce and may conflict with local laws and regulations.

------

**<u>[Table of Content](#i20cde463f9bc41bd8d781febc1d65735_7)[s](#i20cde463f9bc41bd8d781febc1d65735_7)</u>**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The U.S. Government may seek to lower barriers to entry to allow greater involvement by the private sector. While this may provide additional opportunities for us, it may also expose us to greater levels of competition.

***If we fail to comply with the continued minimum closing bid requirements of the Nasdaq Global Market or other requirements for continued listing, our common stock may be delisted and the price of our common stock and our ability to access the capital markets could be negatively impacted.***

Our shares of common stock are listed for trading on the Nasdaq Global Market. We must satisfy Nasdaq continued listing requirements, including, among other things, a minimum closing bid price requirement of $1.00 per share for 30 consecutive business days. If a company's common stock trades for 30 consecutive business days below the $1.00 minimum closing bid price requirement, Nasdaq will send a deficiency notice to us, advising that it has been afforded a "compliance period" of 180 calendar days to regain compliance with the applicable requirements. Thereafter, if such a company does not regain compliance with the bid price requirement, a second 180-day compliance period may be available.

On October 14, 2025, we received written notice from the Nasdaq Staff that it has determined to commence proceedings to delist our common stock from the Nasdaq Global Market. As previously announced in a Current Report filed with the SEC, on April 15, 2025, the Staff notified the Company on April 9, 2025 that, for the prior 30 consecutive business days, the closing bid price of our common stock had been below the minimum of $1.00 per share required for continued listing on The Nasdaq Global Market under Nasdaq Listing Rule 5550(a)(2) (Bid Price Rule). The notification letter stated that we would be afforded 180 calendar days, or until October 6, 2025, to regain compliance. The Company did not regain compliance with the Bid Price Rule by October 6, 2025, and the listed security is now subject to delisting from The Nasdaq Global Market. Unless the Company requests an appeal of the Staff's determination by October 21, 2025, trading of the Company's common stock will be scheduled for delisting at the opening of business on October 23, 2025, and Nasdaq intends to file a Form 25-NSE with the SEC, removing the common stock from listing and registration on The Nasdaq Stock Market. On October 20, 2025, the Company requested a hearing to appeal the Staff's determination to the Panel pursuant to the procedures set forth in the Nasdaq Listing Rule 5800 Series. The hearing request will stay the suspension of the Company's securities and the filing of the Form 25-NSE pending the Panel's decision. The Company received written notice from Nasdaq that the hearing with the Panel is scheduled for November 20, 2025.

On October 27, 2025, we effected the one-for-thirty Reverse Stock Split at the commencement of business. The Company effected the Reverse Stock Split by filing the Second Amendment to the Second Amended and Restated Certificate of Incorporation with the Secretary of State of the State of Delaware on October 24, 2025. The Company's shares of common stock began trading on a split-adjusted basis on The Nasdaq Global Market, when the market opened today, October 27, 2025, under the existing trading symbol "CYCU" and new CUSIP number 95758L305. As a result of the Reverse Stock Split, every thirty of the Company's issued shares of common stock was combined into one issued share of common stock, without any change to the par value per share and without any change in the total number of authorized shares of common stock. The number of outstanding shares of common stock was reduced from approximately 86,533,435 shares to approximately 2,884,447 shares. No fractional shares were issued in connection with the Reverse Stock Split. Stockholders who otherwise held a fraction of a share of common stock of the Company will receive a cash payment (without interest and subject to withholding taxes, as applicable) in lieu thereof at a price equal to that fraction of a share to which the stockholder would otherwise be entitled, multiplied by the closing price of the Company's shares on The Nasdaq Global Market on the trading day immediately preceding the effective date of the Reverse Stock Split.

Despite the implementation of the Reverse Stock Split, and the regained compliance with the Bid Price Rule, there is a risk that our shares of common stock may trade below $1.00 in the future and we could be delisted from Nasdaq, which would adversely impact liquidity of our shares of common stock, potentially result in even lower bid prices for our shares of common stock, and make it more difficult for us to obtain financing through the sale of our shares of common stock.

***The Reverse Stock Split may decrease the liquidity of the shares of our common stock.***

We effected the Reverse Stock Split on October 27, 2025. As a result of the Reverse Stock Split, every thirty of the Company's issued shares of common stock was combined into one issued share of common stock, without any change to the par value per share and without any change in the total number of authorized shares of common stock. The liquidity of the shares of our common stock may be affected adversely by the Reverse Stock Split given the reduced number of shares that will be outstanding following the Reverse Stock Split. In addition, the Reverse Stock Split may increase the number of stockholders who own odd lots (less than 100 shares) of our common stock, creating the potential for such stockholders to experience an increase in the cost of selling their shares and greater difficulty affecting such sales.

------

**<u>[Table of Content](#i20cde463f9bc41bd8d781febc1d65735_7)[s](#i20cde463f9bc41bd8d781febc1d65735_7)</u>**

***The Reverse Stock Split may not increase the price of our shares of our common stock over the long-term and our common stock may be delisted.***

The principal purpose of the Reverse Stock Split was to increase the trading price of our shares of common stock to meet the minimum stock price standards of the Nasdaq Bid Price Rule. However, the effect of a reverse stock split on the market price of our shares of common stock cannot be predicted with any certainty, and we cannot assure you that the Reverse Stock Split will accomplish this objective for any meaningful period of time, or at all. While the reduction in the number of outstanding shares of common stock will proportionally increase the market price of our common stock, we cannot assure you that the Reverse Stock Split will result in any permanent or sustained increase in the market price of our shares of common stock sufficient to regain compliance with the conditions required by the Panel. The market price of our shares of common stock may be affected by other factors which may be unrelated to the number of shares outstanding, including our business and financial performance, general market conditions and prospects for future success.

***Following the Reverse Stock Split, the resulting market price of our common stock may not attract new investors, including institutional investors, and may not satisfy the investing requirements of those investors. Consequently, the trading liquidity of our common stock may not improve.***

Although we believe that a higher market price of our common stock may help generate greater or broader investor interest, there can be no assurance that the Reverse Stock Split will result in a share price that will attract new investors, including institutional investors. In addition, there can be no assurance that the market price of our common stock will satisfy the investing requirements of those investors. As a result, the trading liquidity of our common stock may not necessarily improve.

**Item 2. Unregistered Sales of Equity Securities and Use of Proceeds**

(a)There were no unregistered sales of equity securities for the nine months ended September 30, 2025.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a.On February 14, 2025, we entered into a pre-funded warrant ("Seward & Kissel Pre-Funded Warrant") with Seward & Kissel LLP ("Seward & Kissel") for up to 83,333 shares of common stock issuable to Seward & Kissel upon excise of the Seward & Kissel Pre-Funded Warrant. We chose to issue the Seward & Kissel Pre-Funded Warrant in consideration for Seward & Kissel's outstanding legal fees and expenses of approximately $1.3 million.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b.On April 7, 2025, we entered into a pre-funded warrant ("Yield Point Pre-Funded Warrant") with Yield Point NY LLC (the "Yield Point") for up to 150,000 shares of common stock issuable to Yield Point upon exercise of the Yield Point Pre-Funded Warrant. We chose to issue the Yield Point Pre-Funded Warrant in consideration for the Investor's execution and delivery of the Equity Purchase Agreement, dated April 7, 2025, between us and Yield Point in lieu of paying the Investor $1,800,000 in cash.

(b)None.

(c)None.

**Item 3. Defaults Upon Senior Securities**

(a)None.

(b)None.

**Item 4. Mine Safety Disclosures**

Not applicable.

**Item 5. Other Information**

(a)None.

(b)None.

------

**<u>[Table of Content](#i20cde463f9bc41bd8d781febc1d65735_7)[s](#i20cde463f9bc41bd8d781febc1d65735_7)</u>**

(c)During the three months ended September 30, 2025, no director or officer of the Company adopted, modified, or terminated a "Rule 10b5-1 trading arrangement" or "non-Rule 10b5-1 trading arrangement," as each term is defined in Item 408(a) of Regulation S-K.

**Item 6. Exhibits**

---

| | |
|:---|:---|
| **Exhibit<br>No.** | **Description of Exhibit** |
| 31.1 | <u>[Certification of Chief Executive Officer pursuant to Section 302 of Sarbanes-Oxley Act of 2002](cycu-20250930xexx311.htm)</u> |
| 31.2 | <u>[Certification of Chief Financial Officer pursuant to Section 302 of Sarbanes-Oxley Act of 2002](cycu-20250930xexx312.htm)</u> |
| 32.1 | ¥<u>[Certification of Chief Executive Officer and Chief Financial Officer pursuant to Section 906 of Sarbanes-Oxley Act of 2002](cycu-20250930xexx321.htm)</u> |
| 101.INS | Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document |
| 101.SCH | Inline XBRL Taxonomy Extension Schema |
| 101.CAL | Inline XBRL Taxonomy Extension Calculation |
| 101.DEF | Inline XBRL Taxonomy Extension Definition |
| 101.LAB | Inline XBRL Taxonomy Extension Label |
| 101.PRE | Inline XBRL Taxonomy Extension Presentation |
| 104 | Cover Page Inline Interactive Data File - the cover page interactive data files does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document included as Exhibit 101 |
|  | Filed herewith. |
|  | ¥Furnished herewith. |

---

------

**<u>[Table of Content](#i20cde463f9bc41bd8d781febc1d65735_7)[s](#i20cde463f9bc41bd8d781febc1d65735_7)</u>**

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

---

| | | |
|:---|:---|:---|
| **Cycurion Inc.** | **Cycurion Inc.** | |
| By: | */s/ L. Kevin Kelly* | November 14, 2025 |
|  | L. Kevin Kelly |  |
|  | Chief Executive Officer |  |
|  | (Principal Executive Officer) |  |
|  | */s/ Alvin McCoy III* | November 14, 2025 |
| By: | Alvin McCoy III |  |
|  | Chief Financial Officer |  |
|  | (Principal Financial Officer and Principal Accounting Officer) |  |

---

## Exhibit 31.1

**Exhibit 31.1**

**Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002**

I, L. Kevin Kelly, certify that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.I have reviewed this quarterly report on Form 10-Q of Cycurion, Inc.;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c)Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d)Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and to the audit committee of registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

---

| | | |
|:---|:---|:---|
| By: | */s/ L. Kevin Kelly* | November 14, 2025 |
|  | L. Kevin Kelly |  |
|  | Chief Executive Officer |  |
|  | (Principal Executive Officer) |  |

---

## Exhibit 31.2

**Exhibit 31.2**

**Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002**

I, Alvin McCoy III, certify that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.I have reviewed this quarterly report on Form 10-Q of Cycurion, Inc.;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c)Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d)Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and to the audit committee of registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

---

| | | |
|:---|:---|:---|
| By: | */s/ Alvin McCoy III* | November 14, 2025 |
|  | Alvin McCoy III |  |
|  | Chief Financial Officer |  |
|  | (Principal Financial Officer) |  |

---

## Exhibit 32.1

**Exhibit 32.1**

**Certification Pursuant to 18 U.S.C Section 1350, As Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002**

In connection with the Quarterly Report of Cycurion, Inc. (the "Company") on Form 10-Q for the quarterly period ended September 30, 2025 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), the undersigned, L. Kevin Kelly, Chief Executive Officer of the Company, and Alvin McCoy III, Chief Financial Officer of the Company, each certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 that to his knowledge:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

---

| | | |
|:---|:---|:---|
| By: | */s/ L. Kevin Kelly* | November 14, 2025 |
|  | L. Kevin Kelly |  |
|  | Chief Executive Officer |  |
|  | (Principal Executive Officer) |  |
| By: | */s/ Alvin McCoy III* | November 14, 2025 |
|  | Alvin McCoy III |  |
|  | Chief Financial Officer |  |
|  | (Principal Financial Officer) |  |

---

<br>